STOCK TITAN

Texas Ventures III signs PlusAI deal at $800M valuation

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Texas Ventures Acquisition III Corp (TVA) signed a merger agreement with PlusAI on September 2, 2026, setting PlusAI’s pre-money equity value at $800 million. TVA would domesticate as a Delaware corporation before the two-step merger. Closing remains subject to approvals, an effective registration statement and other conditions, including a $40 million minimum available-cash condition, subject to waiver.

On October 19, 2026, shareholders extended the business-combination deadline monthly through July 24, 2027; each extension requires a $145,000 Trust Account deposit. The first payment, deposited October 21, extended the deadline to November 24. Shareholders redeemed 17,699,488 Class A shares (about 78.66%) for approximately $188,177,658, leaving 4,800,512 outstanding.

TVA reported third-quarter net income of $548,953, versus a $1,200,656 loss in 2025; nine-month net income declined to $1,430,066 from $1,698,895. PIPE and convertible-note commitments were approximately $4 million and $57.5 million, respectively; no securities had been issued and no proceeds received under them as of the report.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Minor pointThird-quarter net income moved to $548,953 from a $1,200,656 loss in 2025.

Negative

  • Major pointShareholders redeemed 17,699,488 Class A shares, withdrawing approximately $188,177,658 from the Trust Account. 59% of market cap
  • Minor pointNine-month net income declined to $1,430,066 from $1,698,895 in 2025.
  • Minor pointNine-month operating cash use rose to $679,519 from $417,643 in 2025.

Filing Explained

The sponsor’s amended note allows conversion of up to $750,000 into 75,000 post-merger units, but share and warrant issuance depends on its election at closing.

The sponsor’s amended note allows conversion of up to $750,000 into 75,000 post-merger units, but share and warrant issuance depends on its election at closing.

The report says the sponsor’s September 30 working-capital note for $250,000 was replaced on November 8 by an amended note with principal of up to $750,000, after the sponsor agreed to lend up to $500,000 more. At a business-combination closing, the sponsor may convert all or part of the principal into units at $10 each, capped at 75,000 units; the note itself is not an issuance of those units. Each unit contains the same securities as an IPO unit—one share and half a warrant—so conversion would add shares and reduce existing holders’ percentage ownership absent offsetting changes.

At September 30, TVA reported $176,612 in cash, $238,741,967 in trust investments, and $4,350,016 in current liabilities; these figures predate the later extension and redemptions.

Third-quarter net income $548,953 Three months ended September 30, 2026; compared with a net loss of $1,200,656 in 2025.
Nine-month net income $1,430,066 Nine months ended September 30, 2026; compared with $1,698,895 in 2025.
Net cash used in operating activities $679,519 Nine months ended September 30, 2026; compared with $417,643 used in 2025.
PlusAI pre-money equity value $800,000,000 Basis for consideration payable to PlusAI stockholders under the Merger Agreement.
Minimum available-cash condition At least $40,000,000 Closing condition after redemptions, subject to waiver under the Merger Agreement.
PIPE Investment commitment Approximately $4.0 million Committed to close substantially concurrently with the Closing; no securities issued or proceeds received as of the report.
Convertible Note Investment commitment Approximately $57.5 million Committed to close substantially concurrently with the Closing; no securities issued or proceeds received as of the report.
Class A shares redeemed 17,699,488 shares; approximately $188,177,658 Shareholder meeting on October 19, 2026; approximately 78.66% of the IPO Class A shares.
pre-money equity value financial
"based on a pre-money equity value of PlusAI of $800,000,000"
The pre-money equity value is the total worth assigned to a company’s outstanding shares immediately before new investment is added; it represents the company’s equity “slice” before the new money changes the pie. Investors use it to calculate how much of the company they will own after a financing round and to judge whether the price per share is fair, similar to agreeing on the size of a pie before cutting it into new portions.
minimum available cash condition financial
"a minimum available cash condition of $40,000,000"
PIPE Investment financial
"the PIPE Investment of approximately $4.0 million"
A pipe investment is a private sale of stock or convertible securities made directly to selected investors by a company that is already publicly traded, allowing the company to raise cash quickly without a full public offering. It matters to investors because it can dilute existing share value and change ownership stakes, but also signals that the company secured financing; like a homeowner taking a quick private loan to cover a repair, it can be a sign of needed funds or investor confidence.
Convertible Note Investment financial
"the Convertible Note Investment of approximately $57,500,000"
Domestication regulatory
"the Company will transfer by way of continuation out of the Cayman Islands and domesticate"
Domestication is the legal process by which a company changes its official ‘legal home’ from one place to another without creating a new business entity, similar to moving a household’s registration from one city to another while keeping the same people and possessions. It matters to investors because it can alter which laws, tax rules, reporting standards and shareholder rights apply, potentially affecting costs, governance and the value or liquidity of the company’s shares.
Extension Payment financial
"each such deposit, an “Extension Payment”"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What valuation does the TVA-PlusAI merger use?

The Merger Agreement bases consideration payable to PlusAI stockholders on an $800 million pre-money equity value. The agreement sets an exchange ratio that determines the shares issued to PlusAI stockholders.

How many TVA shares did shareholders redeem?

At the October 19, 2026 meeting, shareholders redeemed 17,699,488 Class A ordinary shares, approximately 78.66% of the 22,500,000 IPO shares. The redemptions totaled approximately $188,177,658 at approximately $10.63 per share, leaving 4,800,512 Class A shares outstanding.

What is the minimum cash condition for the TVA-PlusAI merger?

The Merger Agreement sets at least $40,000,000 in available cash as a closing condition, subject to waiver. It counts Trust Account cash after redemptions plus gross PIPE and Convertible Note Investment proceeds, before transaction expenses.

What approvals and regulatory steps are required to close the TVA-PlusAI merger?

Closing requires approval by TVA shareholders and PlusAI stockholders, effectiveness of the Form S-4 registration statement, and expiration or termination of the Hart-Scott-Rodino waiting period. The post-merger Class A common stock must also be listed on Nasdaq or another mutually agreed stock exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
http://fasb.org/us-gaap/2026#RelatedPartyMember0002033991--12-31Q3http://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMemberhttp://fasb.org/us-gaap/2026#RelatedPartyMember0.5http://fasb.org/us-gaap/2026#RelatedPartyMemberP1Dfalse0002033991us-gaap:MeasurementInputSharePriceMember2025-12-310002033991us-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310002033991us-gaap:MeasurementInputOptionVolatilityMember2025-12-310002033991us-gaap:MeasurementInputExpectedTermMember2025-12-310002033991us-gaap:MeasurementInputExpectedDividendRateMember2025-12-310002033991us-gaap:MeasurementInputComparabilityAdjustmentMember2025-12-310002033991us-gaap:MeasurementInputSharePriceMember2025-04-240002033991us-gaap:MeasurementInputRiskFreeInterestRateMember2025-04-240002033991us-gaap:MeasurementInputOptionVolatilityMember2025-04-240002033991us-gaap:MeasurementInputExpectedTermMember2025-04-240002033991us-gaap:MeasurementInputExpectedDividendRateMember2025-04-240002033991us-gaap:MeasurementInputComparabilityAdjustmentMember2025-04-240002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMemberus-gaap:SubsequentEventMember2026-10-180002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMemberus-gaap:SubsequentEventMember2026-10-190002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-06-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-03-310002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2025-12-310002033991tva:FounderShares1Member2025-04-242025-04-240002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-04-012025-06-300002033991tva:FounderShares1Membertva:SponsorMember2026-01-012026-09-300002033991tva:FounderShares1Member2024-08-012024-08-010002033991us-gaap:RetainedEarningsMember2026-09-300002033991us-gaap:RetainedEarningsMember2026-06-3000020339912026-06-300002033991us-gaap:RetainedEarningsMember2026-03-3100020339912026-03-310002033991us-gaap:RetainedEarningsMember2025-12-310002033991us-gaap:AdditionalPaidInCapitalMember2025-12-310002033991us-gaap:RetainedEarningsMember2025-09-300002033991us-gaap:RetainedEarningsMember2025-06-3000020339912025-06-300002033991us-gaap:RetainedEarningsMember2025-03-310002033991us-gaap:AdditionalPaidInCapitalMember2025-03-3100020339912025-03-310002033991us-gaap:RetainedEarningsMember2024-12-310002033991us-gaap:AdditionalPaidInCapitalMember2024-12-310002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-09-300002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-06-300002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-03-310002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-12-310002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-09-300002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-06-300002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-03-310002033991us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-12-3100020339912025-04-240002033991us-gaap:WarrantMemberus-gaap:CommonClassAMember2026-09-300002033991tva:PublicSharesMember2026-09-300002033991tva:NonConvertiblePromissoryNotesMembertva:NewSponsorMember2026-10-202026-10-200002033991us-gaap:WarrantMember2026-01-012026-09-300002033991tva:PrivatePlacementWarrantsMember2026-01-012026-09-300002033991us-gaap:IPOMember2025-04-242025-04-240002033991us-gaap:RetainedEarningsMember2025-01-012025-03-3100020339912025-01-012025-03-310002033991tva:SingleReportableSegmentMember2026-07-012026-09-300002033991tva:SingleReportableSegmentMember2026-01-012026-09-300002033991tva:SingleReportableSegmentMember2025-07-012025-09-300002033991tva:SingleReportableSegmentMember2025-01-012025-09-3000020339912025-01-012025-12-310002033991us-gaap:CommonClassBMember2026-07-012026-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-01-012026-09-300002033991us-gaap:CommonClassBMember2025-07-012025-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2025-07-012025-09-300002033991us-gaap:CommonClassBMember2025-01-012025-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2025-01-012025-09-300002033991tva:SponsorAffiliateMember2026-09-300002033991tva:SponsorAffiliateMember2025-12-310002033991tva:PromissoryNotesMember2024-08-012024-08-010002033991srt:MaximumMembertva:AmendedAndRestatedWorkingCapitalNotesMembertva:NewSponsorMemberus-gaap:SubsequentEventMember2026-11-080002033991tva:NonConvertiblePromissoryNotesMembertva:NewSponsorMember2026-10-200002033991tva:ConvertibleNoteMember2026-09-020002033991tva:WorkingCapitalNotesMembertva:NewSponsorMember2026-09-300002033991us-gaap:CommonClassBMember2026-01-012026-09-300002033991us-gaap:CommonClassBMember2026-09-300002033991us-gaap:CommonClassBMember2025-12-310002033991us-gaap:CommonClassAMember2025-12-310002033991tva:FounderShares1Membertva:SponsorMember2025-04-240002033991us-gaap:IPOMember2026-09-300002033991tva:NMSIPrivatePlacementWarrantsMember2026-09-300002033991us-gaap:IPOMember2025-12-310002033991tva:PublicWarrantsMember2025-12-310002033991tva:PrivatePlacementWarrantsMember2025-12-310002033991tva:NMSIPrivatePlacementWarrantsMember2025-12-310002033991tva:PrivatePlacementWarrantsMembertva:SponsorMember2026-09-300002033991tva:PrivatePlacementWarrantsMembertva:JVBFinancialGroupLLCAndClearStreetLLCMember2026-09-3000020339912026-09-020002033991tva:PublicWarrantsMemberus-gaap:CommonClassAMember2026-09-300002033991us-gaap:WarrantMember2026-09-300002033991us-gaap:CommonClassAMember2026-09-300002033991tva:PublicWarrantsMember2026-09-300002033991us-gaap:CommonClassAMember2025-04-2400020339912025-09-3000020339912024-12-310002033991srt:MinimumMember2025-09-180002033991us-gaap:FairValueInputsLevel1Member2026-09-300002033991tva:SingleReportableSegmentMember2026-09-300002033991us-gaap:FairValueInputsLevel1Member2025-12-310002033991tva:SingleReportableSegmentMember2025-12-3100020339912026-09-022026-09-020002033991us-gaap:OverAllotmentOptionMember2026-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-07-012026-09-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-04-012026-06-300002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2026-01-012026-03-310002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMember2025-01-012025-12-310002033991tva:ClassAordinarySharesSubjectToPossibleRedemptionMemberus-gaap:SubsequentEventMember2026-10-192026-10-190002033991us-gaap:IPOMember2025-04-240002033991tva:PipeSubscriptionAgreementsMember2026-09-020002033991us-gaap:RetainedEarningsMember2026-07-012026-09-300002033991us-gaap:RetainedEarningsMember2026-04-012026-06-3000020339912026-04-012026-06-300002033991us-gaap:RetainedEarningsMember2026-01-012026-03-310002033991us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-3100020339912026-01-012026-03-310002033991us-gaap:RetainedEarningsMember2025-07-012025-09-300002033991us-gaap:RetainedEarningsMember2025-04-012025-06-300002033991us-gaap:OverAllotmentOptionMember2025-04-240002033991tva:PrivatePlacementWarrantsMember2025-09-180002033991tva:NMSIPrivatePlacementWarrantsMember2025-09-180002033991tva:FounderShares1Memberus-gaap:CommonClassBMember2025-09-180002033991us-gaap:CommonClassBMember2025-09-180002033991us-gaap:PrivatePlacementMember2026-09-300002033991srt:MinimumMember2026-01-012026-09-300002033991srt:MaximumMember2026-01-012026-09-3000020339912025-09-182025-09-180002033991tva:NMSIPrivatePlacementWarrantsMember2026-01-012026-09-300002033991us-gaap:CommonClassAMember2025-04-242025-04-240002033991tva:RedeemablePublicWarrantMember2025-04-242025-04-2400020339912025-04-242025-04-240002033991tva:FounderShares1Membertva:SponsorMemberus-gaap:CommonClassBMember2025-04-242025-04-240002033991tva:FounderShares1Memberus-gaap:CommonClassBMember2025-04-242025-04-240002033991tva:NonManagingSponsorInvestorsMember2026-01-012026-09-300002033991us-gaap:PrivatePlacementMember2026-01-012026-09-300002033991us-gaap:SubsequentEventMember2026-10-190002033991us-gaap:SubsequentEventMember2026-10-212026-10-2100020339912026-10-212026-10-210002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2025-10-310002033991tva:FounderShares1Memberus-gaap:CommonClassBMember2025-04-240002033991tva:SponsorAffiliateMemberus-gaap:CommonClassAMember2026-08-270002033991tva:SponsorAffiliateMember2026-08-272026-08-2700020339912025-07-012025-09-3000020339912026-09-3000020339912025-12-3100020339912025-01-012025-09-300002033991tva:AmendedAndRestatedWorkingCapitalNotesMembertva:NewSponsorMemberus-gaap:SubsequentEventMember2026-11-080002033991tva:ConvertibleNoteMember2026-09-022026-09-020002033991srt:MaximumMembertva:AmendedAndRestatedWorkingCapitalNotesMembertva:NewSponsorMemberus-gaap:SubsequentEventMember2026-11-082026-11-080002033991us-gaap:CommonClassAMember2026-09-022026-09-020002033991tva:SpacClassCommonStockMember2026-09-022026-09-020002033991tva:PrivatePlacementWarrantsMember2026-09-300002033991tva:NonManagingSponsorInvestorsMember2026-09-300002033991tva:PublicWarrantsMember2025-04-240002033991tva:NMSIPrivatePlacementWarrantsMember2025-04-240002033991tva:PlusaiHoldingsIncMember2026-09-022026-09-020002033991tva:PlusaiHoldingsIncMember2026-09-020002033991us-gaap:CommonClassAMember2026-01-012026-09-300002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2026-07-012026-09-300002033991us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-3000020339912025-04-012025-06-300002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2026-09-300002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2025-12-310002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2026-01-012026-09-300002033991tva:CeoAdvisoryAgreementMembersrt:ChiefExecutiveOfficerMember2025-01-012025-12-3100020339912026-07-012026-09-300002033991tva:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember2026-01-012026-09-300002033991tva:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember2026-01-012026-09-300002033991tva:ClassAOrdinarySharesParValue00001ParValueMember2026-01-012026-09-300002033991us-gaap:CommonClassBMember2026-11-180002033991us-gaap:CommonClassAMember2026-11-1800020339912026-01-012026-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puretva:itemtva:segmenttva:Y
Table of Contents

​

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-42609

Texas Ventures Acquisition III Corp

(Exact Name of Registrant as Specified in Its Charter)

​

Cayman Islands

  ​ ​

98-1802457

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

1012 Springfield Avenue
Mountainside, New Jersey

 

07092

(Address of principal executive offices)

 

(Zip Code)

​

(201) 985-8300

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

  ​ ​

Trading Symbol(s)

  ​ ​

Name of each exchange on which registered

Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant

 

TVACU

 

The Nasdaq Stock Market LLC

Class A ordinary shares, par value $0.0001

 

TVA

 

The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

 

TVACW

 

The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

Large accelerated filer

☐

  ​ ​ ​

Accelerated filer

☐

Non-accelerated filer

☒

​

Smaller reporting company

☒

​

​

​

Emerging growth company

☒

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 18, 2026, there were 4,800,512 Class A ordinary shares, par value $0.0001 per share, and 7,500,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.

​

​

​

Table of Contents

​

TEXAS VENTURES ACQUISITION III CORP

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026

TABLE OF CONTENTS

Page

PART I - FINANCIAL INFORMATION

1

Item 1.

Unaudited Condensed Consolidated Financial Statements

1

Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025

1

​

Condensed Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

2

​

Condensed Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

3

​

Condensed Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited)

4

​

Notes to Unaudited Condensed Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

28

Item 4.

Controls and Procedures

28

PART II - OTHER INFORMATION

29

Item 1.

Legal Proceedings

29

Item 1A.

Risk Factors

29

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

89

Item 3.

Defaults upon Senior Securities

90

Item 4.

Mine Safety Disclosures

90

Item 5.

Other Information

90

Item 6.

Exhibits

91

SIGNATURES

93

​

​

i

Table of Contents

​

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

● “A&R Working Capital Note” are to the amended and restated convertible unsecured promissory note in the aggregate principal amount of up to $750,000 issued by the Company to the New Sponsor on November 8, 2026, which amends, restates, supersedes and replaces the Working Capital Note in its entirety;
●“Administrative Services Agreement” are to the Administrative Services Agreement, dated April 22, 2025, which we entered into with our Prior Sponsor (as defined below), and which was terminated effective September 18, 2025 as of the closing of the transactions provided for by the Purchase Agreement;
●“Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect;
●“ASC” are to the FASB (as defined below) Accounting Standards Codification;
●“ASU” are to the FASB Accounting Standards Update;
●“Board of Directors” or “Board” are to our board of directors;
●“Business Combination” are to a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;
●“Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;
●“Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;
●“Clear Street” means Clear Street LLC;
●“Closing” are to the closing of the Mergers;
●“Cohen & Company” means Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC;
●“Combination Period” are to the period, from the closing of the Initial Public Offering (as defined below) up to July 24, 2027 (as extended by the Extension) that we have to consummate an initial Business Combination; provided that the Combination Period may be further extended pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules;
●“Companies Act” are to the Companies Act (As Revised) of the Cayman Islands, as may be amended from time to time;
●“Company,” “our,” “we” or “us” are to Texas Ventures Acquisition III Corp, a Cayman Islands exempted company;
●“Company Voting and Support Agreements” are to the voting and support agreements, dated September 2, 2026, entered into by and among the Company, PlusAI and certain stockholders of PlusAI;
●“Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account (as defined below) and warrant agent of our Public Warrants (as defined below);
●“Convertible Notes” are to the convertible note and warrant subscription agreements, dated September 2, 2026, entered into by and among the Company, PlusAI and certain accredited investors and qualified institutional buyers in connection with the Convertible Note Investment;

ii

Table of Contents

​

●“Convertible Note Investment” are to the private placement of (i) senior guaranteed convertible PIK notes in an aggregate original principal amount of $63,888,888, issued at a 10% original issue discount (resulting in net cash proceeds to the Domesticated SPAC of $57,500,000), and (ii) warrants to purchase shares of Class A common stock of the Domesticated SPAC, pursuant to the Convertible Notes;
●“Domesticated SPAC” are to the Company following the Domestication, which will be renamed “PlusAI Holdings, Inc.”;
●“Domestication” are to the Company’s transfer by way of continuation out of the Cayman Islands and domestication as a Delaware corporation in connection with the Transactions;
●“Exchange Act” are to the Securities Exchange Act of 1934, as amended;
●“Exchange Ratio” has the meaning set forth in Note 1 to our unaudited condensed financial statements included in this Report;
●“Extension” are to the extension, on a monthly basis, of the date by which the Company must consummate an initial Business Combination from October 24, 2026 up to July 24, 2027, as approved by the Company’s shareholders at the extraordinary general meeting held on October 19, 2026;
●“Extension Amendment” are to the amendment to the Amended and Restated Articles approved by special resolution of the Company’s shareholders on October 19, 2026 to effect the Extension;
●“Extension Payment” are to each monthly deposit of $145,000 into the Trust Account required to extend the date by which the Company must consummate an initial Business Combination by one month pursuant to the Extension;
●“FASB” are to the Financial Accounting Standards Board;
●“Founder Shares” are to the Class B Ordinary Shares initially purchased by our Prior Sponsor prior to the Initial Public Offering and the Class A Ordinary Shares that will be issued upon the automatic conversion of the Class B Ordinary Shares at the time of our Business Combination as described herein (for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares” (as defined below)). Following closing of the transactions provided for by the Purchase Agreement (as defined below), the Founder Shares are held by the New Sponsor (as defined below);
●“IMTA” are to the Investment Management Trust Agreement, dated April 22, 2025, with Continental, as trustee;
●“IMTA Amendment” are to the amendment to the IMTA, approved by our shareholders at the Meeting and entered into by the Company and Continental on October 19, 2026;
●“Initial Public Offering” or “IPO” are to the initial public offering that we consummated on April 24, 2025;
●“Insider Letter” are to the letter agreement, dated September 18, 2025, by and among the Company, the New Sponsor and the individuals designated to become officers and directors upon the closing of the transactions provided for by the Purchase Agreement, addressing, among other things, voting obligations and certain transfer restrictions applicable to the New Sponsor and such individuals;
●“Investment Company Act” are to the Investment Company Act of 1940, as amended;
●“IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $300,000 issued to our Prior Sponsor on August 1, 2024 and as amended and restated on March 14, 2025;
●“IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on February 10, 2025, as amended, and declared effective on April 22, 2025 (File No. 333-284793);
●“JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

iii

Table of Contents

​

●“Letter Agreement” are to the Letter Agreement, dated April 22, 2025, which we entered into with our Prior Sponsor and the individuals then serving as our directors and officers, which, pursuant to the Waiver of Joinder Requirement under the Insider Letter and the Purchase Agreement, dated September 18, 2025, did not require the New Sponsor to execute a joinder and was terminated effective as of the closing of the transactions provided for by the Purchase Agreement;
●“Management” or our “Management Team” are to our executive officers and directors;
●“Meeting” are to the extraordinary general meeting of our shareholders held on October 19, 2026;
●“Merger Agreement” are to the Agreement and Plan of Merger and Reorganization, dated September 2, 2026, by and among the Company, Merger Sub I, Merger Sub II and PlusAI, as it may be amended, restated, supplemented or otherwise modified from time to time;
●“Merger Sub I” are to TVAC Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company;
●“Merger Sub II” are to TVAC Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of the Company;
●“Mergers” are to the merger of Merger Sub I with and into PlusAI, with PlusAI surviving as a wholly owned subsidiary of the Company, followed immediately by the merger of such surviving corporation with and into Merger Sub II, with Merger Sub II surviving;
●“non-managing sponsor investors” or “NMSI” means seven institutional investors (none of which are affiliated with any member of Management, other members of our Prior Sponsor or any other investor) that prior to September 18, 2025, purchased, indirectly, through the purchase of non-managing sponsor membership interests in the Prior Sponsor, an aggregate of 4,100,000 Private Placement Warrants (defined below) at a price of $1.00 per warrant ($4,100,000 in the aggregate); in connection with the non-managing sponsor investors indirectly purchasing, through the Prior Sponsor, the NMSI Private Placement Warrants (defined below) allocated to it in connection with the closing of the IPO, the Prior Sponsor issued membership interests in the Prior Sponsor at a nominal purchase price to the non-managing sponsor investors at the closing of the IPO reflecting interests in an aggregate of 3,280,000 Founder Shares then held by the Prior Sponsor. Pursuant to the Purchase Agreement, the non‑managing sponsor investors have no further rights, claims or interests in or to any securities of the Company (other than any Public Units, Public Shares or Public Warrants they may hold), and all such Private Placement Warrants that had been NMSI Private Placement Warrants are now held by the New Sponsor following the closing of the transactions provided for by the Purchase Agreement;
●“NMSI Private Placement Warrants” means the subset of 4,100,000 Private Placement Warrants that, prior to September 18, 2025, when they were acquired by the New Sponsor, were designated to be distributed to non-managing sponsor investors by the Prior Sponsor upon closing of our initial Business Combination. Following the closing of the transactions provided for by the Purchase Agreement on September 18, 2025, no such Private Placement Warrants are held by, or are distributable to, any non‑managing sponsor investor, and no consent, exchange or other special rights applicable solely to the NMSI Private Placement Warrants are in effect, and all such Private Placement Warrants are held by the New Sponsor following the closing of the transactions provided for by the Purchase Agreement;
●“NMSI Shares” means the Class A Ordinary Shares underlying the NMSI Private Placement Warrants;
●“Nasdaq” are to the Nasdaq Stock Market LLC;
●“Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its Initial Public Offering registration statement;
●“Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of this Report;
●“New Sponsor” are to Yorkville Acquisition Sponsor II, LLC, a Florida limited liability company;

iv

Table of Contents

​

●“Non-Convertible Note” are to the non-convertible promissory note in the aggregate principal amount of $145,000 issued by the Company to the New Sponsor on October 20, 2026 to fund the first Extension Payment;
●“Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;
●“Over-Allotment Option” are to the 45-day option that the underwriters of the Initial Public Offering had to purchase up to an additional 3,000,000 units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was partially exercised;
●“PIPE Investment” are to the private placement of shares of Class A common stock of the Domesticated SPAC and warrants to purchase such shares for an aggregate purchase price of approximately $4.0 million pursuant to the PIPE Subscription Agreements;
●“PIPE Subscription Agreements” are to the subscription agreements, dated September 2, 2026, entered into by and among the Company, PlusAI and certain accredited investors and qualified institutional buyers in connection with the PIPE Investment;
●“PlusAI” are to Plus Automation, Inc., a Delaware corporation;
●“Prior Sponsor” are to TV Partners III, LLC, a Delaware Limited Liability Company;
●“Private Placement” are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the closing of our Initial Public Offering;
●“Private Placement Warrants” are to the aggregate of the 4,700,000 warrants initially issued to our Prior Sponsor and 2,868,750 warrants initially issued to the underwriters of the Initial Public Offering in the Private Placement, with each Private Placement Warrant entitling the holder to purchase one Class A Ordinary Share. Following the closing of the transactions provided for by the Purchase Agreement, the 4,700,000 Private Placement Warrants originally issued to the Prior Sponsor have been sold by the Prior Sponsor to, and are held by, the New Sponsor (subject to permitted transfers), and the remaining Private Placement Warrants are held by the underwriters (or their permitted transferees). For the avoidance of doubt, there no longer are any Private Placement Warrants issued indirectly to the non‑managing sponsor investors;
●“Private Placement Warrants Purchase Agreements” are to the Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and between us and the Prior Sponsor, and the Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and among us, Cohen & Company and Clear Street (in each case as amended, restated, supplemented or otherwise modified from time to time);
●“Public Shares” are to the Class A Ordinary Shares sold as part of the Public Units (as defined below) in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market);
●“Public Shareholders” are to the holders of our Public Shares, including our initial shareholders, Management and any non-managing sponsor investors to the extent our initial shareholders, members of Management, and/or any non-managing sponsor investors purchase Public Shares, provided that each initial shareholder’s, member of Management, and any non-managing sponsor investors’ status as a “Public Shareholder” will only exist with respect to such Public Shares;
●“Public Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-half of one Public Warrant;
●“Public Warrants” are to the redeemable warrants sold as part of the Public Units in our Initial Public Offering (whether they were subscribed for in our Initial Public Offering or purchased in the open market), with each Public Warrant entitling the holder to purchase one Class A Ordinary Share;
●“Purchase Agreement” means that certain Purchase Agreement, dated September 18, 2025, by and among the Company, our Prior Sponsor, and our New Sponsor, as it may be amended, restated, supplemented or otherwise modified from time to time;

v

Table of Contents

​

●“Registration Rights Agreement” are to the Registration Rights Agreement, dated April 22, 2025, by and among the Company, the Prior Sponsor, Cohen & Company, Clear Street, and certain security holders party thereto, as joined and amended by the Joinder to and Amendment of the Registration Rights Agreement, dated September 18, 2025, by the New Sponsor (acknowledged and accepted by the Company and the Prior Sponsor), and as further amended, restated, supplemented or otherwise modified from time to time;
●“Registration Statement” are to the registration statement on Form S-4 filed by the Company with the SEC on October 9, 2026 in connection with the Transactions;
●“Report” are to this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026;
●“Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002;
●“SEC” are to the U.S. Securities and Exchange Commission;
●“Securities Act” are to the Securities Act of 1933, as amended;
●“SPAC” are to a special purpose acquisition company;
●“Sponsor” are to the Prior Sponsor prior to the closing of the transactions contemplated by the Purchase Agreement and the New Sponsor following the closing of the transactions contemplated by the Purchase Agreement;
●“Trust Account” are to the U.S.-based trust account in which an amount of $226,125,000 from the net proceeds of the sale of the Public Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement was placed following the closing of the Initial Public Offering;
●“Sponsor Support Agreement” are to the Sponsor Support Agreement, dated September 2, 2026, by and among the Company, the New Sponsor, PlusAI and certain of the Company’s directors and officers;
●“Transactions” are to the Domestication, the Mergers and the other transactions contemplated by the Merger Agreement;
●“Trust Agreement” are to the Investment Management Trust Agreement, dated April 22, 2025, which we entered into with Continental, as trustee of the Trust Account;
●“Underwriting Agreement” are to the Underwriting Agreement, dated April 22, 2025, which we entered into with Cohen & Company Capital Markets, as representative of the several underwriters;
●“GAAP” are to the accounting principles generally accepted in the United States of America;
●“Warrants” are to the Private Placement Warrants and the Public Warrants, together;
●“Withum” are to WithumSmith+Brown, PC, our independent registered public accounting firm; and
●“Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, loan us; and
●“Working Capital Note” are to the convertible unsecured promissory note in the aggregate principal amount of $250,000 issued by the Company to the New Sponsor on September 30, 2026, which was amended, restated, superseded and replaced in its entirety by the A&R Working Capital Note.

​

​

vi

Table of Contents

​

PART I – FINANCIAL INFORMATION

Item 1. Unaudited Condensed Financial Statements

TEXAS VENTURES ACQUISITION III CORP

CONDENSED BALANCE SHEETS

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 

  ​ ​ ​

December 31, 

​

 

2026

 

2025

​

 

(Unaudited)

​

​

ASSETS

 

​

  ​

 

​

  ​

Current Assets:

 

​

  ​

 

​

  ​

Cash

​

$

176,612

​

$

856,131

Prepaid expenses

​

 

80,149

​

 

102,500

Total Current Assets

​

 

256,761

​

 

958,631

​

​

​

​

​

​

​

Prepaid expenses, non-current

​

 

—

​

 

33,334

Investments held in Trust Account

​

 

238,741,967

​

 

232,460,533

Total Assets

​

$

238,998,728

​

$

233,452,498

​

​

​

​

​

​

​

LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

​

 

​

​

 

  ​

Current Liabilities:

​

 

​

​

 

  ​

Accounts payable

​

$

495,987

​

$

—

Accrued expenses

​

​

3,854,029

​

​

231,427

Due to related party

​

​

—

​

​

2,425

Total Current Liabilities

​

 

4,350,016

​

 

233,852

​

​

​

​

​

​

​

Deferred underwriting commissions

​

 

9,000,000

​

 

9,000,000

Total Liabilities

​

 

13,350,016

​

 

9,233,852

​

​

​

​

​

​

​

Commitments and contingencies (Note 6)

​

 

​

​

 

  ​

Class A ordinary shares subject to possible redemption, 22,500,000 shares issued and outstanding at redemption value of $10.61 and $10.33 per share, at September 30, 2026 and December 31, 2025, respectively

​

 

238,741,967

​

 

232,460,533

Shareholders’ Deficit:

​

 

​

​

 

  ​

Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025

​

 

—

​

 

—

Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding, excluding 22,500,000 shares subject to possible redemption, at September 30, 2026 and December 31, 2025

​

 

—

​

 

—

Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,500,000 shares issued and outstanding at September 30, 2026 and December 31, 2025

​

 

750

​

 

750

Additional paid-in capital

​

 

—

​

 

1,621,805

Accumulated deficit

​

 

(13,094,005)

​

 

(9,864,442)

Total Shareholders’ Deficit

​

 

(13,093,255)

​

 

(8,241,887)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit

​

$

238,998,728

​

$

233,452,498

​

See accompanying notes to the condensed financial statements.

​

1

Table of Contents

​

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the

​

For the

​

​

Three Months Ended

​

Nine Months Ended

​

 

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

EXPENSES

 

​

  ​

​

​

  ​

​

​

  ​

 

​

  ​

General and administrative expenses

​

$

1,613,463

​

$

151,150

​

$

4,857,974

 

$

427,662

TOTAL EXPENSES

​

​

(1,613,463)

​

​

(151,150)

​

​

(4,857,974)

 

​

(427,662)

​

​

​

​

​

​

​

​

​

​

​

​

​

OTHER INCOME (LOSS)

​

 

​

​

 

  ​

​

​

​

 

​

  ​

Interest income earned on investments held in Trust Account

​

 

2,161,724

​

 

2,380,552

​

​

6,281,434

 

​

4,114,464

Interest income earned on cash held in operating account

​

 

692

​

 

10,674

​

​

6,606

 

​

17,143

Forgiveness of debt

​

​

—

​

​

28,614

​

​

—

​

​

28,614

Change in fair value of warrant liability

​

 

—

​

 

(3,469,346)

​

​

—

 

​

(2,033,664)

TOTAL OTHER INCOME (LOSS)

​

 

2,162,416

​

 

(1,049,506)

​

​

6,288,040

 

​

2,126,557

NET INCOME (LOSS)

​

$

548,953

​

$

(1,200,656)

​

$

1,430,066

​

$

1,698,895

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption

​

 

22,500,000

​

 

20,000,000

​

 

22,500,000

​

 

11,648,352

Basic and diluted net income (loss) per share, Class A ordinary shares subject to possible redemption

​

$

0.02

​

$

(0.04)

​

$

0.05

​

$

0.09

Basic weighted average shares outstanding, Class B non-redeemable ordinary shares

​

 

7,500,000

​

 

7,500,000

​

 

7,500,000

​

 

7,152,015

Basic net income (loss) per share, Class B non-redeemable ordinary shares

​

$

0.02

​

$

(0.04)

​

$

0.05

​

$

0.09

Diluted weighted average shares outstanding, Class B non-redeemable ordinary shares

​

 

7,500,000

​

 

7,500,000

​

 

7,500,000

​

 

7,222,222

Diluted net income (loss) per share, Class B non-redeemable ordinary shares

​

$

0.02

​

$

(0.04)

​

$

0.05

​

$

0.09

​

See accompanying notes to the condensed financial statements.

​

2

Table of Contents

​

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class B

​

Additional

​

​

​

​

​

​

​

​

Ordinary Shares

  ​ ​ ​

Paid-In

​

Accumulated

  ​ ​ ​

Shareholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Deficit

Balance, January 1, 2026

 

7,500,000

​

$

750

​

$

1,621,805

​

$

(9,864,442)

​

$

(8,241,887)

Remeasurement of ordinary shares to redemption value

 

—

​

 

—

​

 

(1,621,805)

​

 

(422,205)

​

 

(2,044,010)

Net loss

 

—

​

 

—

​

 

—

​

 

(472,477)

​

 

(472,477)

Balance, March 31, 2026 (unaudited)

 

7,500,000

​

​

750

​

​

—

​

​

(10,759,124)

​

​

(10,758,374)

Remeasurement of ordinary shares to redemption value

 

—

​

 

—

​

 

—

​

 

(2,075,700)

​

 

(2,075,700)

Net income

 

—

​

 

—

​

 

—

​

 

1,353,590

​

 

1,353,590

Balance, June 30, 2026 (unaudited)

 

7,500,000

​

​

750

​

​

—

​

​

(11,481,234)

​

​

(11,480,484)

Remeasurement of ordinary shares to redemption value

 

—

​

 

—

​

 

—

​

 

(2,161,724)

​

 

(2,161,724)

Net income

​

—

​

​

—

​

​

—

​

​

548,953

​

​

548,953

Balance, September 30, 2026 (unaudited)

 

7,500,000

​

$

750

​

$

—

​

$

(13,094,005)

​

$

(13,093,255)

​

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Class B

​

Additional

​

​

​

​

​

​

​

  ​ ​ ​

Ordinary Shares

​

Paid-In

​

Accumulated

​

Shareholders’

​

​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Deficit

Balance, January 1, 2025

  ​ ​ ​

7,666,667

​

$

767

​

$

24,233

​

$

(44,737)

​

$

(19,737)

Net loss

 

—

 

​

—

​

 

—

​

 

(39,596)

​

 

(39,596)

Balance, March 31, 2025 (unaudited)

 

7,666,667

​

​

767

​

​

24,233

​

​

(84,333)

​

​

(59,333)

Forfeiture of Class B ordinary shares

 

(166,667)

​

 

(17)

​

 

17

​

 

—

​

 

—

Payment for private placement

 

—

​

 

—

​

 

3,468,500

​

 

—

​

 

3,468,500

Fair value of public warrants

 

—

​

 

—

​

 

3,037,500

​

 

—

​

 

3,037,500

Remeasurement of ordinary shares to redemption value

 

—

​

 

—

​

 

(6,333,417)

​

 

(13,365,574)

​

 

(19,698,991)

Offering costs

 

—

​

 

—

​

 

(196,833)

​

 

—

​

 

(196,833)

Net income

 

—

​

 

—

​

 

—

​

 

2,939,147

​

 

2,939,147

Balance, June 30, 2025 (unaudited)

 

7,500,000

 

​

750

​

​

—

​

​

(10,510,760)

​

​

(10,510,010)

Remeasurement of ordinary shares to redemption value

​

—

​

​

—

​

​

—

​

​

(2,380,552)

​

​

(2,380,552)

Net loss

​

—

​

​

—

​

​

—

​

​

(1,200,656)

​

​

(1,200,656)

Balance, September 30, 2025 (unaudited)

​

7,500,000

​

$

750

​

$

—

​

$

(14,091,968)

​

$

(14,091,218)

​

See accompanying notes to the condensed financial statements.

​

3

Table of Contents

​

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

​

​

​

​

​

​

​

​

 

For the

​

For the

​

​

Nine Months Ended

​

Nine Months Ended

​

 

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash flows from operating activities:

 

​

  ​

​

​

  ​

Net income

​

$

1,430,066

​

$

1,698,895

Adjustments to reconcile net income to net cash used in operating activities:

​

 

​

​

 

​

Interest income earned on investments held in Trust Account

​

 

(6,281,434)

​

 

(4,114,464)

Change in fair value of warrant liability

​

 

—

​

 

2,033,664

Changes in current assets and liabilities:

​

 

​

​

 

​

Prepaid expenses

​

 

55,685

​

 

(181,315)

Deferred offering costs

​

 

—

​

 

248,425

Accounts payable

​

​

495,987

​

​

—

Accrued expenses

​

 

3,622,602

​

 

19,912

Accrued offering costs

​

 

—

​

 

(122,760)

Due to related party

​

​

(2,425)

​

​

—

Net cash used in operating activities

​

 

(679,519)

​

 

(417,643)

​

​

​

​

​

​

​

Cash flows from investing activities:

​

 

​

​

 

  ​

Investment of cash in Trust Account

​

 

—

​

 

(226,125,000)

Net cash used in investing activities

​

 

—

​

 

(226,125,000)

​

​

​

​

​

​

​

Cash flows from financing activities:

​

 

​

​

 

  ​

Proceeds from the sale of Units

​

​

—

​

​

226,125,000

Proceeds from issuance of promissory note - related party

​

 

—

​

 

397,800

Payment of promissory note – related party

​

 

—

​

 

(550,000)

Proceeds from sale of private placement warrants

​

 

—

​

 

6,968,750

Payment of underwriting fee

​

 

—

​

 

(4,500,000)

Payment of offering costs

​

 

—

​

 

(1,024,662)

Net cash provided by financing activities

​

 

—

​

 

227,416,888

​

​

​

​

​

​

​

Net change in cash

​

 

(679,519)

​

 

874,245

Cash, beginning of the period

​

 

856,131

​

 

2,232

Cash, end of the period

​

$

176,612

​

$

876,477

​

​

​

​

​

​

​

Supplemental disclosure of cash flow information:

​

 

  ​

​

 

  ​

Deferred underwriters’ discount payable charged to additional paid-in capital

​

$

—

​

$

9,000,000

​

See accompanying notes to the condensed financial statements.

​

4

Table of Contents

​

TEXAS VENTURES ACQUISITION III CORP

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

Texas Ventures Acquisition III Corp (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on July 26, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

On April 24, 2025, the Company consummated its Initial Public Offering (“Initial Public Offering” or “IPO”) of 22,500,000 units (the “Public Units” and, with respect to the Class A ordinary shares and public warrants included in the Public Units, the “Public Shares”, and “Public Warrants”, respectively), including 2,500,000 units issued pursuant to the partial exercise of the underwriters’ over-allotment option. The Public Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $225,000,000. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.

Simultaneously with the closing of the IPO, the Company completed the private sale of 3,468,750 warrants (the “Private Placement Warrants”), and 4,100,000 NMSI Private Placement Warrants to the Prior Sponsor, Cohen & Company and Clear Street at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,568,750. The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering, except as otherwise noted in Note 8.

On September 18, 2025, the Company, the Prior Sponsor and the New Sponsor entered into the Purchase Agreement. Pursuant to the Purchase Agreement, the New Sponsor (i) purchased from the Prior Sponsor (a) 7,500,000 shares of Class B Ordinary Shares and (b) 4,700,000 Private Placement Warrants, for an aggregate purchase price of $7,400,000 and (ii) upon closing, became the sponsor of the Company (together, the “Purchase”).

As conditions to the closing of the Purchase, all of the then-existing members of the Board of Directors and then-existing officers of the Company resigned, and the New Sponsor designated a new board of directors and new management team, which were appointed immediately prior to the closing of the Purchase. The New Sponsor also agreed, among other things, to (i) execute a joinder agreement (the “Joinder”) to become a party to the Registration Rights Agreement, and (ii) enter into the Insider Letter with the Company, providing for, among other things, voting obligations and certain transfer restrictions. The Prior Sponsor and the Company, among other things, agreed to cause all parties to the Letter Agreement to execute a waiver to certain requirements of the Letter Agreement such that the New Sponsor need not execute a joinder or become a party to the Letter Agreement.

In addition to the foregoing, the closing of the Purchase was conditional on, among other things, (i) the termination of all Company related party contracts and certain commercial arrangements, (ii) the payment of all outstanding invoices of the Company by the closing, (iii) the Company holding at least $875,000 in cash or cash equivalents, exclusive of the trust account, after payment of all outstanding liabilities, and (iv) the Company’s continued listing on the Nasdaq through the closing. Although the Purchase Agreement included as a condition to closing the execution of a written waiver by the underwriters of the Company’s Initial Public Offering, reducing their rights to receive the deferred underwriting fee contemplated by the Underwriting Agreement, to a new agreed amount, this condition was not satisfied at closing of the Purchase. The New Sponsor consummated the Purchase notwithstanding the failure of this condition to be satisfied. The other conditions to the closing of the Purchase were satisfied.

Upon the closing of the Purchase, the New Sponsor became the sponsor of the Company, the new directors and officers designated by the New Sponsor assumed their positions, and, in accordance with the terms of the Joinder to become a party to the Registration Rights Agreement, the New Sponsor became a party to the Registration Rights Agreement.

5

Table of Contents

​

Seven institutional investors (“non-managing sponsor investors”) previously purchased, indirectly, through the purchase of non-managing sponsor membership interests, an aggregate of 4,100,000 Private Placement Warrants at a price of $1.00 per warrant ($4,100,000 in the aggregate). In connection with such indirect purchase through the Prior Sponsor, the Prior Sponsor issued membership interests at a nominal purchase price to the non-managing sponsor investors reflecting interests in an aggregate of 3,280,000 Founder Shares (as defined in Note 5) then held by the Prior Sponsor. Historically, the NMSI Private Placement Warrants were held by the Prior Sponsor and designated to be transferred to the non-managing sponsor investors only upon the consummation of an initial Business Combination. Following the closing of the transactions provided for by the Purchase Agreement on September 18, 2025, the non-managing sponsor investors have no further rights, claims or interests in or to any Sponsor‑held securities (including any NMSI Private Placement Warrants or NMSI Shares), and there are no NMSI‑specific consent, exchange or other special rights in effect.

Transaction costs for the Initial Public Offering amounted to $14,006,902, consisting of $4,500,000 of cash underwriting fees, $9,000,000 of deferred underwriting fees, and $506,902 of other offering costs.

On April 24, 2025, the underwriters partially exercised the over-allotment option of 2,500,000 Public Units and informed the Company that they would not further exercise the option for the remaining 500,000 Public Units. As a result, the Prior Sponsor forfeited an aggregate 166,667 Founder Shares of the Company, par value $0.0001 per share. Such forfeited shares were cancelled by the Company upon consummation of the Initial Public Offering.

Upon the closing of the Initial Public Offering and the Private Placement, $226,125,000 ($10.05 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described in the IPO Registration Statement. The proceeds deposited in the Trust Account could become subject to the claims of creditors, if any, which could have priority over the claims of public shareholders.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect the Business Combination with PlusAI (as defined below) or any other Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest then in the Trust Account). There will be no redemption rights upon the completion of a Business Combination with respect to the Private Placement Warrants. The Public Shares subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”

6

Table of Contents

​

If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law and its Amended and Restated Articles approving a Business Combination, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the applicable general meeting of the Company, or such other vote as required by law or stock exchange rule. If the Company’s Business Combination is structured as a statutory merger or consolidation with another company under Cayman Islands law, the approval of its Business Combination will also require a special resolution, which requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Articles, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the New Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Articles (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment.

If the Company has not completed a Business Combination within 18 months from the closing of the Initial Public Offering or during any extended time to consummate a Business Combination beyond 18 months (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Public Share ($10.05).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount

7

Table of Contents

​

per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Company’s initial Business Combination and redemptions could be reduced to less than $10.05 per Public Share. In such event, the Company may not be able to complete its initial Business Combination, and the Public Shareholders would receive such lesser amount per share in connection with any redemption of their Public Shares. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

On October 19, 2026, the Company held an extraordinary general meeting of its shareholders (the “Meeting”). At the Meeting, the Company’s shareholders approved, by special resolution, (i) an amendment to the IMTA (the “IMTA Amendment”) and (ii) an amendment to the Amended and Restated Articles (the “Extension Amendment”), which together extend, on a monthly basis, the date by which the Company must consummate an initial Business Combination, and the date on which Continental must liquidate the Trust Account if the Company has not done so, from October 24, 2026 up to July 24, 2027 (the “Extension”). For each monthly extension, the Company is required to deposit $145,000 (each such deposit, an “Extension Payment”) into the Trust Account no later than two business days prior to the 24th day of the applicable month (see Note 11).

In connection with the Extension Amendment, the Company’s shareholders elected to redeem 17,699,488 Class A ordinary shares, which represents approximately 78.66% of the 22,500,000 Class A ordinary shares that were part of the units sold in the Initial Public Offering, at a redemption price of approximately $10.63 per share. Such shareholders redeemed approximately $188,177,658 from the Trust Account. Following such redemptions, 4,800,512 Class A ordinary shares remain outstanding.

Business Combination Agreement

Merger Agreement

On September 2, 2026, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with TVAC Merger Sub I, Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“Merger Sub I”), TVAC Merger Sub II, LLC, a Delaware limited liability company and direct, wholly owned subsidiary of the Company (“Merger Sub II”), and Plus Automation, Inc., a Delaware corporation (“PlusAI”). Pursuant to the Merger Agreement, Merger Sub I will merge with and into PlusAI, with PlusAI surviving as a wholly owned subsidiary of the Company, and immediately thereafter the surviving corporation will merge with and into Merger Sub II, with Merger Sub II surviving (together, the “Mergers” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”). At least one day prior to the closing of the Mergers (the “Closing”), the Company will transfer by way of continuation out of the Cayman Islands and domesticate as a Delaware corporation (the “Domestication”), and will change its name to “PlusAI Holdings, Inc.” (the Company following the Domestication, the “Domesticated SPAC”). Immediately prior to the Domestication, each Class B Ordinary Share will convert on a one-for-one basis into a Class A Ordinary Share, and in the Domestication (i) each Class A Ordinary Share will convert on a one-for-one basis into a share of Class A common stock of the Domesticated SPAC (“SPAC Class A Common Stock”), (ii) each Warrant will convert into a warrant to acquire one share of SPAC Class A Common Stock and (iii) each Public Unit will be cancelled and the holder will be entitled to one share of SPAC Class A Common Stock and one-half of one warrant of the Domesticated SPAC. On October 9, 2026, the Company filed a registration statement on Form S-4 with the SEC in connection with the Transactions (the “Registration Statement”), which has not yet been declared effective.

8

Table of Contents

​

Merger Consideration

The aggregate consideration payable to PlusAI’s stockholders at the Closing is based on a pre-money equity value of PlusAI of $800,000,000 (the “Equity Value”). At the effective time of the first Merger, each outstanding share of PlusAI stock will be exchanged for shares of SPAC Class A Common Stock based on the Exchange Ratio (as defined below), except that (i) each share of PlusAI Class B common stock will be exchanged for shares of Class B common stock of the Domesticated SPAC and (ii) certain shares issued upon conversion of PlusAI’s Series A-3-X, Series A-4-X or Series B-X preferred stock or upon exercise of options granted under PlusAI’s 2021 Share Incentive Plan will be exchanged for shares of Class C common stock of the Domesticated SPAC, in each case based on the Exchange Ratio. The “Exchange Ratio” equals (i) the Equity Value plus the aggregate exercise price of PlusAI’s vested options, divided by the fully diluted number of shares of PlusAI common stock (including shares issuable upon conversion of PlusAI’s preferred stock and SAFEs, vested options, RSUs that vest as a result of the Mergers and vested warrants, on a net issuance basis), divided by (ii) $10.00.

Conditions to Closing

The Closing is subject to customary closing conditions, including, among others: (i) expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended; (ii) the absence of any order or law preventing or materially restraining the Transactions; (iii) the Company having at least $5,000,001 of net tangible assets remaining after redemptions; (iv) approval of the Transactions and related matters by the Company’s shareholders and by PlusAI’s stockholders; (v) adoption of the organizational documents and agreements necessary to give effect to the contemplated governance arrangements; (vi) the listing of the SPAC Class A Common Stock on Nasdaq or another mutually agreed stock exchange; (vii) the Registration Statement having become effective; (viii) available cash in the Trust Account (after redemptions) plus the gross proceeds of the PIPE Investment (as defined below) and the Convertible Note Investment (as defined below), before payment of transaction expenses, of at least $40,000,000, subject to waiver as provided in the Merger Agreement; and (ix) the absence of a continuing material adverse effect with respect to the Company or PlusAI.

Related Agreements

Company Voting and Support Agreements. Concurrently with the execution of the Merger Agreement, certain stockholders of PlusAI holding sufficient shares to approve the Transactions on behalf of PlusAI entered into voting and support agreements with the Company and PlusAI (the “Company Voting and Support Agreements”), pursuant to which they agreed, among other things, to deliver written consents adopting the Merger Agreement and approving the Transactions, to vote against alternative transactions and other matters that could reasonably be expected to materially delay or impair the Transactions, to refrain from exercising dissenters’ rights and, subject to certain exceptions, not to transfer their PlusAI shares prior to the Closing.

Sponsor Support Agreement. Concurrently with the execution of the Merger Agreement, the New Sponsor, the Company, PlusAI and certain of the Company’s directors and officers (the “Insiders”) entered into a sponsor support agreement (the “Sponsor Support Agreement”), pursuant to which the New Sponsor agreed, among other things, to vote all Company shares held by it or its affiliate, YA II PN, Ltd., (i) in favor of the Transactions and related shareholder matters, (ii) against any alternative business combination or other action that would impede the Transactions and (iii) in favor of any extension of the Company’s deadline to complete a Business Combination sought in connection with the Transactions. The New Sponsor and the Insiders also irrevocably waived any anti-dilution adjustment to the conversion ratio of the Class B Ordinary Shares, such that the Class B Ordinary Shares will convert on a one-for-one basis in connection with the Transactions. In addition, if the Company’s transaction expenses exceed $7.5 million, the New Sponsor will, at its election, pay the excess in cash or forfeit a number of Founder Shares equal to the unpaid excess divided by $10.00, up to the number of Founder Shares it owns.

PIPE Subscription Agreements. Concurrently with the execution of the Merger Agreement, the Company and PlusAI entered into subscription agreements (the “PIPE Subscription Agreements”) with certain accredited investors and qualified institutional buyers, pursuant to which the Company agreed to issue and sell, in a private placement to close following the Domestication and substantially concurrently with the Closing, shares of SPAC Class A Common Stock and warrants to purchase shares of SPAC Class A Common Stock for an aggregate purchase price of approximately $4.0 million (the “PIPE Investment”). The fair value of the PIPE subscription agreement is not significant to the interim financial statements as of September 30, 2026.

9

Table of Contents

​

Convertible Note Agreements. Concurrently with the execution of the Merger Agreement, the Company and PlusAI entered into convertible note and warrant subscription agreements (the “Convertible Notes) with certain accredited investors and qualified institutional buyers, pursuant to which the Company agreed to issue and sell, in a private placement to close following the Domestication and substantially concurrently with the closing, (i) senior guaranteed convertible PIK notes in an aggregate original principal amount of $63,888,888, issued at a 10% original issue discount (resulting in net cash proceeds of $57,500,000), and (ii) warrants to purchase shares of SPAC Class A Common Stock (the “Convertible Note Investment”).

Going Concern Considerations

At September 30, 2026, the Company had cash of $176,612 and a working capital deficit of $4,093,255.

Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). Management expects the Company to incur significant expenses in connection with the consummation of the Business Combination with PlusAI and any subsequent Extension Payments. As a result, management has determined that the current liquidity condition of the Company, coupled with the fact that the Company is within one year of mandatory liquidation, raises substantial doubt about the Company’s ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties. As such, the accompanying unaudited condensed financial statements have been prepared assuming the Company will continue as a going concern and do not include any adjustments that might result should the Company be required to liquidate.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 15, 2026. The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different

10

Table of Contents

​

application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Merger Sub I and Merger Sub II, which are inactive. All intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2026 and December 31, 2025.

Offering Costs Associated with the Initial Public Offering

The offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering and that were charged to shareholders’ deficit upon the completion of the Initial Public Offering.

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate the Initial Public Offering proceeds from the Public Units between ordinary shares and warrants, using the residual method by allocating the Initial Public Offering proceeds first to assigned value of the warrants and then to the ordinary shares. Offering costs allocated to the Public Shares are charged to temporary equity and offering costs allocated to the Public and Private Placement Warrants are charged to shareholders’ deficit as Public and Private Placement Warrants after management’s evaluation are accounted for under equity treatment. Offering costs allocated to the NMSI Private Placement Warrants were charged to the condensed statements of operations as the NMSI Private Placement Warrants after management’s evaluation were accounted for as liabilities prior to the December 31, 2025 amendment to the warrant agreement.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest

11

Table of Contents

​

and penalties as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

Investments Held in Trust Account

As of September 30, 2026 and December 31, 2025, the Company had $238,741,967 and $232,460,533 invested in mutual funds held in the Trust Account, respectively. The Company’s portfolio of investments held in the Trust Account are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act.

Net Income (Loss) per Ordinary Share

The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with the accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The Company has not considered the effect of the Public Warrants in the calculation of diluted net income (loss) per share, since the exercise of such warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

For diluted earnings per share, the Class B non-redeemable ordinary shares subject to forfeiture are included in the calculation of total diluted shares at the beginning of the interim period in which the contingency was resolved. For basic earnings per share, the forfeited Class B non-redeemable ordinary shares are considered forfeited on the date of forfeiture.

The following tables reflect the calculation of basic net income (loss) per ordinary share for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the 

  ​ ​ ​

For the 

​

​

Three Months Ended

 

Three Months Ended

​

​

September 30, 

 

September 30, 

​

​

2026

  ​ ​ ​

2025

Class A ordinary shares subject to possible redemption

 

​

  ​

​

​

​

Numerator: Allocation of net income (loss), basic

​

$

411,715

​

$

(873,204)

Denominator: Basic weighted average shares outstanding

​

 

22,500,000

​

​

20,000,000

Basic net income (loss) per Class A ordinary share subject to possible redemption

​

$

0.02

​

$

(0.04)

Class B non-redeemable ordinary shares

​

 

​

​

​

​

Numerator: Allocation of net income (loss), basic

​

$

137,238

​

$

(327,452)

Denominator: Basic weighted average shares outstanding

​

 

7,500,000

​

​

7,500,000

Basic net income (loss) per Class B non-redeemable ordinary share

​

$

0.02

​

$

(0.04)

​

12

Table of Contents

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the

  ​ ​ ​

For the

​

 

Nine Months Ended

​

Nine Months Ended

​

 

September 30, 

​

September 30, 

​

​

2026

  ​ ​ ​

2025

Class A ordinary shares subject to possible redemption

 

​

​

​

​

​

Numerator: Allocation of net income, basic

​

$

1,072,550

​

$

1,052,603

Denominator: Basic weighted average shares outstanding

​

 

22,500,000

​

​

11,648,352

Basic net income per Class A ordinary share subject to possible redemption

​

$

0.05

​

$

0.09

Class B non-redeemable ordinary shares

​

 

​

​

​

​

Numerator: Allocation of net income, basic

​

$

357,516

​

$

646,292

Denominator: Basic weighted average shares outstanding

​

 

7,500,000

​

​

7,152,015

Basic net income per Class B non-redeemable ordinary share

​

$

0.05

​

$

0.09

​

The following tables reflect the calculation of diluted net income (loss) per ordinary share for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the 

  ​ ​ ​

For the 

​

​

Three Months Ended

 

Three Months Ended

​

​

September 30, 

 

September 30, 

​

​

2026

  ​ ​ ​

2025

Class A ordinary shares subject to possible redemption

 

​

  ​

​

​

​

Numerator: Allocation of net income (loss), diluted

​

$

411,715

​

$

(873,204)

Denominator: Diluted weighted average shares outstanding

​

 

22,500,000

​

​

20,000,000

Diluted net income (loss) per Class A ordinary share subject to possible redemption

​

$

0.02

​

$

(0.04)

Class B non-redeemable ordinary shares

​

 

​

​

​

​

Numerator: Allocation of net income (loss), diluted

​

$

137,238

​

$

(327,452)

Denominator: Diluted weighted average shares outstanding

​

 

7,500,000

​

​

7,500,000

Diluted net income (loss) per Class B non-redeemable ordinary share

​

$

0.02

​

$

(0.04)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the

  ​ ​ ​

For the

​

 

Nine Months Ended

​

Nine Months Ended

​

 

September 30, 

​

September 30, 

​

​

2026

  ​ ​ ​

2025

Class A ordinary shares subject to possible redemption

 

​

​

​

​

​

Numerator: Allocation of net income, diluted

​

$

1,072,550

​

$

1,048,687

Denominator: Diluted weighted average shares outstanding

​

 

22,500,000

​

​

11,648,352

Diluted net income per Class A ordinary share subject to possible redemption

​

$

0.05

​

$

0.09

Class B non-redeemable ordinary shares

​

 

​

​

​

​

Numerator: Allocation of net income, diluted

​

$

357,516

​

$

650,208

Denominator: Diluted weighted average shares outstanding

​

 

7,500,000

​

​

7,222,222

Diluted net income per Class B non-redeemable ordinary share

​

$

0.05

​

$

0.09

​

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs

13

Table of Contents

​

used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Warrant Instruments

The Company accounts for the Public Warrants issued in connection with the Initial Public Offering, the Private Placement Warrants and the NMSI Private Placement Warrants in accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging.” Under ASC 815-40, the Public Warrants and the Private Placement Warrants meet the criteria for equity treatment and as such are recorded in shareholders’ deficit. The NMSI Private Placement Warrants did not meet the criteria for equity treatment and as such were recorded as a liability and remeasured each period with changes recorded in the condensed statements of operations. If the Public and Private Placement Warrants no longer meet the criteria for equity treatment, they will record as a liability and be remeasured each period with changes recorded in the condensed statements of operations. On December 31, 2025, the Company issued an amendment to the warrant agreement that removed the settlement provision that precluded the NMSI Private Placement Warrants from equity treatment. As a result of this amendment, the Company determined that the NMSI Private Placement Warrants met the criteria for equity treatment and as such were reclassified to additional paid-in capital.

Class A Ordinary Shares Subject to Redemption

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.

​

14

Table of Contents

​

​

​

​

​

Gross proceeds

  ​ ​ ​

$

225,000,000

Less: Proceeds allocated to public warrants

​

 

(3,037,500)

Less: Class A ordinary share issuance costs

​

 

(13,802,579)

Add: Accretion of carrying value to redemption value

​

 

19,698,991

Add: Remeasurement of carrying value to redemption value

​

​

4,601,621

Class A ordinary shares subject to possible redemption, December 31, 2025

​

​

232,460,533

Add: Remeasurement of carrying value to redemption value

​

​

2,044,010

Class A ordinary shares subject to possible redemption, March 31, 2026

​

​

234,504,543

Add: Remeasurement of carrying value to redemption value

​

​

2,075,700

Class A ordinary shares subject to possible redemption, June 30, 2026

​

​

236,580,243

Add: Remeasurement of carrying value to redemption value

​

​

2,161,724

Class A ordinary shares subject to possible redemption, September 30, 2026

​

$

238,741,967

​

Recent Accounting Standards

In November 2024, the FASB issued ASU 2024-03, “Disaggregation of Income Statement Expenses,” which requires disclosures of certain disaggregated income statement expense captions into specified categories within the footnotes to the financial statements. The requirements of the ASU are effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The requirements will be applied prospectively with the option for retrospective application. The Company is currently evaluating the impact ASU 2024-03 will have on its financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on April 24, 2025, the Company sold 22,500,000 Public Units at a purchase price of $10.00 per Public Unit. Each Public Unit consists of one Class A ordinary share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the consummation of the Initial Public Offering on April 24, 2025 and the sale of the Public Units, the Company consummated the Private Placement of Private Placement Warrants. The Prior Sponsor, Cohen & Company and Clear Street purchased an aggregate of 7,568,750 warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $7,568,750. Cohen & Company and Clear Street purchased an aggregate of 2,868,750 Private Placement Warrants and the Prior Sponsor purchased 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants). Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was placed in the Trust Account with the net proceeds from the Initial Public Offering. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or saleable until 30 days after the completion of an initial Business Combination, subject to certain exceptions (see Note 8).

NOTE 5 — RELATED PARTIES

Founder Shares

On August 1, 2024, the Prior Sponsor received 7,666,667 of the Company’s Class B ordinary shares (the “Founder Shares”) in exchange for a payment of $25,000.

On April 24, 2025, 166,667 Founder Shares were forfeited as the underwriters did not fully exercise the over-allotment option.

15

Table of Contents

​

On September 18, 2025, pursuant to the Purchase Agreement, the Prior Sponsor sold 7,500,000 Founder Shares and 4,700,000 Private Placement Warrants to the New Sponsor for an aggregate purchase price of $7,400,000, and, upon closing, the New Sponsor became the Company’s sponsor.

The New Sponsor has agreed not to transfer or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the closing of the Company’s initial Business Combination; except to affiliates, members or partners of the Sponsor or their affiliates, or any employees of such affiliates, provided that in each case the transferee agrees in writing to be bound by the terms of the Insider Letter. In connection with the Purchase, the parties also entered into a joinder to and amendment of the Registration Rights Agreement that removed lock‑up obligations under that agreement for the New Sponsor.

General and Administrative Services

Commencing on the effective date of the Initial Public Offering on April 24, 2025 and through the earlier of the Company’s consummation of a Business Combination or its liquidation, the Company has agreed to pay the Sponsor or an affiliate thereof a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. For the three months ended September 30, 2025, the Company had incurred and paid the Prior Sponsor $30,000 of administrative costs and for the nine months ended September 30, 2025, the Company had incurred and paid the Prior Sponsor $50,000 of administrative costs. Pursuant to the Purchase Agreement executed on September 18, 2025, the Administrative Services Agreement with the Prior Sponsor was terminated and no further fees were accrued thereafter.

CEO Advisory Agreement

Effective October 2025, the Company agreed to pay a monthly advisory fee of $15,000 to the Chief Executive Officer, Kevin McGurn, to provide advisory services to the Company in connection with identifying, investigating, negotiating and completing the Company’s initial Business Combination and related matters. The advisory fee continues on a monthly basis until the earliest to occur of (i) the closing and completion of the Company’s initial Business Combination or (ii) the liquidation of the Company. Other than the foregoing, none of the Company’s officers or directors have received any compensation for services rendered to the Company. For the three and nine months ended September 30, 2026, the Company has incurred $0 and $56,250, respectively, in advisory fees and paid $0 and $101,250, respectively. As of September 30, 2026 and December 31, 2025, there was $0 and $45,000 outstanding under the agreement. The obligation to pay this monthly advisory fee terminated upon the resignation of Mr. McGurn as Chief Executive Officer on April 22, 2026. There are $11,109 of accrued expense reimbursements for Mr. McGurn as of September 30, 2026 and December 31, 2025 recorded to accrued expenses in the condensed balance sheets.

Promissory Notes — Related Party

On August 1, 2024, the Prior Sponsor issued an unsecured promissory note (the “Promissory Note”) to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of up to $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2024, or (ii) the consummation of the Initial Public Offering. On March 14, 2025, the Company amended and restated the Promissory Note to extend the maturity date of the Promissory Note from December 31, 2024 to December 31, 2025. As of September 30, 2026 and December 31, 2025, there was nothing outstanding under the Promissory Note. As of September 30, 2026, the Promissory Note is not available for further draw down.

Working Capital Note

On September 30, 2026, the Company (the “Maker”) issued a convertible unsecured promissory note (the “Working Capital Note”) in the aggregate principal amount of $250,000 to the New Sponsor (the “Payee”) in order to provide the Company with additional working capital. The Working Capital Note is non-interest bearing and payable on the earlier of (i) the date on which the Company consummates its initial Business Combination or (ii) the date that the winding up of the Maker is effective. Upon the consummation of the initial Business Combination and at the Payee’s option, at any time prior to payment in full of the principal balance, the Payee may elect to convert all or any portion of the Working Capital Note into that number of units of the post-business combination entity (the “New Units”) equal to: (i) the portion of the principal amount of the Working Capital Note being converted, divided by (ii) $10.00, rounded down to the nearest whole number. Each New Unit shall consist of the same securities as those contained in the units issued in the Maker’s initial public offering. On November 8, 2026, the Payee agreed to loan up to an additional $500,000 to the Company for working capital purposes and, in order to document such additional loan, the Company issued to the Payee an amended and restated convertible unsecured promissory note (the “A&R Working Capital Note”) in the aggregate principal amount of up to $750,000, which

16

Table of Contents

​

amends, restates, supersedes and replaces the Working Capital Note in its entirety. The A&R Working Capital Note has the same interest, maturity and conversion terms as the Working Capital Note and is convertible into a maximum of 75,000 New Units.

Non-Convertible Note

On October 20, 2026, in connection with the Extension, the Company issued a non-convertible promissory note (the “Non-Convertible Note”) in the aggregate principal amount of $145,000 to the New Sponsor, in exchange for the New Sponsor’s funding of $145,000 to the Company. On October 21, 2026, the Company deposited the $145,000 into the Trust Account as the first monthly Extension Payment, extending the date by which the Company must consummate a Business Combination to November 24, 2026. The Non-Convertible Note does not accrue interest and is payable on the earlier of the date on which the Company consummates its initial Business Combination or the date that the winding up of the Company is effective (see Note 11).

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2026 and December 31, 2025, there was no amount outstanding under the Working Capital Loans.

Due to Related Party

On December 31, 2025, the Sponsor paid for certain expenses on behalf of the Company totaling $2,425. This due to related party is not a drawdown on the above Working Capital Loans, it is non-interest bearing and is due on demand. The Company repaid the Sponsor in full on March 12, 2026. As of September 30, 2026 and December 31, 2025, there is $0 and $2,425 due to a related party, respectively.

Forward Purchase Agreement

On August 27, 2026, the Company and YA II PN, Ltd. (“Sponsor Affiliate”) entered into a Confirmation of an OTC Equity Prepaid Forward Transaction, dated as of August 27, 2026 (the “Forward Purchase Agreement”), pursuant to which the Company agreed to pay to Sponsor Affiliate a prepayment amount equal to the product of up to 1,050,000 Class A ordinary shares of the Company (the “FPA Shares”) acquired by Sponsor Affiliate in open market purchases in February 2026, multiplied by the applicable per-share redemption price (the “Prepayment Amount”). The Company is expected to pay the Prepayment Amount to Sponsor Affiliate one business day following the Closing. The Forward Purchase Agreement matures 35 days after the Closing.

Prior to maturity, Sponsor Affiliate may sell FPA Shares to third parties at a price of at least $12.00 per share and pay to the Company an early termination obligation equal to the number of shares sold multiplied by the redemption price, reducing the number of FPA Shares to be returned to the Company at maturity. No FPA Shares will be delivered to the Company prior to maturity. Upon maturity, in exchange for the return of any remaining FPA Shares to the Company, the Company shall pay Sponsor Affiliate a settlement amount equal to the number of remaining FPA Shares multiplied by the redemption price, which settlement amount is fully offset by the Prepayment Amount previously paid to Sponsor Affiliate, resulting in no additional cash payment at maturity. If the Merger Agreement is terminated pursuant to its terms prior to Closing, the Forward Purchase Agreement terminates without amounts or other obligations owed by either party. Sponsor Affiliate waived redemption rights with respect to the FPA Shares during the term of the Forward Purchase Agreement.

As of September 30, 2026 and December 31, 2025, no amounts have been recorded for the Forward Purchase Agreement.

17

Table of Contents

​

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lockup restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Risks and Uncertainties

The Company’s results of operations and its ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond the Company’s control. The Company’s results of operations and its ability to consummate an initial Business Combination could be impacted by, among other things, various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics) that may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the rising conflict between Russia and Ukraine, and the rising conflicts in the Middle East, and resulting market volatility could adversely affect the Company’s ability to complete a Business Combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 3,000,000 additional Public Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts. In connection with the Initial Public Offering on April 24, 2025, the underwriters exercised the option and purchased 2,500,000 additional Public Units. On April 24, 2025, the underwriters advised the Company that they would not further exercise the option for the remaining 500,000 Public Units.

The underwriters were paid a cash underwriting discount of $0.20 per share, or $4,500,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $0.40 per share, or up to $9,000,000 in the aggregate. The deferred fee will become payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of Public Shares, for deferred underwriting commissions to be placed in the Trust Account located in the United States solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Deferred Legal Fees

As of September 30, 2026 and December 31, 2025, the Company has accrued $3,842,921 and $123,561, respectively, in legal fees that will be due at the closing of the Company’s initial Business Combination. These amounts are recorded to accrued expenses on the condensed balance sheets.

18

Table of Contents

​

NOTE 7 — SHAREHOLDERS’ DEFICIT

Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, there were no Class A Ordinary Shares issued or outstanding, excluding 22,500,000 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. On April 24, 2025, 166,667 of the 1,000,000 Founder Shares subject to forfeiture were forfeited as the underwriters did not fully exercise the over-allotment option. Only holders of the Class B ordinary shares have the right to vote on the appointment of directors prior to the Business Combination. Accordingly, as of September 30, 2026 and December 31, 2025, there were 7,500,000 Class B ordinary shares issued and outstanding.

Holders of ordinary shares will vote together as a single class on all matters submitted to a vote of shareholders except as otherwise required by law. In connection with the Business Combination with PlusAI, the Company may enter into a shareholders agreement or other arrangements with the shareholders of PlusAI or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of the Initial Public Offering.

The Founder Shares are designated as Class B ordinary shares and will automatically convert at a ratio of one-for-one into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination.

NOTE 8 — WARRANTS

As of September 30, 2026 and December 31, 2025, there were 18,818,750 warrants outstanding, including 11,250,000 Public Warrants, 7,568,750 Private Placement Warrants (inclusive of the 4,100,000 NMSI Private Placement Warrants owned by the New Sponsor that were allocated to the non-managing sponsor investors as a result of the non-managing sponsor investor’s membership interests in the Prior Sponsor).

On September 18, 2025, the Company, the Prior Sponsor and the New Sponsor entered into the Purchase Agreement. Pursuant to the Purchase Agreement, the New Sponsor (i) purchased from the Prior Sponsor (a) 7,500,000 shares of Class B Ordinary Shares and (b) 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants) for an aggregate purchase price of $7,400,000 and (ii) upon closing, became the sponsor of the Company. After the closing of the Purchase Agreement, the non-managing sponsor investors ceased to have any rights, claims, or interests in or to any Sponsor held securities.

On December 31, 2025, the Company issued an amendment to the warrant agreement that removed the settlement provision that precluded the NMSI Private Placement Warrants from equity treatment. As a result of this amendment, the Company determined that the NMSI Private Placement Warrants met the criteria for equity treatment and as such were reclassified to additional paid-in capital.

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Public Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary share pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue

19

Table of Contents

​

any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. Notwithstanding the above, if the Class A ordinary share is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants. When the price per Class A ordinary share equals or exceeds $18.00, the warrants become exercisable and the Company may redeem the outstanding Public Warrants:

●in whole and not in part;
●at a price of $0.01 per Public Warrant;
●upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and
●if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganization, recapitalizations and the like) for any 10 trading days within a 20-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by its board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of its initial Business Combination on the date of the completion of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 day trading period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per-share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the Public Warrants underlying the Public Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

20

Table of Contents

​

NOTE 9 — FAIR VALUE MEASUREMENTS

The following table presents information about the Company’s assets that are measured at fair value at September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

​

  ​ ​ ​

​

  ​ ​ ​

September 30, 

​

December 31, 

Description

 

Level

  ​ ​ ​

2026

  ​ ​ ​

2025

Assets:

 

  ​

 

​

​

​

​

  ​

Investments held in Trust Account

 

1

​

$

238,741,967

​

$

232,460,533

​

Upon consummation of the Initial Public Offering through December 31, 2025, the NMSI Private Placement Warrants were accounted for as a liability in accordance with ASC 815-40 and were presented within liabilities in the balance sheets. The Warrant liabilities were measured at fair value. On December 31, 2025, the Company issued an amendment to the warrant agreement that removed the settlement provision that precluded the NMSI Private Placement Warrants from equity treatment. As a result of this amendment, the Company determined that the NMSI Private Placement Warrants meet the criteria for equity treatment and as such were fair valued as of the date of the amendment and subsequently reclassified from warrant liabilities to additional paid-in capital. The Company fully realized the gain on the change in fair value of the warrant liability as of December 31, 2025.

The table below provides a summary of the changes in fair value of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2025:

​

  ​ ​ ​

Fair Value

​

 

Measurement

​

 

Using Level 3

​

 

Inputs Total

Balance, December 31, 2024

​

$

—

Initial fair value

​

 

4,100,000

Change in fair value of derivative warrant liabilities

​

 

2,033,664

Balance, September 30, 2025

​

$

6,133,664

​

The Company used a Monte Carlo simulation model to value the Public Warrants and NMSI Private Placement Warrants at April 24, 2025. As a result of the model, the Company marked the 11,250,000 Public Warrants and 4,100,000 NMSI Private Placement Warrants to fair values of $0.27 and $0.61 per warrant, respectively, at April 24, 2025.

​

​

  ​ ​ ​

April 24,

​

 

2025

Public Warrants

​

$

3,036,621

NMSI Private Placement Warrants

​

​

2,480,500

​

The Company used the following assumptions to value the Public Warrants and NMSI Private Placement Warrants at April 24, 2025.

Volatility

  ​ ​ ​

​

6.6

%

Risk-Free Rate

 

​

3.8

%

Dividends

​

$

0.00

​

Market Adjustment

​

 

16.7

%

Stock Price

​

$

9.87

​

Weighted Term (years)

​

 

2.83

​

​

21

Table of Contents

​

The Company used a Monte Carlo simulation model with the following assumptions to value the NMSI Private Placement Warrants at December 31, 2025.

Volatility

  ​ ​ ​

​

21.20

%

Risk-Free Rate

 

​

3.48

%

Dividends

​

$

0.00

​

Market Adjustment

​

 

14.50

%

Stock Price

​

$

10.65

​

Weighted Term (years)

​

 

1.34

​

​

​

NOTE 10 — SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reporting segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash

​

$

176,612

​

$

856,131

Investments held in Trust Account

​

$

238,741,967

​

$

232,460,533

​

​

​

​

​

​

​

​

​

​

For the 

​

​

Three Months Ended

​

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

General and administrative expenses

​

$

1,613,463

​

$

151,150

​

​

​

​

​

​

​

Interest income earned on investments held in Trust Account

​

$

2,161,724

​

$

2,380,552

​

​

​

​

​

​

​

​

​

  ​ ​ ​

For the

​

​

Nine Months Ended

​

​

September 30, 

​

​

2026

  ​ ​ ​

2025

General and administrative expenses

​

$

4,857,974

​

$

427,662

​

​

​

​

​

​

​

Interest income earned on investments held in Trust Account

​

$

6,281,434

​

$

4,114,464

​

General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also evaluates general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative expenses, as reported on the condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

Interest income earned on investments held in Trust Account are reviewed and monitored by the CODM to forecast amounts held in the Trust Account that can be utilized to consummate an initial Business Combination. The CODM also evaluates this metric to ensure the investments are generating an appropriate rate of return.

22

Table of Contents

​

All other segment items included in net income are reported on the condensed statements of operations and described within their respective disclosures.

NOTE 11 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the accompanying unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed financial statements, other than those described below.

On October 9, 2026, the Company filed the Registration Statement with the SEC in connection with the Transactions contemplated by the Merger Agreement. The Registration Statement has not yet been declared effective.

On October 19, 2026, at the Meeting, the Company’s shareholders approved, by special resolution, the IMTA Amendment, which extends the date on which Continental must liquidate the Trust Account if the Company has not completed its initial Business Combination, from October 24, 2026 up to July 24, 2027, effective immediately. Following such approval, the Company and Continental entered into the IMTA Amendment on October 19, 2026.

At the Meeting, the Company’s shareholders also approved, by special resolution, the Extension Amendment, which extends, on a monthly basis, the date by which the Company must (1) consummate an initial Business Combination, (2) cease its operations except for the purpose of winding up if it fails to complete an initial Business Combination, and (3) redeem all of the Company’s Public Shares, from October 24, 2026 up to July 24, 2027. For each monthly extension, the Company is required to deposit an Extension Payment of $145,000 into the Trust Account no later than two business days prior to the 24th day of each applicable month.

On October 20, 2026, the Company issued the Non-Convertible Note On October 21, 2026, the Company deposited the $145,000 principal amount of the Non-Convertible Note into the Trust Account as the first monthly Extension Payment, extending the date by which the Company must consummate a Business Combination to November 24, 2026. Pursuant to the terms of the Non-Convertible Note, the principal balance shall not accrue interest and shall be payable by the Company on the earlier of the date on which the Company consummates its initial Business Combination or the date that the winding up of the Company is effective.

In connection with the Extension Amendment, the Company’s shareholders elected to redeem 17,699,488 Class A ordinary shares, which represents approximately 78.66% of the 22,500,000 Class A ordinary shares that were part of the units sold in the Initial Public Offering, at a redemption price of approximately $10.63 per share. Such shareholders redeemed approximately $188,177,658 from the Trust Account. Following such redemptions, 4,800,512 Class A ordinary shares remain outstanding.

On November 8, 2026, the New Sponsor agreed to loan up to an additional $500,000 to the Company for working capital purposes, and the Company issued the A&R Working Capital Note to the New Sponsor in the aggregate principal amount of up to $750,000, which amends, restates, supersedes and replaces the Working Capital Note in its entirety. The A&R Working Capital Note is non-interest bearing, is payable on the earlier of the date on which the Company consummates its initial Business Combination or the date that the winding up of the Company is effective and is convertible at the New Sponsor’s election upon the consummation of the initial Business Combination into a maximum of 75,000 New Units at a price of $10.00 per New Unit.

​

23

Table of Contents

​

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Report under “Item 1. Financial Statements”.

Overview

We are a blank check company incorporated in the Cayman Islands on July 26, 2024, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar Business Combination with one or more businesses. On September 2, 2026, we entered into the Merger Agreement with PlusAI, as described below.

We expect to continue to incur significant costs in the pursuit of the Business Combination with PlusAI. We cannot assure you that we will complete a Business Combination with PlusAI or any other Business Combination.

We may seek to extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete our initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our Management Team.

Business Combination

On September 2, 2026, we entered into the Merger Agreement with Merger Sub I, Merger Sub II and PlusAI, pursuant to which, following the Domestication, Merger Sub I will merge with and into PlusAI, with PlusAI surviving as our wholly owned subsidiary, and immediately thereafter the surviving corporation will merge with and into Merger Sub II, with Merger Sub II surviving. In connection with the Domestication, we will change our name to “PlusAI Holdings, Inc.” Concurrently with the execution of the Merger Agreement, we also entered into the Company Voting and Support Agreements, the Sponsor Support Agreement, and the PIPE Subscription Agreements, which provide for the PIPE Investment of approximately $4.0 million to close substantially concurrently with the Closing and the Convertible Notes, which provide for the Convertible Note Investment of approximately $57,500,000 to close substantially concurrently with the Closing. The PIPE Subscription Agreements and Convertible Notes represent commitments only, and no securities have been issued or proceeds received thereunder as of the date of this Report. The Closing is subject to customary closing conditions, including approval by our shareholders and PlusAI’s stockholders, effectiveness of the Registration Statement, which we filed with the SEC on October 9, 2026, and a minimum available cash condition of $40,000,000.

Extension

To provide additional time to complete the Business Combination with PlusAI, at the Meeting our shareholders approved, by special resolution, the Extension Amendment and the IMTA Amendment, which extend the date by which we must consummate an initial Business Combination, on a monthly basis, from October 24, 2026 up to July 24, 2027. Each monthly extension requires us to deposit an Extension Payment of $145,000 into the Trust Account no later than two business days prior to the 24th day of the applicable month,

24

Table of Contents

​

and we expect to extend on a month-to-month basis as needed until the Closing. On October 21, 2026, we deposited the first Extension Payment, funded by the Non-Convertible Note, extending such date to November 24, 2026.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since July 26, 2024 (inception) through September 30, 2026 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering, and (y) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after the completion of our Business Combination. Following our Initial Public Offering, we have generated non-operating income in the form of interest income on investments held in the Trust Account. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.

For the three months ended September 30, 2026, we had a net income of $548,953, which consisted of $2,161,724 of interest income on investments held in the Trust Account and $692 of interest earned on cash held in the operating account, partially offset by general and administrative expenses of $1,613,463.

For the nine months ended September 30, 2026, we had a net income of $1,430,066, which consisted of $6,281,434 of interest income on investments held in the Trust Account and $6,606 of interest earned on cash held in the operating account, partially offset by general and administrative expenses of $4,857,974.

For the three months ended September 30, 2025, we had a net loss of $1,200,656, which consisted of a loss on the change in fair value of warrant liability of $3,469,346 and general and administrative expenses of $151,150, partially offset by $2,380,552 of interest income on investments held in the Trust Account, $10,674 of interest earned on cash held in the operating account, and a gain from forgiveness of debt of $28,614.

For the nine months ended September 30, 2025, we had a net income of $1,698,895, which consisted of $4,114,464 of interest income on investments held in the Trust Account, $17,143 of interest earned on cash held in the operating account, and a gain from forgiveness of debt of $28,614, partially offset by a loss on the change in fair value of warrant liability of $2,033,664 and general and administrative expenses of $427,662.

Liquidity and Capital Resources

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares by the Prior Sponsor and loans from the Prior Sponsor.

On April 24, 2025, we consummated our Initial Public Offering of 22,500,000 Public Units, including 2,500,000 Public Units issued pursuant to the partial exercise of the underwriters’ over-allotment option. The Public Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $225,000,000.

Following the Initial Public Offering and the Private Placement, a total of $226,125,000 ($10.05 per Unit) was placed in the Trust Account.

We incurred offering costs of $14,006,902, including underwriting fees of $4,500,000, deferred underwriting fees of $9,000,000 and other costs of $506,902.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less deferred underwriting commissions and taxes payable), to complete our initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

25

Table of Contents

​

In order to finance a working capital deficit or to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor may, but are not obligated to, loan us funds as may be required. If we complete the initial Business Combination, we would repay the Working Capital Loans. In the event that the initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into Private Placement Warrants of the post Business Combination entity at a price of $1.00 per Private Placement Warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants.

On September 30, 2026, we issued the Working Capital Note in the aggregate principal amount of $250,000 to the New Sponsor to provide us with additional working capital. The Working Capital Note is non-interest bearing and payable on the earlier of the consummation of our initial Business Combination or the effectiveness of our winding up, and, at the New Sponsor’s election upon the consummation of our initial Business Combination, all or a portion of the principal balance may be converted into New Units at a price of $10.00 per New Unit, with each New Unit consisting of the same securities as those contained in the units issued in connection with our Initial Public Offering. On November 8, 2026, the New Sponsor agreed to loan us up to an additional $500,000 for working capital purposes, and we issued the A&R Working Capital Note to the New Sponsor in the aggregate principal amount of up to $750,000, which amends, restates, supersedes and replaces the Working Capital Note in its entirety. The A&R Working Capital Note has the same interest, maturity and conversion terms as the Working Capital Note and is convertible into a maximum of 75,000 New Units.

In addition, on October 20, 2026, we issued the Non-Convertible Note in the aggregate principal amount of $145,000 to the New Sponsor to fund the first Extension Payment, which we deposited into the Trust Account on October 21, 2026. The Non-Convertible Note is non-interest bearing and payable on the earlier of the consummation of our initial Business Combination or the effectiveness of our winding up.

Our estimate of the costs of completing the Business Combination with PlusAI may be less than the actual amount necessary to do so, in which case we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

We may need to raise additional capital through loans or additional investments from our Sponsor, shareholders, officers, directors, or third parties. Our officers, directors and our Sponsor may, but are not obligated to, loan us funds as may be required. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions, coupled with being one year from mandatory liquidation, raise substantial doubt about our ability to continue as a going concern for a reasonable period of time which is considered to be one year from the date of the issuance of the unaudited condensed financial statements, the date that we will be required to cease all operations, except for the purpose of winding up, if a Business Combination is not consummated. The unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the deferred underwriting fee described below. We previously had a monthly administrative services fee of $10,000 for office space, utilities and secretarial and administrative support. We began incurring these fees on April 24, 2025. Pursuant to the Purchase Agreement executed on September 18, 2025, the Administrative Services Agreement with the Prior Sponsor was terminated.

26

Table of Contents

​

The underwriters are entitled to a deferred underwriting fee of $0.40 per share, or up to $9,000,000 in the aggregate. The deferred fee will become payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of Public Shares, for deferred underwriting commissions to be placed in a Trust Account located in the United States solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies and Estimates

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Class A Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ equity section of our balance sheet.

Net Income (Loss) Per Share

The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with the accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The Company has not considered the effect of the Public Warrants in the calculation of diluted net income per share, since the exercise of such warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

For diluted earnings per share, the Class B non-redeemable ordinary shares subject to forfeiture are included in the calculation of total diluted shares at the beginning of the interim period in which the contingency was resolved. For basic earnings per share, the forfeited Class B non-redeemable ordinary shares are considered forfeited on the date of forfeiture.

Recent Accounting Standards

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, “Disaggregation of Income Statement Expenses,” which requires disclosures of certain disaggregated income statement expense captions into specified categories within the footnotes to the financial statements. The requirements of the ASU are effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The requirements will be applied prospectively with the option for retrospective application. We are currently evaluating the impact ASU No. 2024-03 will have on our financial statements.

We do not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

27

Table of Contents

​

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2026.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

28

Table of Contents

​

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

Item 1A. Risk Factors

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in the Risk Factors section in our annual report on Form 10-K filed with the SEC on April 15, 2026 (the “Annual Report”). As of the date of this Report, we supplement those risk factors disclosed in such Annual Report with the following risk factors. Furthermore, in light of our entry into a Merger Agreement during the quarter, you should also consider the transaction-specific risks associated with the proposed Business Combination and related transactions. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Risks Related to the Company, the Domestication and the Business Combination

Unless the context otherwise requires, references in this section to “we,” “us” or the “Company” refer to the Company prior to the Closing.

The consummation of the proposed Business Combination is subject to a number of conditions and, if those conditions are not satisfied or waived, the definitive agreements relating to the proposed Business Combination, including the Merger Agreement, may be terminated in accordance with such definitive agreement’s terms and the proposed Business Combination may not be completed.

The proposed Mergers are subject to certain conditions as outlined in the Merger Agreement. If the conditions are not met, there is a risk that the Mergers may not occur as planned. Even if the Merger Agreement is approved by our shareholders, specified conditions must be satisfied or waived before the parties to the Merger Agreement are obligated to complete the proposed Business Combination. We do not control the satisfaction of all such conditions. If the closing conditions are not satisfied or waived, the proposed Business Combination will not occur, or will be delayed pending later satisfaction or waiver, and such delay may cause us and PlusAI to each lose some or all of the intended benefits of the proposed Business Combination and this could have a significant material impact on our business.

There may be significant redemptions by our Public Shareholders in connection with the Business Combination, which may leave the combined company under-capitalized.

As of October 31, 2026, there was $51,286,961 million in the Trust Account. The Merger Agreement provides that the consummation of the Business Combination is conditioned upon us having at least $5,000,001 of net tangible assets as of the Closing and available cash in the Trust Account (after redemptions) plus the gross proceeds of the PIPE Investment and the Convertible Notes, before payment of transaction expenses, being at least equal to $40,000,000 as of the Closing, subject to waiver of such condition as provided for in the Merger Agreement and the related side letter.

There can be no assurances that we will be able to retain all of the cash in the Trust Account. In particular, if a significant number of our Public Shareholders exercise their redemption right in connection with the Business Combination, the amount of cash left remaining in the Trust Account upon consummation of the Business Combination will be lower than contemplated. Raising additional financing, or increasing the equity portion of the aggregate consideration to be paid to PlusAI equityholders, in either case, if so authorized by PlusAI, may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. These considerations may limit our ability to complete the Business Combination or optimize the Domesticated SPAC’s capital structure. Any such shortfall will reduce the amount of available working capital for PlusAI, which may materially and adversely affect PlusAI’s business, financial condition and results of operations.

29

Table of Contents

​

If, before distributing the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

If, before distributing the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy or insolvency estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy or insolvency claims deplete the Trust Account, the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

Additionally, if we are forced to file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, any distributions received by our shareholders could be viewed under applicable debtor/creditor and/or bankruptcy and/or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover all amounts received by our shareholders. Because we intend to distribute the proceeds held in the Trust Account to our Public Shareholders promptly after the expiration of the time period to complete a Business Combination, this may be viewed or interpreted as giving preference to our Public Shareholders over any potential creditors with respect to access to or distributions from our assets. Furthermore, our Board may be viewed as having breached its fiduciary duties to our creditors and/or as having acted in bad faith by paying our Public Shareholders from the Trust Account prior to addressing the claims of creditors, thereby exposing itself and us to claims of punitive damages. We cannot assure you that claims will not be brought against us for these reasons.

Our Sponsor, the Sponsor Affiliate and the Insiders have agreed to vote in favor of the Business Combination, regardless of how our Public Shareholders vote.

Pursuant to the terms of the Sponsor Support Agreement, the Sponsor, Sponsor Affiliate and the Insiders have each agreed to vote their, and to cause the Sponsor Affiliate to vote its, ordinary shares, including Class B Ordinary Shares and any Public Shares held by them as of the record date for the extraordinary general meeting, in favor of the Business Combination proposal and the other proposals described in the Registration Statement. The New Sponsor holds 7,500,000 Founder Shares and 4,700,000 Private Placement Warrants, and the Sponsor Affiliate holds 1,050,000 Public Shares. Together they collectively own of record and are entitled to vote an aggregate of 69.5% of the outstanding ordinary shares. As a result, in addition to the Founder Shares and Private Placement Warrants held by such holders, we do not need any of the other of the Public Shares sold in the Initial Public Offering that remain outstanding to be voted in favor of a transaction (assuming all issued and outstanding shares are voted) in order to have such initial Business Combination approved. Accordingly the necessary shareholder approval will be received irrespective of the votes cast by our Public Shareholders.

The Sponsor, certain members of our Board and certain of our officers have interests in the Business Combination that are different from or are in addition to other shareholders in recommending that shareholders vote in favor of approval of the Business Combination proposal and approval of the other proposals described in the Registration Statement.

In considering the recommendation of our Board to vote in favor of approval of the Business Combination proposal and the other proposals, our shareholders should keep in mind that the Sponsor and the Insiders have interests in such proposals that are different from, or in addition to, the interests of our shareholders generally. In particular:

●If the Transactions or another Business Combination are not consummated by the end of the Combination Period, we will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding Public Shares for cash and, subject to the approval of our remaining shareholders and our Board, dissolving and liquidating, and subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such event, the 7,500,000 Founder Shares and the 4,700,000 Private Placement Warrants held by the Sponsor will become worthless because the holders thereof are not entitled to participate in any redemption or distribution with respect to such shares. Such shares had an aggregate market value of approximately $80,400,000 based upon the closing price of $10.72 per share on Nasdaq on November 12, 2026, the record date for the extraordinary general meeting.
●The Prior Sponsor purchased from us an aggregate of 7,500,000 Founder Shares for $25,000 and the 4,700,000 Private Placement Warrants, generating gross proceeds of $7,400,000 ($1.00 per Private Placement Warrants). Of the proceeds from the sale of the Public Shares and Private Placement Warrants, $226,125,000 was placed in the Trust Account. The New Sponsor then paid the Prior Sponsor an aggregate of $7,400,000 for the 7,500,000 Founder Shares and 4,700,000 Private Placement

30

Table of Contents

​

Warrants. The Founder Shares had an aggregate market value of approximately $80,400,000 based upon the closing price of $10.72 per share on Nasdaq on November 12, 2026, the record date for the extraordinary general meeting. The Founder Shares and the Private Placement Warrants will become worthless if we do not consummate a Business Combination by the Combination Period.
●Mark Angelo, one of our directors, and the president and manager of Yorkville Advisors Global, LP, which is the manager of the Sponsor and the investment manager of the Sponsor Affiliate, may be deemed to beneficially own our securities owned by Sponsor.
●If we are unable to complete a Business Combination within the Combination Period, our executive officers will be personally liable under certain circumstances to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by us for services rendered or contracted for or products sold to us. If we consummate a Business Combination, on the other hand, we will be liable for all such claims.
●The Sponsor and the Insiders will receive material benefits from the completion of an initial Business Combination and may be incentivized to complete the Transactions rather than liquidate (in which case the Sponsor would lose its entire investment), even if PlusAI is a less favorable target company or the terms of the Transactions are less favorable to our shareholders than an alternative transaction.
●The Sponsor has invested an aggregate of $7,400,000 (consisting of 7,500,000 Founder Shares and the 4,700,000 Private Placement Warrants), which means the Sponsor, following the Transactions, may experience a positive rate of return on their investment, even if our other shareholders experience a negative rate of return on their investment.
●The Sponsor (including its representatives and affiliates) and our directors and officers presently have, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or will be required to present a Business Combination opportunity to such entities. Accordingly, if any of such officers or directors become aware of a Business Combination opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such other entity, subject to their fiduciary duties under Cayman Islands law. The Amended and Restated Articles provide that, to the fullest extent permitted by law: (1) no individual serving as a director or an officer, among other persons, shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us, and (2) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which (a) may be a corporate opportunity for any director or officer, on the one hand, and us, on the other or (b) the presentation of which would breach an existing legal obligation of a director or officer to any other entity. We do not believe that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete the initial Business Combination.
●Our officers and directors, and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on our behalf, such as identifying and investigating possible business targets and business combinations. As of the date of this Report, such reimbursement is estimated to be approximately $3,000 in the aggregate. However, if we fail to consummate a Business Combination within the Combination Period, they will not have any claim against the Trust Account for reimbursement. Accordingly, we may not be able to reimburse these expenses if the Transactions or another Business Combination are not completed within the Combination Period.
●The continued indemnification of current directors and officers and the continuation of the current directors’ and officers’ liability insurance by obtaining a six-year “tail” policy containing terms not materially less favorable than the terms of such current insurance coverage with respect to claims existing or occurring at or prior to the Closing.

Our Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Transactions, in reaching the determination that it was advisable to consummate the Transactions, that the Transactions are just, equitable and fair and in the best interests of us and our shareholders and in recommending to our shareholders that they vote “FOR” the proposals presented at the extraordinary general meeting.

31

Table of Contents

​

Prior to the Closing, the Nasdaq or, after the Closing, the Nasdaq may delist Class A Ordinary Shares or SPAC Class A Common Stock, as applicable, from trading on its exchange, which could limit investors’ ability to transact in our securities and subject us to additional trading restrictions.

Class A Ordinary Shares are currently listed on the Nasdaq. We cannot assure you that Class A Ordinary Shares will continue to be listed on the Nasdaq in the future and prior to the Business Combination. In order to continue listing Class A Ordinary Shares on the Nasdaq prior to the Business Combination, we must maintain certain financial, distribution and stock price levels. Our continued eligibility for listing may depend on, among other things, the number of Public Shares that are redeemed in connection with the Transactions. There can be no assurance that the Domesticated SPAC will be able to comply with the continued listing standards of the Nasdaq following the Business Combination. It is possible that the Domesticated SPAC’s securities will cease to meet the Nasdaq’s listing requirements following the Business Combination. If, after the Business Combination, the Nasdaq delists SPAC Class A Common Stock from trading on its exchange for and the Domesticated SPAC is unable to list such securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, the Domesticated SPAC and its stockholders could face significant material adverse consequences including:

●a limited availability of market quotations for the Domesticated SPAC’s securities;
●reduced liquidity for the Domesticated SPAC’s securities;
●a determination that SPAC Class A Common Stock is a “penny stock” which will require brokers trading in such securities to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for the Domesticated SPAC’s securities;
●a limited amount of news and analyst coverage; and
●a decreased ability to issue additional securities or obtain additional financing in the future.

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because Class A Ordinary Shares are listed on the Nasdaq, Class A Ordinary Shares qualify as covered securities under such statute. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on the Nasdaq, our securities would not qualify as covered securities under such statute and we would be subject to regulation in each state in which we offer our securities.

The exercise of our directors’ and officers’ discretion in agreeing to changes or waivers in the terms of the Transactions may result in a conflict of interest when determining whether such changes to the terms of the Transactions or waivers of conditions are appropriate and in our shareholders’ best interest.

In the period leading up to the Closing, events may occur that, pursuant to the Merger Agreement, would require us to agree to amend the Merger Agreement, to consent to certain actions taken by PlusAI or to waive rights that we are entitled to under the Merger Agreement. Such events could arise because of changes in the course of PlusAI’s business, a request by PlusAI to undertake actions that would otherwise be prohibited by the terms of the Merger Agreement or the occurrence of other events that would have a material adverse effect on PlusAI’s business and would entitle us to terminate the Merger Agreement. In any of such circumstances, it would be at our discretion, acting through our Board, to grant our consent or waive those rights. We may waive the occurrence of a material adverse effect affecting PlusAI and consummate the Business Combination despite the occurrence of such event. If a material adverse effect affecting PlusAI occurs and the parties still consummate the Business Combination, the market trading price of the Domesticated SPAC’s securities may suffer. The existence of the financial and personal interests of the directors described in the Registration Statement may result in a conflict of interest on the part of one or more of the directors between what he, she or they may believe is best for us and what he, she or they may believe is best for himself, herself or themselves in determining whether or not to take the requested action. As of the date of this Report, we do not believe there will be any material changes or waivers that our directors and officers would be likely to make after the mailing of the Registration Statement. We will circulate a new or amended proxy statement/prospectus

32

Table of Contents

​

or supplement thereto if changes to the terms of the Transactions that would have a material impact on our shareholders are required prior to the vote on the Business Combination proposal.

We may not be able to complete the Transactions or another initial Business Combination within the Combination Period, in which case we will cease all operations except for the purpose of winding up and we would redeem our Public Shares and liquidate, in which case our Public Shareholders would only receive approximately $10.68364 per share, based on amounts in the Trust Account at October 31, 2026, or less than such amount in certain circumstances.

Pursuant to the Amended and Restated Articles, we must complete the Transactions or another initial Business Combination within the Combination Period. There can be no assurances that we will be able to complete the Business Combination or to find a suitable alternative target business within such time period. Our ability to complete an initial Business Combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and the other risks described herein. For example, the U.S. debt ceiling and budget deficit concerns have increased the possibility of credit-rating downgrades and economic slowdowns, or a recession in the United States. Financial markets also may be adversely affected by current or anticipated military conflict, including the ongoing war between Russia and Ukraine, ongoing conflicts in the Middle East, including in Iran, terrorism, sanctions or other geopolitical events globally, which could cause or continue to cause, as applicable, market disruptions, including significant volatility in commodity prices, energy prices, credit and capital markets, as well as supply chain interruptions, and adversely affect the global economy and financial markets leading to instability and lack of liquidity in capital markets. Any negative impact on the global economy, capital markets or other geopolitical conditions resulting from downgrades to the U.S. government’s sovereign credit rating or its perceived creditworthiness, the war in Ukraine and subsequent actions could adversely affect our search for a Business Combination and any target business with which we may ultimately consummate a Business Combination.

Further, any potential target business with which we enter into negotiations concerning an initial Business Combination will be aware that we must complete an initial Business Combination by the end of the Combination Period, unless we amend our articles of association to further extend the time to consummate an initial Business Combination. Consequently, if we are unable to complete this business combination, a potential target business may obtain leverage over us in negotiating an alternative initial Business Combination. This risk will increase as we get closer to the end of the Combination Period. In addition, we may have limited time to conduct due diligence and may enter into an initial Business Combination on terms that we would have rejected upon a more comprehensive investigation.

If we have not completed our initial Business Combination within the Combination Period, we will: (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law; and (3) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such case, our Public Shareholders may receive only $10.68364 per share (based on amounts in the Trust Account at October 31, 2026), or less than per share in certain circumstances where a third party brings a claim against us that the Sponsor is unable to indemnify (as described herein), on the redemption of their shares.

If our sources of working capital are insufficient, it could limit the amount available to complete our initial Business Combination. If we are unable to obtain such loans, we may be unable to complete our initial Business Combination.

If we are required to seek additional capital, we would need to borrow funds from our Sponsor, management team or other third parties to operate or may be forced to liquidate. Pursuant to the terms of the Extension Amendment, we are required to deposit an Extension Payment into the Trust Account for each monthly extension. On October 20, 2026, we issued the Non-Convertible Note to the New Sponsor in the aggregate principal amount of $145,000 in exchange for their funding to us of $145,000, and we used such funds to make the first Extension Payment, which extended the date by which we must consummate the Business Combination to November 24, 2026.

None of our Sponsor, members of our management team or any of their respective affiliates is under any obligation or other duty to loan funds to us, including to fund the monthly Extension Payments. Any such loans would be repaid only from funds held outside the Trust Account or from funds released to us upon completion of our initial Business Combination. If we are unable to complete our initial Business Combination because of insufficient funds, we will be forced to cease operations and liquidate the Trust Account. In

33

Table of Contents

​

such case, our Public Shareholders may receive only $10.68364 per share (based on amounts in the Trust Account at October 31, 2026), or less in certain circumstances.

We must fund a monthly Extension Payment to extend the date by which we must consummate an initial Business Combination, and any failure to do so, or any further extension, could have a material adverse effect on the amount held in the Trust Account and other adverse effects on us.

At the Meeting, our shareholders approved the Extension Amendment, which permits us to extend, on a monthly basis, the date by which we must consummate an initial Business Combination from October 24, 2026 up to July 24, 2027, subject to the deposit of an Extension Payment of $145,000 into the Trust Account for each monthly extension. On October 21, 2026, we deposited the first Extension Payment, funded by the Non-Convertible Note, extending such date to November 24, 2026. In connection with the Extension Amendment, holders of 17,699,488 Public Shares exercised their right to redeem such shares for an aggregate redemption amount of approximately $188,177,658, and 4,800,512 Public Shares remain outstanding. We expect to fund each subsequent Extension Payment with loans from the New Sponsor or its affiliates, none of which is obligated to make such loans. If we are unable to fund an Extension Payment when due, or if we do not complete the Business Combination by July 24, 2027, we will be required to cease operations and liquidate unless our shareholders approve a further extension, in which case our Public Shareholders would again be provided another opportunity to redeem all or a portion of their Public Shares. Any such delays in completing the Business Combination, redemptions, or any additional conditions imposed in order to complete the Business Combination, may have a material adverse effect on the amount held in the Trust Account, our capitalization, principal shareholders and other impacts on us or our officers and members of our Board, such as our ability to maintain our listing on the Nasdaq.

Uncertainty in connection with certain international economic and political relationships, including the imposition of tariffs on international trade, political disputes, regulatory changes and other international matters could have a material adverse effect on our ability to consummate the Business Combination, identify any other potential target business, and could adversely affect the financial performance of any target, either foreign or domestic.

The international economic and political environment is dynamic and subject to change. There is currently significant uncertainty about the future economic and political relationships between the United States and a number of other countries. These uncertainties include, among other things, the potential imposition of protective tariffs on goods imported from other countries and reciprocal tariffs other countries may impose on United States products, political disputes that may affect relationships between the United States and other countries and the imposition of regulatory or other restrictions on trade and commerce. Any such matters could potentially limit the number of potential targets we may consider, and could also have a material adverse effect on the financial performance of such potential targets. Among other things, historical financial performance of companies affected by these international matters may not provide as accurate a barometer of future performance as would pertain in a more stable economic environment.

Because we are incorporated under the laws of the Cayman Islands, in the event the Business Combination is not completed, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited.

Because we are currently incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests and your ability to protect your rights through the U.S. federal courts may be limited prior to the Domestication. We are currently an exempted company under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon members of our Board or our executive officers, or enforce judgments obtained in the U.S. courts against members of our Board or our officers.

Until the Domestication is effected, our corporate affairs are governed by the Amended and Restated Articles, the Companies Act (As Revised) of the Cayman Islands and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United States. The rights of shareholders to take action against members of our Board, actions by minority shareholders and the fiduciary responsibilities of members of our Board to us under the laws of the Cayman Islands are to a large extent governed by the common law of the Cayman Islands. The common law in the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands and from English common law. Appeals from the Cayman Islands Courts to the Privy Council (which is the final Court of Appeal for British overseas territories such as the Cayman Islands) are binding on courts in the Cayman Islands. Decisions of the English courts, and particularly the Supreme Court and the Court of Appeal are generally of persuasive authority but are not binding in the courts of the Cayman Islands. Decisions of courts in other Commonwealth jurisdictions are similarly of persuasive but not binding authority. The rights of our shareholders and the fiduciary responsibilities of members of our Board under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and certain states, such as

34

Table of Contents

​

Delaware, may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a federal court of the United States.

We have been advised by Harney Westwood & Riegels, our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (1) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (2) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

As a result of the above, the Public Shareholders may have more difficulty in protecting their interests in the face of actions taken by our executive officers, members of our Board or controlling shareholders than they would as Public Shareholders of a U.S. company.

The Domestication may result in adverse tax consequences for holders of Class A Ordinary Shares or Warrants.

We intend for the Domestication to qualify as a reorganization within the meaning of Section 368(a)(1)(F) of the Code, i.e., an F Reorganization (and is not otherwise treated as a reorganization within the meaning of Section 368(a)(1) of the Code). If the Domestication fails to qualify as an F Reorganization, a U.S. Holder (as defined below) generally would recognize gain or loss with respect to its Class A Ordinary Shares or Warrants in an amount equal to the difference, if any, between the sum of the fair market value of the corresponding SPAC Class A Common Stock or Warrants received in the Domestication and the U.S. Holder’s adjusted tax basis in its Class A Ordinary Shares or Warrants surrendered. U.S. Holders exercising redemption rights will be subject to the potential tax consequences of the Domestication. Additionally, Non-U.S. Holders generally will become subject to withholding tax on any amounts treated as dividends paid on common stock of the Domesticated SPAC after the Domestication.

For purposes of this risk factor, a “U.S. Holder” is a beneficial owner of our securities who or that is, for United States federal income tax purposes: (i) an individual who is a citizen or resident of the United States; (ii) a corporation (or other entity taxable as a corporation) organized in or under the laws of the United States, any state thereof or the District of Columbia; (iii) an estate whose income is subject to United States federal income tax regardless of its source; or (iv) a trust, if (a) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more United States persons (as defined in the Code) have authority to control all substantial decisions of the trust, or (b) it has a valid election in effect under Treasury Regulations to be treated as a United States person (as defined in the Code). Assuming that the Domestication qualifies as an F Reorganization, subject to the passive foreign investment company (“PFIC”) rules discussed below, U.S. Holders generally will be subject to Section 367(b) of the Code in connection with the Domestication, and, as a result:

●a U.S. Holder who is a 10% U.S. Shareholder on the date of the Domestication generally will be required to include in income as a deemed dividend deemed paid by us the “all earnings and profits amount” (as defined in the Treasury Regulations under Section 367(b) of the Code) attributable to the Class A Ordinary Shares held directly by such U.S. Holder;
●a U.S. Holder whose Class A Ordinary Shares have a fair market value of $50,000 or more on the date of the Domestication and who, on the date of the Domestication, is not a 10% U.S. Shareholder generally will recognize gain (but not loss) with respect to its Class A Ordinary Shares as if such U.S. Holder exchanged its Class A Ordinary Shares for SPAC Class A Common Stock in a taxable transaction, unless such U.S. Holder elects in accordance with applicable Treasury Regulations to include in income as a deemed dividend deemed paid by us the “all earnings and profits” amount (as defined in the Treasury Regulations under Section 367(b) of the Code) attributable to such U.S. Holder’s Class A Ordinary Shares; and
●a U.S. Holder whose Class A Ordinary Shares have a fair market value of less than $50,000 on the date of the Domestication and who, on the date of the Domestication, is not a 10% U.S. Shareholder, generally will not recognize any gain or loss or include any part of our earnings and profits in income under Section 367 of the Code in connection with the Domestication.

35

Table of Contents

​

Additionally, even if the Domestication qualifies as an F Reorganization, proposed Treasury Regulations promulgated under Section 1291(f) of the Code and certain other PFIC rules (which have retroactive proposed effective dates) generally require that a U.S. person who disposes of stock of a PFIC (including for this purpose, under a proposed Treasury Regulation that generally treats an “option” to acquire the stock of a PFIC as stock of the PFIC, exchanging Warrants for newly issued warrants of the Domesticated SPAC in the Domestication) must recognize gain equal to the excess of the fair market value of such PFIC stock over its adjusted tax basis, notwithstanding any other provision of the Code. We believe that we are likely classified as a PFIC for U.S. federal income tax purposes. As a result, these proposed Treasury Regulations, if finalized in their current form, would generally require a U.S. Holder of Class A Ordinary Shares to recognize gain under the PFIC rules on the exchange of Class A Ordinary Shares for SPAC Class A Common Stock pursuant to the Domestication unless such U.S. Holder has made certain tax elections with respect to such U.S. Holder’s Class A Ordinary Shares. The proposed Treasury Regulations provide coordinating rules with other sections of the Code, including Section 367(b), which affect the manner in which the rules under such other sections apply to transfers of PFIC stock. These proposed Treasury Regulations, if finalized in their current form, would also apply to a U.S. Holder who exchanges Warrants for newly issued warrants of the Domesticated SPAC; under current law, however, the elections mentioned above do not apply to Warrants. Any gain recognized from the application of the PFIC rules described above would be taxable income with no corresponding receipt of cash. The tax on any such gain would be imposed at the rate applicable to ordinary income and an interest charge would apply based on complex rules designed to offset the tax deferral to such U.S. Holder on our undistributed earnings, if any. It is not possible to determine at this time whether, in what form, and with what effective date, final Treasury Regulations under Section 1291(f) of the Code may be adopted or how any such Treasury Regulations would apply.

All investors in our securities are urged to consult their tax advisors for the tax consequences of the Domestication to their particular situation. The opinion of DLA Piper LLP (US), a copy of which is attached as an exhibit to the Registration Statement, expresses no opinion on the potential U.S. federal income tax consequences of the Domestication pursuant to Section 367 of the Code or the PFIC rules.

Upon the Closing, the rights of holders of SPAC Class A Common Stock arising under the DGCL will differ from and may be less favorable to the rights of holders of ordinary shares arising under the Companies Act (As Revised) of the Cayman Islands.

Upon the Closing, the rights of holders of SPAC Class A Common Stock will arise under the DGCL. The DGCL contains provisions that differ in some respects from those in the Companies Act (As Revised) of the Cayman Islands. Therefore, some rights of holders of SPAC Class A Common Stock could differ from the rights that holders of ordinary shares currently possess.

Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

If we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it were proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our Board may be viewed as having breached their fiduciary duties to our creditors or as having acted in bad faith, exposing themselves and us to claims, by paying Public Shareholders from the Trust Account prior to addressing the claims of creditors. The claims may be brought against us for these reasons. Our Board and our officers who knowingly and willfully authorized or permitted any distribution to be paid out of the share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offense and may be liable for a fine of $18,293 and imprisonment for five years in the Cayman Islands.

Activities taken by us, the Sponsor and/or our existing shareholders to increase the likelihood of approval of the Business Combination proposal and the other proposals described in the Registration Statement could have a depressive effect on the ordinary shares.

At any time prior to the extraordinary general meeting, during a period when they are not then aware of any material nonpublic information regarding us or our securities, the Sponsor, directors, officers, advisors or any of their respective affiliates and/or their respective affiliates may purchase shares from institutional and other investors who vote, or indicate an intention to vote, against the Business Combination proposal, or execute agreements to purchase such shares from such investors in the future, or they may enter into transactions with such investors and others to provide them with incentives to acquire ordinary shares or vote their shares in favor of the Business Combination proposal. While the exact nature of any such transactions, if any, has not been determined, the purpose of such share purchases and other transactions would be to decrease the number of redemptions to increase the likelihood of satisfaction of the requirements to consummate the Transactions. Entering into any such arrangements may have a depressive effect on ordinary shares.

36

Table of Contents

​

For example, as a result of these arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely to sell the shares they own, either prior to or immediately after the extraordinary general meeting. Further, the public “float” of the Public Shares and the number of beneficial holders of our securities may be reduced as a result of such purchases, possibly making it difficult to obtain or maintain the quotation, listing or trading of our securities on Nasdaq or any other stock exchange. As of the date of this Report, no such transactions have occurred nor are they planned to occur. We will file a Current Report on Form 8 - K to disclose arrangements entered into or significant purchases made by any of the aforementioned persons that would affect the vote on the Business Combination proposal or the redemption threshold. Any such report will include descriptions of any arrangements entered into or significant purchases by any of the aforementioned persons.

There are risks to unaffiliated investors by taking PlusAI public through a merger rather than through an underwritten offering.

Unaffiliated investors are subject to certain risks as a result of PlusAI going public through a merger rather than through a traditional underwritten initial public offering. Unlike a traditional underwritten initial public offering of PlusAI securities, the initial listing of the SPAC Class A Common Stock as a result of the Business Combination will not involve a book-building process as is the case in an underwritten public offering, or underwriter support to help stabilize, maintain or affect the public price of the new issue immediately after listing.

In any underwritten public offering, the initial value of a company is set by investors who ind icate the price at which they are prepared to purchase shares from the underwriters. In the case of a special purpose acquisition company transaction, the value of the company is established by means of negotiations between the target company, the special purpose acquisition company and, in some cases, investors who agree to purchase shares at the time of the Business Combination. The process of establishing the value of a company in a special purpose acquisition company business combination may be less effective than the book-building process in an underwritten public offering and also does not reflect events that may have occurred between the interim period. In addition, underwritten public offerings are frequently oversubscribed resulting in additional potential demand for shares in the aftermarket following the underwritten public offering. There is no such book of demand built up in connection with a special purpose acquisition company transaction and no underwriters with the responsibility of stabilizing the share price, which may result in the share price being harder to sustain after the transaction.

In addition, since no underwriter is involved in the Business Combination, no underwriter due diligence has been conducted on PlusAI in order to establish a due diligence defense with respect to the disclosure presented in the Registration Statement. Section 11 of the Securities Act (“Section 11”) imposes liability on parties, including underwriters, involved in a securities offering if the registration statement contains a materially false statement or material omission. To effectively establish a due diligence defense against a cause of action brought pursuant to Section 11, a defendant, including an underwriter, carries the burden of proof to demonstrate that such defendant, after reasonable investigation, believed that the statements in the registration statement were true and free of material omissions. In order to meet this burden of proof, underwriters in a registered offering typically conduct extensive due diligence of the registrant and vet the registrant’s disclosure. Such due diligence may include calls with the issuer’s management, review of material agreements, and background checks on key personnel, among other investigations. If such investigation had occurred, certain information in the Registration Statement may have been presented in a different manner or additional information may have been presented at the request of such underwriter.

The lack of such a process in connection with the listing of the Domesticated SPAC’s securities could result in diminished investor demand, inefficiencies in pricing and a more volatile public price for Domesticated SPAC’s securities during the period immediately following the listing than in connection with an underwritten initial public offering.

In addition, the Sponsor and the Insiders have interests in the Business Combination that may conflict with the interests of our stockholders and that would not be present in a traditional underwritten public offering of the SPAC Class A Common Stock.

The estimated net cash per share of ordinary shares that will be contributed to the Domesticated SPAC in the Business Combination is less than the redemption price.

Each Public Unit sold in the Initial Public Offering at an offering price of $10.00 per Public Unit consisted of one Public Share and one-half of one Public Warrant. Of the proceeds we received from the Initial Public Offering and the Private Placement, $226,125,000 (or $10.05 per Public Unit) was placed in our Trust Account. We will provide our shareholders the opportunity to redeem all or a portion of the Public Shares in connection with the completion of the Business Combination, and potentially upon the occurrence of certain other events prior to the Business Combination. Any holder of Public Shares will be entitled to demand that such holder’s shares be redeemed for cash in an amount equal to their pro rata portion of the funds held in the Trust Account. Such amount, less any taxes

37

Table of Contents

​

payable, will be paid promptly upon consummation of the Business Combination. As a result, our Public Shareholders who own our Public Shares on a redemption date can anticipate receiving the redemption price in connection with a redemption for each Public Share that they choose to redeem.

There can be no assurance that, after the Business Combination, our Public Shareholders would be able to sell their shares in the post-business combination company for the redemption price, or any higher price. It is therefore possible that the share price of the Domesticated SPAC may decline below the redemption price. In recent years, the share prices of many post-business combination companies have fallen following a Business Combination. As a result, if our Public Shareholders continue to hold shares in the Domesticated SPAC following the Business Combination, we cannot assure our shareholders that the trading price of such shares will be greater than the redemption price.

Our shareholders will experience dilution as a consequence of, among other transactions, the issuance of shares and securities exercisable into shares of the Domesticated SPAC as consideration in the Business Combination. Having a minority share position may reduce the influence that our current stockholders have on the management of the Domesticated SPAC.

Our current Public Shareholders will experience dilution as a consequence of the Transactions. Further, any additional private placement or strategic commercial transaction that may be entered into prior to the Closing may result in additional dilution to our current Public Shareholders. For example, in March 2026, TRATON and PlusAI entered into an Autonomy Acceleration Program Agreement to expand their global partnership to accelerate autonomous truck commercialization, which contemplates that TRATON will receive warrants to purchase up to 7,500,000 shares of SPAC Class A Common Stock at an exercise price of $11.50 per share.

Following the Closing, stockholders of the Domesticated SPAC may also experience significant dilution from the conversion of the Public Warrants, the Private Placement Warrants, the warrants issued in the PIPE Investment and the Convertible Notes, to the extent such securities are exercised or converted at a time when the exercise and/or conversion price of such securities is less than the then-current price of the SPAC Class A Common Stock.

Having a minority ownership interest in the Domesticated SPAC may reduce the influence that our Public Shareholders have on the management of the Domesticated SPAC.

The Domesticated SPAC’s actual financial information and results of operations may differ materially from the unaudited pro forma condensed combined financial information included in the Registration Statement.

We and PlusAI currently operate as separate companies and have had no prior history as a combined entity. Our and PlusAI’s operations have not previously been managed on a combined basis. The Registration Statement includes unaudited pro forma condensed combined financial statements for the Domesticated SPAC. The unaudited pro forma condensed combined statement of loss of the Domesticated SPAC combines our historical audited results of operations and those of PlusAI.

The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only, are based on certain assumptions, address a hypothetical situation and reflect limited historical financial data. Therefore, the unaudited pro forma condensed combined financial statements are not necessarily indicative of the results of operations and financial position that would have been achieved had the Business Combination been consummated on the dates indicated above, or the future consolidated results of operations or financial position of the Domesticated SPAC. The pro forma adjustments are based on the information currently available and the assumptions and estimates underlying the pro forma adjustments are described in the accompanying notes. Additionally, we may enter into one or more financings or strategic commercial transactions prior to Closing providing for the sale of SPAC Class A Common Stock and/or securities convertible into SPAC Class A Common Stock, including but not limited to preferred stock, notes and warrants, on terms that are not yet known and may be less favorable than the terms of prior financing arrangements. For example, in March 2026, TRATON and PlusAI entered into an Autonomy Acceleration Program Agreement, which contemplates that TRATON will receive warrants to purchase up to 7,500,000 shares of SPAC Class A Common Stock at an exercise price of $11.50 per share.

The assumptions used in preparing the unaudited pro forma financial information may not prove to be accurate and other factors may affect the Domesticated SPAC’s financial condition or results of operations following the Closing. Any potential decline in the Domesticated SPAC’s financial condition or results of operations may cause significant variations in the price of the Domesticated SPAC’s securities.

38

Table of Contents

​

Our warrant agreement, which will be amended and restated pursuant to an Amended and Restated Warrant Agreement upon the Closing, designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of our warrant holders to obtain a favorable judicial forum for disputes with us.

In connection with the Closing, we, PlusAI and Continental will enter into the Amended and Restated Warrant Agreement, pursuant to which, among other things, the warrant agreement will be amended to cause each Warrant to represent the right to receive, from the Closing, a warrant to purchase one share of SPAC Class A Common Stock, on the terms and subject to the conditions set forth therein. All of our warrants under the Amended and Restated Warrant Agreement will no longer be exercisable for Class A Ordinary Shares, but instead will be exercisable for SPAC Class A Common Stock.

The Amended and Restated Warrant Agreement will provide that, subject to applicable law, (1) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (2) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. We note, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

Notwithstanding the foregoing, these provisions of the Amended and Restated Warrant Agreement do not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of the Public Warrants shall be deemed to have notice of and to have consented to the forum provisions in the Amended and Restated Warrant Agreement. If any action, the subject matter of which is within the scope of the forum provisions of the Amended and Restated Warrant Agreement is filed in a court other than a court of the State of New York located in the County of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of the Public Warrants, such holder shall be deemed to have consented to: (1) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions, and (2) having service of process made upon such warrant holder in any such action brought in such court to enforce the forum provisions by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

This choice-of-forum provision may limit a warrant holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Warrant holders who are unable to bring their claims in the judicial forum of their choosing may be required to incur additional costs in pursuit of actions which are subject to our choice-of-forum provisions. Alternatively, if a court were to find this provision of our Amended and Restated Warrant Agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors.

Changes in laws, regulations or rules, or a failure to comply with any laws, regulations or rules, may adversely affect our business, including our ability to negotiate and complete the Business Combination, investments and results of operations.

We are subject to laws, regulations and rules enacted by national, regional and local governments and the Nasdaq. In particular, we are required to comply with certain SEC, the Nasdaq and other legal or regulatory requirements. Compliance with, and monitoring of, applicable laws, regulations and rules may be difficult, time consuming and costly. Those laws, regulations or rules and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws, regulations or rules, as interpreted and applied, could have a material adverse effect on our business, including its ability to consummate the Business Combination, investments and results of operations.

On January 24, 2024, the SEC adopted the certain rules and regulations which became effective on July 1, 2024, requiring, among other items, (i) additional disclosures relating to SPAC sponsors and related persons; (ii) additional disclosures relating to SPAC business combination transactions; (iii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their Affiliates in both SPAC initial public offerings and business combination transactions; (iv) additional disclosures regarding projections included in SEC filings in connection with proposed Business Combination transactions; and (v) the requirement that both the SPAC and its

39

Table of Contents

​

acquisition target be co-registrants for business combination registration statements (the “2024 SPAC Rules”). Changes in guidance from the SEC or industry-wide consensus could result in additional changes in the accounting treatment related to special purpose acquisition companies. Changes could result in the identification of accounting errors in our previously issued financial statements, restatements of our previously issued financial statements, the filing of notices that previously issued financial statements may not be relied upon, and findings of material weaknesses and significant deficiencies in internal controls over financial reporting. In addition, changes in accounting treatment, or the time required to evaluate any such changes, could delay our ability to consummate an initial Business Combination or otherwise have a material adverse effect on our ability to consummate the Business Combination with PlusAI, or another Business Combination.

In addition, the SEC’s adopting release provided the further guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act, including its duration, asset composition, business purpose and the activities of the SPAC and its management team in furtherance of such goals (the “SPAC Guidance”).

We and PlusAI have incurred and expect to incur significant costs associated with the Business Combination, which could be higher than currently anticipated. Whether or not the Business Combination is completed, the incurrence of these costs will reduce the amount of cash available to be used for other corporate purposes by us if the Business Combination is not completed.

We and PlusAI have both incurred and expect to continue to incur significant costs associated with consummating the Business Combination. Certain transaction expenses incurred in connection with the Business Combination, including legal, accounting, consulting, investment banking and other fees, expenses and costs, will be paid by the Domesticated SPAC following the Closing. Even if the Business Combination is not completed, we expect to incur approximately $7.5 million in expenses. These expenses will reduce the amount of cash available to be used for other corporate purposes by us if the Business Combination is not completed.

We and PlusAI will be subject to business uncertainties and contractual restrictions while the Business Combination is pending.

Uncertainty about the consummation of the Business Combination on employees and third parties may have an adverse effect on PlusAI and consequently on us. These uncertainties may impair our or PlusAI’s ability to attract, retain and motivate key personnel and could cause third parties that deal with any of us or them to defer entering into contracts or making other decisions or seek to change existing business relationships. If key employees depart because of uncertainty about their future roles and the potential complexities of the Business Combination, our or PlusAI’s business following the Business Combination could be negatively affected. Further, covenants in the Merger Agreement impede our ability to make or consider other acquisitions or complete other transactions that are not in the ordinary course of business pending completion of the Business Combination. As a result, we may be at a disadvantage to our competitors during that period. While the Merger Agreement is in effect, neither we nor PlusAI may solicit, assist, initiate, engage or facilitate the making, submission or announcement of or encourage any alternative acquisition proposal, such as a merger, material sale of assets or equity interests or other business combination, with any third party, even though any such alternative acquisition could be more favorable to our shareholders than the Transactions. If the Business Combination with PlusAI is not completed, these provisions will make it more difficult to complete an alternative business combination following the termination of the Merger Agreement due to the passage of time during which these provisions have remained in effect.

Following the consummation of the Business Combination, the Domesticated SPAC’s only significant asset will be its ownership interest in the PlusAI business, and such ownership may not be sufficiently profitable or valuable to enable the Domesticated SPAC to satisfy the Domesticated SPAC’s other financial obligations. The Domesticated SPAC does not anticipate paying any cash dividends for the foreseeable future.

Following the consummation of the Business Combination, the Domesticated SPAC will have no direct operations and no significant assets other than its ownership interest in the PlusAI business. The Domesticated SPAC will depend on the PlusAI business for distributions, loans and other payments to generate the funds necessary to meet its financial obligations, including its expenses as a publicly traded company. The earnings from, or other available assets of, the PlusAI business may not be sufficient to pay dividends or make distributions or loans to enable the Domesticated SPAC to pay any dividends on the common stock or satisfy its other financial obligations.

In addition, PlusAI has never declared or paid cash dividends on its capital stock, and it does not anticipate paying any cash dividends in the foreseeable future. PlusAI currently intends to retain its future earnings, if any, for the foreseeable future, to fund the development and growth of its business. Any future determination to pay dividends will be at the discretion of the board of directors of the Domesticated SPAC and will be dependent upon its financial condition, results of operations, capital requirements, applicable

40

Table of Contents

​

contractual restrictions and such other factors as the board of directors may deem relevant. As a result, capital appreciation in the price of SPAC Class A Common Stock, if any, will be your only source of gain on an investment in SPAC Class A Common Stock.

Subsequent to the completion of the Business Combination, the Domesticated SPAC may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on the Domesticated SPAC’s financial condition, results of operations and stock price, which could cause you to lose some or all of your investment.

Although we have conducted due diligence on the PlusAI business, we cannot assure you that this diligence will surface all material issues that may be present in such business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the PlusAI business and outside of our and PlusAI’s control will not later arise. As a result of these factors, the Domesticated SPAC may be forced to later write-down or write-off assets, restructure operations, or incur impairment or other charges that could result in losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, charges of this nature could contribute to negative market perceptions about the Domesticated SPAC or its securities. Accordingly, any of our shareholders who choose to remain stockholders of the Domesticated SPAC following the Business Combination could suffer a reduction in the value of their shares.

A market for the Domesticated SPAC’s securities may not develop, which would adversely affect the liquidity and price of the Domesticated SPAC’s securities and may limit your ability to sell such securities.

Following the Business Combination, the price of the Domesticated SPAC’s securities may fluctuate significantly due to the market’s reaction to the Business Combination and general market and economic conditions. An active trading market for the Domesticated SPAC’s securities following the Business Combination may never develop or, if developed, it may not be sustained. In addition, the price of the Domesticated SPAC’s securities after the Business Combination can vary due to general economic conditions, the Domesticated SPAC’s general business condition and the release of the Domesticated SPAC’s financial reports. Additionally, if the Domesticated SPAC’s securities become delisted from the Nasdaq for any reason, and are quoted on an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of the Domesticated SPAC’s securities may be more limited than if the Domesticated SPAC was quoted or listed on the Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

If the Business Combination’s benefits do not meet the expectations of investors, stockholders or financial analysts, the market price of the Domesticated SPAC’s securities may decline.

The benefits of the proposed Business Combination may not be realized to the extent currently anticipated by us and PlusAI, or at all. The ability to recognize any such benefits may be affected by, among other things, competition, the ability of the Domesticated SPAC to grow and manage growth profitability, maintain relationships with customers and suppliers and retain its management and key employees. If the benefits of the Business Combination do not meet the expectations of investors, stockholders or securities analysts, the market price of the Domesticated SPAC’s securities following the consummation of the Business Combination may decline. The market values of the Domesticated SPAC’s securities at the time of the Business Combination may vary significantly from their prices on the date the Merger Agreement was executed, the date of the Registration Statement, or the date on which our shareholders vote on the Business Combination.

In addition, following the Business Combination, fluctuations in the price of the Domesticated SPAC’s securities could contribute to the loss of all or part of your investment. Immediately prior to the Business Combination, there has not been a public market for stock relating to PlusAI’s business and trading in Class A Ordinary Shares has not been active. Accordingly, the valuation ascribed to the PlusAI business and Class A Ordinary Shares in the Business Combination may not be indicative of the price that will prevail in the trading market following the Business Combination.

The trading price of SPAC Class A Common Stock following the Business Combination may fluctuate substantially and may be lower than its current price. This may be especially true for companies like ours with a small public float. If an active market for the Domesticated SPAC’s securities develops and continues, the trading price of the Domesticated SPAC’s securities following the Business Combination could be volatile and subject to wide fluctuations. The trading price of SPAC Class A Common Stock following the Business Combination will depend on many factors, including those described in this “Risk Factors” section, many of which are beyond our, PlusAI’s and the Domesticated SPAC’s control and may not be related to our, PlusAI’s and the Domesticated SPAC’s operating performance. These fluctuations could cause you to lose all or part of your investment in Class A Ordinary Shares since you might be unable to sell your shares at or above the price attributed to them in the Business Combination. Any of the factors listed below could

41

Table of Contents

​

have a material adverse effect on your investment in our securities and PlusAI’s and the Domesticated SPAC’s securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of our or the Domesticated SPAC’s securities, as applicable, may not recover and may experience a further decline.

Factors affecting the trading price of the Domesticated SPAC’s securities following the Business Combination may include:

●market conditions in the broader stock market in general, or in the Domesticated SPAC’s industry in particular;
●actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to the Domesticated SPAC;
●changes in the market’s expectations about the Domesticated SPAC’s operating results;
●the public’s reaction to the Domesticated SPAC’s press releases, other public announcements and filings with the SEC;
●speculation in the press or investment community;
●actual or anticipated developments in the Domesticated SPAC’s business, competitors’ businesses or the competitive landscape generally;
●the Domesticated SPAC’s operating results failing to meet the expectation of securities analysts or investors in a particular period;
●the timing of the achievement of objectives under the Domesticated SPAC’s business plan and the timing and amount of costs it incurs in connection therewith;
●the failure to achieve regulatory approvals to support the Domesticated SPAC’s business on the timeline it expects, or at all;
●the failure of non-binding letters of intent to be converted into definitive purchase agreements at the rate that the Domesticated SPAC expects or at all;
●the failure to retain the Domesticated SPAC’s future customers;
●changes in financial estimates and recommendations by securities analysts concerning us or the market in general;
●operating and stock price performance of other companies that investors deem comparable to the Domesticated SPAC;
●changes in laws and regulations affecting the Domesticated SPAC’s business;
●commencement of, or involvement in, litigation or investigations involving the Domesticated SPAC;
●changes in the Domesticated SPAC’s capital structure, such as future issuances of securities or the incurrence of additional debt;
●the volume of SPAC Class A Common Stock available for public sale;
●any major change in the board of directors of the Domesticated SPAC or management;
●sales of substantial amounts of SPAC Class A Common Stock by its directors, officers or significant stockholders or the perception that such sales could occur;
●general economic and political conditions such as recessions, interest rates, “trade wars” and acts of war or terrorism; and
●other risk factors listed under these “Risk Factors.”

42

Table of Contents

​

Broad market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock market in general and the Nasdaq have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities, may not be predictable. A loss of investor confidence in the market for the stocks of other companies which investors perceive to be similar to us could depress our share price regardless of our business, prospects, financial conditions or results of operations. Broad market and industry factors, as well as general economic, political and market conditions such as recessions or interest rate changes, may seriously affect the market price of Class A Ordinary Shares, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our stock shortly following the Business Combination. A decline in the market price of our securities also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.

Furthermore, the stock markets in general have experienced extreme volatility, which has sometimes been unrelated to the operating performance of the issuer. The trading price of the common stock of the Domesticated SPAC may be adversely affected by third parties trying to drive down or drive up the market price. Short sellers and others, some of whom post anonymously on social media, may be positioned to profit if our stock declines or otherwise exhibits volatility, and their activities can negatively affect our stock price and increase the volatility of our stock price. These broad market and industry factors may seriously harm the market price of our common stock, regardless of our operating performance.

In addition, in the past, following periods of volatility in the overall market and the market prices of particular companies’ securities, securities class action litigations have often been instituted against these companies. Litigation of this type, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources. Any adverse determination in any such litigation or any amounts paid to settle any such actual or threatened litigation could require that we make significant payments.

Regulatory delays could cause us to be unable to consummate the Business Combination.

We are not aware of any material regulatory approvals or actions that are required for completion of the Business Combination besides the SEC’s review of the Registration Statement and the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. It is presently contemplated that if any such additional regulatory approvals or actions are required, those approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained. This includes any potential review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (“CFIUS”), on account of certain regulatory requirements related to foreign investment. We do not believe that either we or our Sponsor constitute or are controlled by a “foreign person” under applicable rules and regulations and intend to structure the post-closing board and management of the Domesticated SPAC in such a way as to limit influence over that entity exercisable by foreign persons. More specifically, the Merger Agreement contains a representation made by both us and our Sponsor as to “foreign person” status under Section 721 of the Defense Production Act of 1950, as amended, including the implementing regulations thereof, as well as a covenant restricting the composition of the board of directors of the Domesticated SPAC contained in the Merger Agreement based in part on the experiences of our Sponsor and its affiliates with prior SPAC transactions. U.S. regulatory considerations related to foreign investment controls were also among the considerations that led PlusAI to separate from its former PRC-based affiliate in connection with the Restructuring (as defined below) and to create certain low-vote preferred stock for selected holders of PlusAI. However, the primary reasons to undertake the Restructuring were related to the diverging businesses of each of such former affiliate and PlusAI and a conscious effort to increase overall stockholder value, which resulted in a fundamental shift in the business model, products offered, target customers and target geographies of PlusAI following the Restructuring.

Based on our self-assessment and future intentions, as expressed in the aforementioned representations and covenants, we do not believe that we are a “foreign person” for CFIUS purposes. However, if CFIUS considers us to be a “foreign person,” we could be subject to such foreign ownership regulatory requirements and/or CFIUS review. Please see risk factor entitled “CFIUS or other regulatory agencies may modify, delay or prevent the Business Combination.”

Because we have only a limited time to complete our initial Business Combination our failure to obtain any required regulatory approvals in connection with the Business Combination or to resolve the above-mentioned investigations within the requisite time period may require us to liquidate. If we liquidate, our Public Shareholders may only receive an amount per share based on the funds available in our Trust Account. This would also cause our shareholders to lose any potential investment opportunity in a target company and the chance of realizing future gains on our shareholders’ investment through any price appreciation in the Domesticated SPAC.

43

Table of Contents

​

CFIUS or other regulatory agencies may modify, delay or prevent the Business Combination.

CFIUS has authority to review direct or indirect foreign investments in U.S. companies. Among other things, CFIUS is empowered to require certain foreign investors to make mandatory filings, to charge filing fees related to such filings and to self-initiate national security reviews of foreign direct and indirect investments in U.S. companies if the parties to that investment choose not to file voluntarily. If CFIUS determines an investment to be a threat to national security, CFIUS has the power to unwind or place restrictions on the investment. Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on, among other factors, the nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result in “control” of a U.S. business by a foreign person always are subject to CFIUS jurisdiction. CFIUS’s expanded jurisdiction under the Foreign Investment Risk Review Modernization Act of 2018 and implementing regulations that became effective on February 13, 2020 expanded CFIUS jurisdiction to also cover, and require mandatory filings with respect to, certain investments that do not result in control of a U.S. business by a foreign person but afford certain foreign investors certain information or governance rights in a U.S. business that has the requisite nexus to “critical technologies,” “critical infrastructure” and/or “sensitive personal data.” The Merger Agreement contains a representation made by PlusAI that it does not have such a nexus.

The business combination may be subject to CFIUS and/or other foreign investment review, which depends in large part on the ultimate share ownership of the Company and Domesticated SPAC following the Business Combination, among other factors. If the Business Combination were to be subject to U.S. foreign investment review, we risk national security-related regulatory intervention, before or after closing the transaction. For example, CFIUS may decide to modify or delay the Business Combination, impose conditions with respect to such business combination, request the President of the United States to order us to divest all or a portion of PlusAI if we were to acquire it without first obtaining CFIUS approval or prohibit the Business Combination entirely. The time necessary for CFIUS or other agency review of the Business Combination or a decision to delay or prohibit the Business Combination may also prevent the Business Combination from occurring within the applicable time period required under our certificate of incorporation. These risks may limit the attractiveness of, delay or prevent us from pursuing the Business Combination.

Moreover, the process of government review, whether by CFIUS or otherwise, could be lengthy, and we have limited time to complete the Business Combination. If we are unable to consummate the Business Combination within the applicable time-period required under our certificate of incorporation, we will be required to wind up, redeem and liquidate. If we are required to wind up, redeem and liquidate, our shareholders will miss the opportunity to benefit from an investment in a target company and the appreciation in value of such investment through a Business Combination.

Legal proceedings in connection with the Business Combination, the outcomes of which are uncertain, could delay or prevent the completion of the Business Combination.

Lawsuits may be filed against us or our directors and officers in connection with the Transactions. Defending such additional lawsuits could require us to incur significant costs and draw the attention of our management team away from the Transactions. Further, the defense or settlement of any lawsuit or claim that remains unresolved at the time the Transactions are consummated may adversely affect the Domesticated SPAC’s business, financial condition, results of operations and cash flows. Such legal proceedings could delay or prevent the Business Combination from becoming effective within the agreed upon timeframe.

Currently, there is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding in the 12 months preceding the date hereof.

If third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per-share redemption amount received by shareholders may be less than $10.05 per share.

Our placing of funds in the Trust Account may not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers (other than our independent registered public accounting firm), prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Shareholders, such parties may not execute such agreements, or even if they execute such agreements, they may not be prevented from bringing claims against the Trust Account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our

44

Table of Contents

​

management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative. Making such a request of potential target businesses may make our acquisition proposal less attractive to them and, to the extent prospective target businesses refuse to execute such a waiver, it may limit the field of potential target businesses that we might pursue.

Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where we are unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. Upon redemption of our Public Shares, if we are unable to complete the Business Combination, or another initial Business Combination within the Combination Period, or upon the exercise of a redemption right in connection with the Business Combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by our Public Shareholders could be less than the $10.05 per Public Share initially held in the Trust Account, due to claims of such creditors. Pursuant to the Insider Letter, our Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (other than our independent public accounting firm) for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.05 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, in each case net of taxes payable, provided that such liability will not apply to any claims by a third party that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our Sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Business Combination, or another initial Business Combination, and redemptions could be reduced to less than $10.05 per Public Share. In such event, we may not be able to complete the Business Combination, or another initial Business Combination, and you would receive such lesser amount per share in connection with any redemption of your Public Shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Past performance by the Sponsor and members of our management team or our strategic and operating partners may not be indicative of future performance of an investment in us.

Information regarding performance by, or businesses associated with, the Sponsor and other members of our management team or our strategic and operating partners is presented for informational purposes only. Any past experience or performance, including related to acquisitions, of the Sponsor and members of our management team or our strategic and operating partners is not a guarantee either: (1) that we have successfully identified a suitable candidate for our initial Business Combination; or (2) of any results with respect to the Business Combination. You should not rely on the historical record and performance of the Sponsor and members of our management team or our strategic and operating partners as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward.

The Sponsor Support Agreement may be amended without shareholder approval.

The Sponsor Support Agreement contains provisions related to the Sponsor and Insiders’ agreement to vote their shares in favor of the Transactions and the other matters to be submitted to our shareholders in connection with the Transactions, to vote in favor of the appointment or election of individuals nominated for election of the board of directors of the Domesticated SPAC and to pay certain transaction expenses or to forfeit certain of the Founder Shares held by such Sponsor or Insider. Our Board, in exercising its business judgment and subject to its fiduciary duties, may choose to approve one or more amendments to the Sponsor Support Agreement. Any such amendments to the agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.

45

Table of Contents

​

Even if we consummate the Business Combination, there is no guarantee that the Warrants will ever be in the money, and they may expire worthless.

Upon the Closing, the Warrants will become public warrants of the Domesticated SPAC. The exercise price for the warrants of the Domesticated SPAC will be $11.50 per share of common stock of the Domesticated SPAC, subject to adjustment. There is no guarantee that the Warrants, following the consummation of the Business Combination, will ever be in the money prior to their expiration, and as such, the Warrants may expire worthless.

We may amend the terms of the Public Warrants in a manner that may be adverse to holders of Public Warrants with the approval by the holders of at least 50% of the then-outstanding Public Warrants. As a result, the exercise price of your Public Warrants could be increased, the Public Warrant could be converted into cash or shares (at a ratio different than initially provided), the exercise period could be shortened and the number of Class A Ordinary Shares purchasable upon exercise of a Public Warrant could be decreased, all without your approval.

Public Warrants are issued in registered form under a warrant agreement between Continental, as warrant agent, and us. The warrant agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then-outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants.

Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then-outstanding Public Warrants approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then-outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares (at a ratio different than initially provided), shorten the exercise period or decrease the number of Class A Ordinary Shares purchasable upon exercise of a warrant.

We may redeem your unexpired Public Warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants without value to the holder.

We have the ability to redeem the outstanding Public Warrants beginning 30 days after completion of our initial Business Combination and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day prior to the date on which we give proper notice of such redemption and provided certain other conditions are met. If and when the Public Warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the issuance of any underlying securities for sale under all applicable state securities laws. As a result, we may redeem the Public Warrants as set forth above even if the holders are otherwise unable to exercise the Public Warrants. Redemption of the outstanding Public Warrants could force you (1) to exercise your Public Warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (2) to sell your Public Warrants at the then-current market price when you might otherwise wish to hold your Public Warrants or (3) to accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of your warrants.

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial Business Combination.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including, without limitation, restrictions on the nature of our investments, restrictions on the issuance of securities, and restrictions on the enforceability of agreements entered into by us, each of which may make it difficult for us to complete the Business Combination. In addition, we may have imposed upon us burdensome requirements, including, without limitation, registration as an investment company with the SEC (which may be impractical and would require significant changes in, among other things, our capital structure); adoption of a specific form of corporate structure; and reporting, record keeping, voting, proxy and disclosure requirements and compliance with other rules and regulations that we are currently not subject to.

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets

46

Table of Contents

​

(exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business is to identify and complete a Business Combination and thereafter to operate the post-transaction business or assets for the long-term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.

It is possible that a claim could be made that we have been operating as an unregistered investment company. If we were deemed to be an investment company for purposes of the Investment Company Act, we might be forced to abandon our efforts to complete an initial Business Combination and instead be required to liquidate. If we are required to liquidate, our investors would not be able to realize the benefits of owning stock in a successor operating business, including the potential appreciation in the value of our shares following such a transaction.

We do not believe that our principal activities currently subject us to the Investment Company Act. To this end, from the time beginning with the consummation of the Initial Public Offering, the proceeds held in the Trust Account have been invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less, in money market funds meeting certain conditions under Rule 2a - 7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations or cash. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments and by subsequently holding all funds in the Trust Account in cash, which may include demand deposit accounts (as described in the following paragraph), and by having a business plan targeted at acquiring and growing businesses for the long-term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we do not believe we are an “investment company” within the meaning of the Investment Company Act.

The Initial Public Offering was not intended for persons seeking a return on investments in government securities or investment securities. The Trust Account is intended as a holding place for funds pending the earliest to occur of: (1) the completion of our primary business objective, which is a Business Combination; (2) the redemption of any Public Shares properly submitted in connection with a shareholder vote (a) to modify the substance or timing of our obligation to redeem 100% of the Public Shares if we have not consummated an initial Business Combination within the Combination Period, or (b) with respect to any other provision of the articles relating to the rights of holders of Class A Ordinary Shares or pre-initial Business Combination activity; and (3) the redemption of our Public Shares if we have not completed an initial Business Combination within the Combination Period. Because we have invested only in permitted instruments, we believe we are not an investment company. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to consummate our initial Business Combination. If we are unable to complete our initial Business Combination within the Combination Period our Public Shareholders may receive only approximately $10.05 per share on the liquidation of our Trust Account. In certain circumstances, our Public Shareholders may receive less than $10.05 per share on the redemption of their shares if we are unable to complete our initial Business Combination within the Combination Period.

To mitigate the risk of being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act of 1940, as amended), all funds in the Trust Account are held and will be held in cash (which may include demand deposit accounts) until the earlier of consummation of our initial Business Combination or liquidation.

Furthermore, such cash (which may include demand deposit accounts) is held in bank accounts, which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation (the “FDIC”). While we have only placed our Trust Account deposits with Continental, only a small portion of the funds in our Trust Account will be guaranteed by the FDIC.

We may be subject to a 1% U.S. federal excise tax in connection with redemptions of the common stock of the Domesticated SPAC.

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022, which, among other things, imposes a 1% excise tax on the fair market value of stock repurchased by “covered corporations” beginning in 2023, with certain exceptions (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from whom or which the stock is repurchased. Because we are domesticating and continuing as a Delaware corporation and our securities will continue to trade on Nasdaq, we believe that we are a “covered corporation” for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase.

However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances (such as the shares of common stock of the Domesticated SPAC being issued in the Mergers) against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax.

47

Table of Contents

​

Any redemption or other repurchase that we make after the Domestication may be subject to the Excise Tax. Whether and to what extent we would be subject to the Excise Tax would depend on a number of factors, including (1) the fair market value of the redemptions and repurchases in connection with the Business Combination, (2) the nature and amount of any equity issuances in connection with the Business Combination, including the Mergers, and (3) the content of regulations and other guidance from the U.S. Department of Treasury. Prior to the consummation of the Business Combination, funds in the Trust Account, including any interest thereon, will not be used to pay for any Excise Tax. If we consummate the Business Combination, any Excise Taxes from redemptions of Public Shares in connection with the Business Combination would reduce the funds available to PlusAI for working capital following the Business Combination.

Risks Related to the Redemption

Unless the context otherwise requires, references in this section to “we,” “our” and “us” refer to the Company prior to the Closing.

You must tender your Public Shares in order to validly exercise your redemption rights.

In connection with tendering your shares for redemption, you must request in writing that we redeem your Public Shares for cash and elect either to physically tender your share certificates to the Continental or to deliver your shares to the Continental electronically using The Depository Trust Company’s DWAC System, which election would likely be determined based on the manner in which you hold your shares, in each case, by two business days prior to the initially scheduled vote on the Business Combination proposal or such later date as our directors may determine. The requirement for physical or electronic delivery by two business days prior to the initially scheduled vote on the Business Combination proposal or such later date as our directors may determine ensures that a redeeming holder’s election to redeem is irrevocable once the Business Combination is approved. Any failure to observe these procedures will result in your loss of redemption rights in connection with the vote on the Business Combination.

The Merger Agreement provides that our and PlusAI’s respective obligations to consummate the Business Combination are conditioned on us having at least $5,000,001 of net tangible assets as of the Closing and available cash in the Trust Account (after redemptions) plus the gross proceeds of the PIPE Investment and the Convertible Notes, before payment of transaction expenses, being at least equal to $40,000,000 as of the Closing, subject to waiver of such condition as provided for in the Merger Agreement and the related side letter.

The Sponsor Affiliate holds 1,050,000 Public Shares and has agreed pursuant to the terms of the Forward Purchase Agreement not to redeem its shares in contemplation of the Business Combination, it is not expected that we would be left with less than $5,000,001 of net tangible assets as a result of redemptions by the holders of Public Shares. As a result, we may be able to complete the Business Combination even though a substantial portion of Public Shareholders do not agree with the transaction and have redeemed their shares or have entered into privately negotiated agreements to sell their shares to Sponsor, directors or officers or their affiliates. As of the date of this Report, no agreements with respect to the private purchase of Public Shares by us or the persons described above have been entered into with any such investor or holder. We will file a Current Report on Form 8 - K with the SEC to disclose private arrangements entered into or significant private purchases made by any of the aforementioned persons that would affect the vote on the Business Combination proposal or other proposals at the extraordinary general meeting.

In the event that the aggregate cash consideration that we would be required to pay for all Public Shares that are validly submitted for redemption, plus any amount required to satisfy the foregoing cash condition pursuant to the terms of the Merger Agreement, exceeds the aggregate amount of cash available to us, we may not complete the Business Combination or redeem any shares, and all Public Shares submitted for redemption will be returned to the holders thereof and we may instead search for an alternate business combination.

Public shareholders, together with any affiliates of theirs or any other person with whom they are acting in concert or as a “group,” will be restricted from seeking redemption rights with respect to more than 15% of the Public Shares.

The Amended and Restated Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13(d) of the Exchange Act), will be restricted from redeeming in the aggregate his, her or its shares or, if part of such a group, the group’s shares, in excess of 15% of the Public Shares unless such shareholder first obtains our prior consent. Your inability to redeem such excess shares will reduce your influence over our ability to consummate the Business Combination and you could suffer a material loss on your investment in us if you sell such excess shares in open market transactions.

48

Table of Contents

​

Additionally, you will not receive redemption distributions with respect to such excess shares if we consummate the Business Combination. As a result, you will continue to hold that number of shares aggregating to more than 15% of the shares sold in the Initial Public Offering and, in order to dispose of such excess shares, would be required to sell your stock in open market transactions, potentially at a loss. We cannot assure you that the value of such excess shares will appreciate over time following the Business Combination or that the market price of Public Shares will exceed the per-share redemption price. Notwithstanding the foregoing, shareholders may challenge our determination as to whether a shareholder is acting in concert or as a group with another shareholder in a court of competent jurisdiction.

However, our shareholders’ ability to vote all of their shares (including such excess shares) for or against the Business Combination is not restricted by this limitation on redemption.

There is no guarantee that a shareholder’s decision whether to redeem its shares for a pro rata portion of the Trust Account will put the shareholder in a better future economic position.

We can give no assurance as to the price at which a shareholder may be able to sell its Public Shares in the future following the completion of the Business Combination or any alternative business combination. Certain events following the consummation of any initial Business Combination, including the Business Combination, may cause an increase in our share price, and may result in a lower value realized now than one of our shareholders might realize in the future had the shareholder not redeemed its shares. Similarly, if a shareholder does not redeem its shares, the shareholder will bear the risk of ownership of the Public Shares after the consummation of any initial Business Combination, and there can be no assurance that a shareholder can sell its shares in the future for a greater amount than the redemption price set forth in the Registration Statement. A shareholder should consult the shareholder’s own tax and/or financial advisor for assistance on how this may affect his, her or its individual situation.

Our shareholders who wish to redeem their Public Shares for a pro rata portion of the Trust Account must comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline. If shareholders fail to comply with the redemption requirements specified in the Registration Statement, they will not be entitled to redeem their Public Shares for a pro rata portion of the funds held in the Trust Account.

Shareholders electing to redeem their Public Shares will receive their pro rata portion of the Trust Account less taxes payable, calculated as of two business days prior to the anticipated consummation of the Business Combination.

If, despite our compliance with the proxy rules, a shareholder fails to receive our proxy materials, such shareholder may not become aware of the opportunity to redeem its Public Shares. In addition, the proxy materials that we are furnishing to holders of Public Shares in connection with the Business Combination describes the various procedures that must be complied with in order to validly redeem Public Shares. In the event that a shareholder fails to comply with these procedures, its Public Shares may not be redeemed.

Risks Related to PlusAI

For purposes of this section only, unless the context otherwise requires, all references in this section to “PlusAI,” “we,” “us” or “our” refer to the business of PlusAI prior to the consummation of the Business Combination, which will be the business of the Domesticated SPAC and its subsidiaries following the consummation of the Business Combination. References in this subsection to the “Company” continue to refer to Texas Ventures Acquisition III Corp.

Risks Related to Our Technology, Business Model and Industry

Autonomous driving technology is an emerging technology, and we face significant technical challenges to commercialize our technology. If we cannot successfully overcome those challenges or do so on a timely basis, our ability to grow our business will be negatively impacted.

Autonomous driving technology is an emerging technology and presents major engineering challenges. The industry faces significant technical and commercial challenges, including demand for driving performance superior to human drivers, significant capital requirements, long development lead times, particularized skills and expertise required by personnel, inconsistent and evolving regulatory frameworks, a need to build public trust and brand reputation, and transitioning novel technology into real-world operation. If we are not able to overcome these challenges, in a timely manner or at all, our business, prospects, financial condition, and results of operations will be negatively impacted.

49

Table of Contents

​

Although we believe that our virtual driver software and supporting technology are promising, we have not commercially launched our software and supporting technology and cannot assure you that our technology will succeed commercially. The successful development of our virtual driver software and related technology involves many challenges and uncertainties, including:

●achieving sufficiently safe virtual driver software performance as determined by us, government and regulatory agencies, our partners, customers, and the general public;
●finalizing virtual driver software design, specification, and vehicle integration;
●successfully completing software testing, validation, and safety approvals;
●obtaining additional approvals, licenses or certifications from regulatory agencies, if required, and maintaining current approvals, licenses or certifications;
●successful collaboration with OEMs and other third parties with whom we intend to partner to develop and deploy our virtual driver software;
●•preserving core intellectual property rights, while obtaining intellectual property rights, technology or materials from third parties that may be critical to our R&D activities; and
●continuing to fund and maintain our current technology development activities.

We have incurred net losses since our inception, and we expect to incur significant expenses and continuing losses for the foreseeable future.

We have incurred net losses on an annual basis since our inception. During the six month periods ended September 30, 2026 and 2025, we incurred net losses of $7.9 million and $56.9 million, respectively. During the years ended December 31, 2025 and 2024, we incurred net losses of $93.4 million and $61.1 million, respectively. We believe that we will continue to incur operating and net losses each quarter until at least the time we have begun to scale commercial operation of our virtual driver software, which may take longer than we currently expect or may never occur. Even if we successfully develop and commercialize our virtual driver technology, there can be no assurance that we will be commercially successful. We expect the rate at which we will incur losses may be substantially higher in future periods as we continue to scale our development and begin commercialization of our technology. Because we expect to incur the costs and expenses from these efforts before we receive significant revenues from commercial launch, we expect that our losses in future periods will be significant. In addition, our development and commercialization efforts may be more expensive than we currently anticipate or these efforts may not result in revenue in the timeframes expected, or at all, which would further increase our losses.

Our limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter.

PlusAI was formed in July 2023 as a result of the restructuring (the “Restructuring”) of the operations of PlusAI Corp (“Original Plus”), which was itself originally formed in 2016. Prior to the Restructuring, Original Plus was a hardware/software combination-based model focused on retrofitting existing trucks in China. Original Plus was party to a joint venture with a Chinese heavy-duty truck manufacturer targeting the PRC market, had received a pre-order from a Chinese customer, and engaged in various development activities with other manufacturers and trucking companies primarily in China and the United States. Following the Restructuring, PlusAI shifted its geographic focus to the United States and Europe and changed its business to a software-based model focused on partnering with original equipment manufacturers (“OEMs”) to deploy its software solutions to new vehicles. Following the Restructuring, PlusAI also shifted its focus to development of L4 virtual driver software, which is characterized by full system redundancy, fault tolerance and deployment on higher-cost, higher-performance platforms that require more advanced compute and sensor configurations. Our relatively limited operating history, particularly with our new, post-Restructuring business model, makes it difficult to evaluate our future prospects and the risks and challenges we may encounter. Risks and challenges we have faced or expect to face include our ability to:

●design, develop, test, and validate our virtual driver software for commercial applications;
●produce and deliver our technology at an acceptable level of safety and performance;

50

Table of Contents

​

●attract, retain, and successfully collaborate with our OEM partners to develop and deploy our virtual driver software;
●properly price our products and services;
●plan for and manage capital expenditures for our current and future products;
●hire, integrate and retain talented people at all levels of our organization;
●forecast our revenue, budget for, and manage our expenses;
●navigate an evolving and complex regulatory environment;
●manage our supply chain and supplier relationships related to our current and future products;
●anticipate and respond to macroeconomic changes and changes in the markets in which we operate;
●maintain and enhance the value of our reputation and brand;
●effectively manage our growth and business operations, including the impacts of unforeseen market changes on our business;
●develop and protect intellectual property rights; and
●successfully develop new solutions, features, and applications to enhance the experience of partners and end-customers.

If we fail to address the risks and difficulties that we face, including those associated with the challenges listed above, as well as those described elsewhere in this “Risk Factors” section, our business, financial condition and results of operations could be adversely affected. Further, because we have limited historical financial data and operate in a rapidly evolving market, any predictions about our future revenue and expenses may not be as accurate as they would be if we had a longer operating history, both prior to and since the Restructuring, or operated in a more developed market. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently experienced by growing companies with limited operating histories in rapidly changing industries. If our assumptions regarding these risks and uncertainties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, our results of operations could differ materially from our expectations and our business, financial condition, and results of operations could be adversely affected.

Our technology may be lesser performing or developing and commercializing and scaling our technology may take us longer to complete than we currently anticipate, which would adversely impact our business, financial condition, and results of operations.

Our virtual driver software is highly technical and complex, and successful commercial deployment of our technology will require that we meet very high standards for technology performance and system safety. If we are unable to develop and commercialize our technology in a sufficiently performant or timely manner, our ability to monetize our technology will be impaired. These risks are particularly relevant for factors such as our virtual driver software’s operational domain (i.e., the conditions under which our software is designed to operate), which includes variables such as traversable road networks, speeds, and weather patterns. It is possible that there may be additional limitations in our operating capabilities that are dependent upon a number of factors, including, for example, vehicle type (e.g., car, truck) and actor density (e.g., pedestrians, cyclists). If that is the case, we may be more restricted in our addressable market opportunities.

To date, the autonomous driving industry has generally taken longer to develop than many anticipated, and it may take us longer to complete our own technology development and commercialization than is currently projected. Successful deployment of autonomous driving technology for broad use cases will require further technology improvements including, for example, handling non-compliant or unexpected actor behavior and inclement weather conditions. Developing a system that adequately manages these challenges may take us longer than expected (or may not be achieved at all), which would increase our capital requirements for technology development, delay our timeline to commercialization, and otherwise harm our business, financial condition, and results of operations.

51

Table of Contents

​

We track certain business and operational metrics that we use to make various financial and operational decisions, which are based on certain assumptions and estimates and are subject to inherent challenges in measurement and comparison with similar metrics of other businesses, and actual or perceived inaccuracies in such metrics may harm our reputation and materially adversely affect our stock price, business, results of operations, and financial condition.

We track certain business and operational metrics which may differ from estimates or similar metrics published by third parties due to differences in sources, methodologies, or the assumptions on which we rely. Our internal systems and tools are subject to a number of limitations, and our methodologies for tracking these metrics may change over time, which could result in unexpected changes to our metrics, including any metrics we publicly disclose. If the internal systems and tools we use to track these metrics undercount or overcount performance or contain algorithmic or other technical errors, the data we report may not be accurate. We use such business and operational metrics to make various financial operations decisions and, if such metrics are inaccurate or misleading, our business, results of operations, and financial condition could be harmed. Further, investors should not place undue reliance on these metrics as an indicator of our future or expected results. If investors or analysts do not perceive any metrics that we publicly disclose to be accurate representations of our business, or if we discover material inaccuracies in such metrics, our reputation, business, results of operations, and financial condition would be harmed.

For example, we have publicly disclosed a measurement of our progress toward completing the safety case and achieving full readiness for the commercial launch of SuperDrive, referred to as Safety Case Readiness. There are inherent challenges in calculating Safety Case Readiness, including the fact that management judgment is used when assessing the completeness of the supporting evidence for the safety case. If our Safety Case Readiness is not an accurate representation of our progress toward completing the safety case and achieving full readiness for the commercial launch of SuperDrive, or if investors perceive this measure not to be accurate, or if we discover material inaccuracies in Safety Case Readiness, our reputation may be significantly harmed, the timing of our commercial launch could be delayed, and our stock price could decline, any of which could materially and adversely affect our business, prospects, financial condition, and results of operations.

We operate in an intensely competitive market and some market participants have substantially greater resources. If one or more of our competitors broadly commercialize their self-driving technology before we do, develop superior technology, or are perceived to have better or safer technology, our business prospects and financial performance would be adversely affected.

The market for self-driving technology is intensely competitive and subject to rapid technological change. Our future success will depend on our ability to develop and commercialize our virtual driver software in a sufficiently timely manner in order to maintain competitiveness. Several companies, including, but not limited to, Torc Robotics, Aurora, and Kodiak Robotics are investing heavily in building self-driving technology for similar use cases to ours. If our competitors, including those previously mentioned, broadly commercialize their technology before we do, develop superior technology, or are perceived to have better or safer technology, they may capture market opportunities and establish relationships with customers and partners that might otherwise have been available to us.

Commercialization of autonomous trucking technology is currently generally limited to pilot deployments, which we and other competitors are currently performing. Competitors may initiate similar deployments in various different use cases and/or geographies earlier than we will or may perform better than we do in such deployments. Several of these competitors have substantially greater financial, marketing, research and development, and other resources than we do. In the event that one or more of these competitors broadly commercializes their technology before we do, our business prospects and financial performance would be adversely impacted.

We expect to rely on a limited number of customers for a significant portion of our future revenue. The loss of, or a reduction in our commercial relationship with, any of those customers may adversely affect our business, financial condition, and results of operations.

We expect to rely on a limited number of customers for substantially all of our future revenue. To date, we have limited revenue from the deployment of our technology and the substantial majority of our revenue has been derived from a limited number of pilot projects and other nonrecurring engineering fees. For example, during each of the periods presented in the Registration Statement, we had one contract with a revenue-generating customer. Particularly as we approach commercial launch of SuperDrive, the composition of our significant customers may vary. We believe our business, financial condition, and results of operations for the foreseeable future will continue to depend on the deployment of our software through a relatively limited number of OEMs. OEMs may decide not to distribute, or their customers may decide not to purchase, autonomous vehicles utilizing our technology or may take other actions that affect us for reasons that we cannot anticipate or control. Those reasons could relate to the OEM’s or their customer’s financial condition, changes in the OEM’s or their customer’s business strategy or operations, changes in technology, the introduction of alternative

52

Table of Contents

​

competing products, or the perceived quality or cost-effectiveness of our technology. Our agreements with certain of our OEM partners are non-exclusive and may be terminated by the OEM partner without cause with between 60 and 90 days’ written notice, subject in certain cases to the payment of a termination fee. Further, our OEM partners or their customers may not perform as well as their respective competitors, which may cause them to delay or reduce the level of their investment in autonomous vehicles utilizing our technology or decide not to renew their agreements with us, which may in turn impact our business, financial condition and results of operations. OEMs’ or their customers’ individual or aggregate needs may decline due to a number of factors, including supply chain challenges and macroeconomic conditions. Our agreements with OEMs may be cancelled on relatively short notice, including for reasons outside of our control. In addition, our OEM partners may seek to renegotiate the terms of agreements or renewals or choose not to renew or expand their licenses of our technology. We could enter into one or more strategic commercial transactions providing for the issuance of equity in the Domesticated SPAC, which may result in one or more of our OEM partners becoming a significant stockholder of the Domesticated SPAC. For example, in March 2026, TRATON and PlusAI entered into an Autonomy Acceleration Program Agreement to expand their global partnership to accelerate autonomous truck commercialization. Pursuant to the agreement, TRATON agreed to pay PlusAI up to an aggregate of $25 million upon certain agreed performance milestones, in exchange for providing certain autonomy data, tools & services to TRATON in support of the accelerated progression of their Level 2+ program. The agreement also contemplates that TRATON will receive warrants to purchase up to 7,500,000 shares of SPAC Class A Common Stock at an exercise price of $11.50 per share. If any of our OEM partners becomes a significant stockholder of the Domesticated SPAC, such partners may seek to leverage their shareholdings to receive better terms in our partnership agreements or to influence our relationships with other OEM partners. The loss of or a reduction in sales or anticipated sales to any of our OEM partners or our inability to attract new significant OEMs and other partners may adversely affect our business, financial condition, and results of operations. These risks are heightened due to the limited number of our existing and anticipated OEM partners.

Our technology may not achieve market acceptance at the pace we expect or at all.

Autonomous driving technology is an emerging technology that has not achieved general market acceptance. Any public incident involving autonomous vehicles (whether involving us or a competitor) could result in adverse publicity and decreased demand for autonomous driving technology. We will not be able to successfully commercialize our virtual driver software if we cannot gain sufficient trust in our safety and reliability. Concerns regarding the loss of human jobs to automation and artificial intelligence, and the related disruptions that may occur in the economy, may also result in adverse publicity and hinder market acceptance of autonomous driving technology. Labor unions may also raise concerns about autonomous truck safety, displacing drivers or otherwise negatively affecting employment opportunities for their members. This has in the past resulted in, and could in the future result in, negative publicity, lobbying efforts to U.S. local, state and federal authorities, or equivalent authorities in the foreign jurisdictions in which we seek to do business, to implement legislation or regulations that make it more difficult to operate our business.

As the market for autonomous vehicles matures, differences between our approach and those of our competitors will become more widely known to suppliers, insurers, regulators, and others. Until then, adverse perceptions of a single market participant may be applied to the autonomous driving industry as a whole. In that event, actions or inactions by a third-party may cause suppliers, insurers, regulators and others to refuse or cease to interact with or conduct business with the autonomous driving industry as a whole, including us. If the market does not accept and adopt our services and technology at the pace we expect or at all, it could materially and adversely affect our business, prospects, financial condition, and results of operations.

It is possible that our model does not materialize as expected, in particular as a result of our software-focused business model. This could significantly hinder our ability to generate a commercially viable product and adversely affect our business prospects.

Our business model is a software-focused approach to virtual-driving technology that is intended to flexibly integrate with a variety of OEMs. This approach is less vertically integrated than those of certain of our competitors and gives rise to a number of uncertainties regarding our business model, including:

●dependency on OEMs to integrate, deploy, and effectively commercialize our technology;
●revenue concentration associated with our limited set of OEM partners;
●our ability to realize anticipated benefits of our software-focused business model, including reduced capital requirements and operating expenses associated with ownership, deployment and commercialization of our technology;

53

Table of Contents

​

●reduced control over the cost of autonomous driving hardware and other fixed and variable costs associated with autonomous vehicle operation;
●the relative margins associated with software-focused approaches compared to vertically-integrated approaches;
●complexity associated with interoperability between our software and diverse hardware architectures; and
●product pricing.

As a result of our software-focused business model, we expect to realize certain benefits including reduced capital requirements associated with fleet ownership and operation, as well as reduced operating expenses required to market and commercialize our technology. However, such benefits may not materialize. For example, as a result of this approach our success will depend in large part on our OEM partners’ ability to integrate, deploy, and effectively commercialize our technology. We may experience significant revenue concentration with our limited set of OEM partners who may as a result have increased negotiating leverage in their dealings with us. The expected cost savings associated with our software-focused business model may not be sufficient to offset the value-sharing associated with our OEM partnerships or may cause our approach to be less profitable than vertically-integrated business models.

Moreover, autonomous driving technology is a new offering, and the appropriate price points and pricing models are as yet undetermined. While we believe that our Driver-as-a-Service (“DaaS”) model will be attractive to fleet operators, the DaaS model is unproven and may fail to gain commercial acceptance. Going forward, we expect the volume of committed DaaS contracts to be an important indicator of our future performance, and we currently have no binding commitments from fleet operators to enter into DaaS agreements. As more market participants achieve sufficient safety and autonomy to begin commercialization, increased competition may result in pricing pressure and reduced margins and may impede our ability to increase revenue or cause us to lose market share, any of which could materially and adversely affect our business, financial condition, and results of operations. Unfavorable changes in any of these or other factors, many of which are beyond our control, could materially and adversely affect our business, prospects, financial condition and results of operations.

Deployment and commercialization may be delayed due to delays in our anticipated timeline for completion and validation of acceptable safety testing and measures for our technology and the development of plans for ensuring acceptable driver-out safety, delays in the production, reliability or revision of truck and computer hardware required for our technology from our partners or suppliers.

We are currently in pilot operations with International Motors, LLC including trial operations on live commercial freight routes, however we currently have no fully driverless active deployments for SuperDrive and there can be no guarantee that such deployments will be achieved. Deployment and commercialization of our technology requires that we meet exacting standards for safety and reliability, which may be delayed. Until we have completed and validated acceptable safety testing and measures for our technology, the commercial applications of our technology will be limited, and our OEM partners’ deployment of our technology may be delayed. If our technology fails to perform as intended or its development takes longer than currently projected, our commercial competitiveness, prospects, business, financial condition and results of operations may be adversely affected.

Once validated, deployment and commercialization of our technology will also depend on our OEM partners’ manufacture and distribution of autonomous vehicles that utilize our technology. This could be subject to delays or challenges experienced by our OEM partners in integrating our technology, changes in their designs, or challenges in production of autonomous vehicles that utilize our technology, including due to potential disruption to our OEM partners’ supply chains. If our OEM partners’ deployment of our technology is subject to unforeseen delays, our commercial competitiveness, prospects, business, financial condition and results of operations may be adversely affected.

Our OEM partners and their customers, or the industry more generally, may delay, scale back or deprioritize the necessary investment required for the adoption of our technology or autonomous technology generally.

Adoption of our technology, and autonomous technology generally, involves significant changes to the manufacture and operation of trucks. Our business model is dependent on our OEM partners’ ability to sell vehicles fitted with our technology to their end fleet customers. Accordingly, our future growth is dependent on the demand for, and end fleets’ willingness to adopt, autonomous driving solutions for their trucking needs as well as regulation of autonomous driving solutions. If demand for our technology by our OEM partners and their customers is not as we anticipate, our business, results of operations and financial condition will be harmed. Our OEM

54

Table of Contents

​

partners and their customers, or the industry more generally, may delay, scale back or deprioritize the necessary investment required for the adoption of our technology or autonomous technology generally. The amount of time and capital required for our OEM partners to retool their manufacturing facilities to produce autonomous vehicles that utilize autonomous technology is significant. Our OEM partners and their customers, and the industry generally, may delay, scale back or deprioritize this investment due to financial constraints, a desire to evaluate or pursue alternative technologies, adverse safety incidents (whether involving our technology or that of a competitor), adverse publicity, political, employee or organized labor pressures, and ethical concerns regarding the use of artificial intelligence, among others. And delay in the adoption of our technology, or autonomous technology generally, could harm our business, results of operations and financial condition.

We are highly dependent on the services of our senior management team and, specifically, our Co-Founders. If we are not successful in retaining our senior management team or in attracting and retaining other highly qualified personnel, our business, financial condition, and results of operations may be harmed.

We are highly dependent on the continued services of our senior management team, which has extensive experience in the autonomous driving industry. The loss of any one or more members of our senior management team, for any reason, including resignation or retirement, could impair our ability to execute our business strategy and could materially and adversely affect our business, financial condition, and results of operations. In particular, we are highly dependent on our co-founders, who remain deeply involved in all aspects of our business, including product development. If our co-founders ceased to be involved with us, it could make it more difficult for us to, among other things, compete with other market participants, manage our R&D activities and retain existing partners or cultivate new ones.

Our success similarly hinges on the ability to attract, motivate, develop and retain a sufficient number of other highly skilled personnel, including software, systems engineering, automotive, safety, operations, design, finance, marketing, and support personnel. Competition for qualified highly skilled personnel can be strong, especially in the autonomous driving industry, and we can provide no assurance that we will be successful in attracting or retaining such personnel now or in the future. Employees may be more likely to leave us if the shares of our capital stock they own or the shares of our capital stock underlying their equity incentive awards have significantly reduced in value or the vested shares of our capital stock they own or vested shares of our capital stock underlying their equity incentive awards have significantly appreciated. The significant reduction in the value of the common stock of the Domesticated SPAC may require us to grant additional or larger individual equity incentive awards in order to prevent employee departures and to attract new personnel. The issuance of additional shares upon settlement or exercise of those awards would result in dilution to the holders of the common stock of the Domesticated SPAC and increase the number of shares eligible for resale in the public market and may have a negative impact on our stock price.

Many of our employees may receive significant proceeds from sales of our equity in the public markets once their applicable vesting restrictions are satisfied and applicable lock-up restrictions expire, which may reduce their motivation to continue to work for us. Further, any inability to recruit, develop and retain qualified employees, particularly in the highly competitive market for AI developers and engineers, may limit our ability to grow our teams as we commercialize or result in high employee turnover and may force us to pay significantly higher wages, which may harm our profitability.

Laws and regulations may also restrict our ability to attract, motivate and retain the required level of qualified personnel. For example, many of our personnel in the United States are qualified foreign nationals whose ability to live and work in the United States is contingent upon the continued availability of appropriate visas. We expect to continue to rely on foreign nationals to fill part of our recruiting needs. As a result, changes in United States immigration policies, work permit regulations, or visa requirements, including changes that limit the availability of certain work visas or increase visa fees, may adversely affect our ability to retain and hire qualified personnel. If work permits are denied, revoked, or not renewed, we may face disruptions in our operations, increased costs for hiring and training replacements, and potential delays in project execution. While it is difficult to predict the political and economic events that could affect immigration laws, or the restrictive impact they could have on obtaining or renewing work visas for our technology professionals, the current United States administration has made restricting immigration and reforming the work visa process a priority. If we are not able to continue to attract and retain, on acceptable terms, the qualified personnel necessary for the continued development of our business, we may not be able to sustain our operations or growth.

In addition, California, where we are based, recently enacted two new state laws that expand the geographic reach of California’s existing limitations on the enforceability of certain non-compete and other restrictive covenants and provide for affirmative notice of, and private enforcement rights relating to, the enforceability of certain non-compete and other restrictive covenants with respect to California-based employees. To the extent these types of non-solicitation and non-competition covenants are not enforceable against employees following any departure from employment with us, our ability to retain key personnel may be diminished and competition

55

Table of Contents

​

for human resources, customers and business may increase, which could adversely affect our financial condition, results of operations and cash flow.

Additionally, we do not carry key person insurance for any of our management executives, and the loss of any key employee or our inability to recruit, develop and retain these individuals as needed, could materially and adversely affect our business, financial condition and results of operations.

Our brand and reputation may be harmed by negative publicity or safety and other concerns, including due to any flaws or misuse of autonomous driving technologies, whether actual or perceived, intended or inadvertent, committed by us or by other third parties.

Our technology and our industry generally are frequently the subject of publicity, including negative publicity. In addition, independent industry sources may provide reports evaluating our technology, as well as those of our competitors, and the perception of our technology in the marketplace may be significantly influenced by these reports. If publicity regarding us is negative, or less positive as compared to those of our competitors, our reputation may be adversely affected.

Autonomous driving technology presents a risk of significant injury, including fatalities, and any road incidents involving vehicles associated with us may result in negative publicity, reputational damage or slower market adoption of our technology. Because autonomous vehicles represent an emerging technology with a limited history of commercial operation, they are not well understood among the public. Concerns regarding the safety of our technology, and of autonomous driving technologies generally, may result from misperceptions of us, our partners or other third parties. Moreover, because we operate in a highly competitive market with a limited history of commercialization, differences in reputation or perceived differences in safety may be particularly influential and it may be particularly challenging to address negative publicity or safety concerns should they occur. Any damage to our brand and reputation could significantly harm our business, results of operations and financial condition.

Risks Related to Our Business Operations

Our business plan requires additional capital investment. In addition, our future capital needs may require us to sell additional equity or debt securities that may dilute our stockholders. The terms of any financing that we pursue may be less favorable than previously anticipated and could become less favorable depending on the amount of capital we may require.

As a result of our limited operating history and limited historical data on the demand for our technology, our future capital requirements are uncertain and actual capital requirements may be different from those we currently anticipate. We expect to continue investing in research and development to develop and deploy our virtual driver software. While we expect the proceeds of the Business Combination to fund our operations until commercialization of our SuperDrive technology, the net cash proceeds from the Business Combination may be less than expected due to high levels of redemptions or otherwise and unexpected increases in costs or delays in the timing of the deployment of our technology, including SuperDrive, may cause us to require additional equity or debt financing to fund a portion of our future expenditures. Such financing might not be available to us in a timely manner, on favorable terms, or at all.

Our ability to obtain any necessary additional financing to carry out our business plan is subject to a number of factors, including general market conditions and investor acceptance of our business model. We may raise these additional funds through the issuance of equity, equity-linked, or debt securities. To the extent that we raise additional financing by issuing equity securities or equity-linked securities, our stockholders may experience substantial dilution. To the extent we engage in debt financing, we may become subject to restrictive covenants that may limit our flexibility in conducting future business activities. Financial institutions may request credit enhancements such as third-party guarantees and pledges of equity interest in order to extend loans to us. Additional funding may be more difficult to obtain, or may be more expensive, as a result of increases in inflation and interest rates in the U.S. economy generally. These factors may make the timing, amount, terms and conditions of such financing unattractive or unavailable to us. If we are unable to raise sufficient funds, we could have to significantly reduce our spending, delay or cancel our planned development activities, or substantially modify our business plan, which could have an adverse impact on our business and financial prospects.

Our budget for capital expenditures and expenses may exceed our expectations or there may be significant redemptions in connection with the Business Combination, in which cases we may need to raise capital sooner or change our operating plans and timelines.

We are spending significant amounts to develop our virtual driver software. Our actual cash expenses may differ materially from estimates. We expect to continue to incur operating and net losses each quarter until at least the time we begin commercial deployment of our virtual driver software at scale, which could take longer than we expect, or may not occur at all. Our operations may also prove more expensive than we anticipate or may generate lower revenue than we expect, either of which would increase our cash needs and

56

Table of Contents

​

losses. For example, our estimates and assumptions regarding our future expenses and working capital, including future sales, marketing, general and administrative expenses, research and development expenses and expected capital expenditures both before first commercial deployment of our technology and long-term, may be incorrect and actual expenses and working capital may exceed such estimates. If our cash expenditures are higher than expected, we may need to raise capital sooner than expected or change our business plans and timelines. In particular, the terms of capital available to us as a development-stage company may be less favorable than if we were to raise additional capital following successful deployment of our virtual driver software. There can be no assurance that we will be able to raise additional capital on acceptable terms or at all.

In addition, if there are significant redemptions in connection with the proposed Business Combination, we may need to make significant adjustments to our business plan and timelines and will need to seek additional capital. Depending on our available capital resources, we may need to delay or discontinue expected near-term expenditures, which could materially impact our business prospects, financial condition, results of operations and cash flows by limiting our ability to pursue some of our other strategic objectives and/or reducing the resources and third-party contracts available to further develop our design, sales, and manufacturing efforts.

We may experience difficulties in managing our growth and expanding our operations.

As we approach commercial deployment of our virtual driver software, we expect to experience significant growth in the scope and nature of our operations and, accordingly, we expect our expenses to increase as we grow. Our ability to manage our operations and future growth will require us to continue to improve our operational, financial and management controls, compliance programs and systems automation. We are also currently in the process of strengthening our compliance programs, including in relation to export controls, privacy, data protection, cybersecurity and anti-corruption. We will also need to expand our financial and accounting resources and make certain other improvements to support our complex arrangements and the rules governing revenue and expense recognition for our future operations. We may not be able to implement these improvements in an efficient or timely manner, or we may discover deficiencies in existing controls, programs, systems and procedures. Any of these challenges could have an adverse effect on the accuracy of our reporting or on our business relationships, reputation and financial results.

Forward-looking estimates and predictions as to the future deployment of our technology, and the associated adoption curve are subject to significant uncertainty and are based on assumptions and estimates that may prove inaccurate.

We use various estimates in formulating our business plans. We base our estimates upon a number of assumptions that are inherently subject to significant business and economic uncertainties and contingencies, many of which are beyond our control. Our estimates therefore may prove inaccurate, causing the actual amount to differ from our estimates. These factors include, without limitation:

●the timing and breadth of our technology’s operating domain and product models;
●the anticipated number of autonomous miles per truck;
●the expected timing and rate of deployment and adoption of our technology, including our target deployment estimates and estimated total number of L4 autonomous trucks operating in the United States and Europe in the future;
●our estimates and assumptions regarding our future expenses and working capital, including future sales, marketing, general and administrative expenses, research and development expenses and expected capital expenditures both before first commercial deployment of our technology and long-term;
●the expected future cost of truck driver labor and workforce shortages;
●the time it takes us to develop and commercialize our autonomous driving technology to scale;
●the degree of utilization achieved by our virtual driver technology;
●the savings achievable through autonomy;
●the share of the value derived from our technology relative to our OEM partners;
●our ability to maintain our relationships with our OEM partners;

57

Table of Contents

​

●growth in research and development and operating expenses;
●the extent to which our technology is successfully and efficiently deployed by our OEM partners, and our market penetration more broadly;
●the timing of when our partners and end customers adopt our technology on a commercial basis which could be delayed for regulatory, safety or reliability issues including for reasons unrelated to our technology;
●the timing of future autonomous vehicle hardware generations and vehicle platforms;
●competitive pricing pressures, including from established and future competitors;
●the amount of capital required to get to commercialization and to commercialize at scale;
●whether we can obtain sufficient capital to continue investing in core technology development and sustain and grow our business in accordance with our plans;
●the overall strength and stability of domestic and international markets, including, but not limited to trucking, passenger mobility, and local goods delivery; and
●other risk factors set forth in the Registration Statement.

In particular, our total addressable market and opportunity estimates, estimates of unit economics, pricing, cost, and customer demand that have been or may in the future be publicly disclosed are subject to significant uncertainty and are based on assumptions and estimates that may prove inaccurate. Any estimates relating to the expected size and growth of the markets for virtual driver technology in both the United States and Europe for virtual driver technology in the trucking industry are based on assumptions and estimates that may prove similarly imprecise. We are pursuing prospects in multiple markets that are undergoing rapid changes, including in technological and regulatory areas, and it is difficult to predict the timing and size of the opportunities.

Further, our targets, estimates and forecasts with respect to future deployment of our technology and expenses and working capital associated with the commercialization and deployment of our technology are based on numerous estimates and assumptions with respect to matters specific to our business and general matters, including estimates and assumptions with respect to our business and the revenue models we expect to use in connection with the deployment our technology, industry-wide business, economic, regulatory, market and financial conditions and other future events, all of which are difficult to predict and many of which are beyond our and the Company’s control. The time at which the assumptions underlying such targets, estimates and forecasts will be realized, if they are realized at all, is highly uncertain. As a result, there can be no assurance that such targets, estimates and forecasts will be realized or that actual performance will yield similar results. In addition, because the many of these targets, estimates and forecasts relate to estimates at scale, the timing of which is uncertain, such information by its nature becomes less predictive with the passage of time.

Unfavorable changes in any of the above or other factors, including around the total addressable market and market opportunity, deployment schedule and capital expenditures, most of which are beyond our control, could materially and adversely affect our business, prospects, financial condition and results of operations. There is no guarantee that we will be able to successfully commercialize our technology at scale within the addressable market opportunities presented.

Any interruption or failure of information technology and communications systems that we rely upon to operate our business could materially and adversely affect our business, financial condition and results of operations.

We currently rely on Amazon Web Services (“AWS”) to host our technology and support our technology development. The availability and quality of our services, and our ability to operate our business depends on the continued operation of AWS and other information technology, communications systems and other related products and services from third parties. Although we utilize reputable third-party service providers or vendors for telecommunications, computing, storage and hosting of a substantial portion of our data and source code, our systems and those of our providers are vulnerable to damage, interruption or any other compromise as the result of, among others, software bugs and other technical errors, physical theft, fire, terrorist attacks, natural disasters, power loss, war, telecommunications failures, viruses, ransomware, and other malicious code, denial or degradation of service attacks, social engineering schemes, insider theft or misuse or similar risks. It may become increasingly difficult to maintain and improve our performance,

58

Table of Contents

​

especially during peak usage times, as we expand the usage of our platform. Some of our systems may not be fully redundant, and our disaster recovery planning cannot account for all eventualities. Any problems with our third-party cloud hosting providers could result in lengthy interruptions in our business, adversely affecting our business, financial condition and results of operations.

We are subject to cybersecurity risks to our operational systems, security systems, infrastructure, integrated software and partners’ and end-customers’ data processed by us or third-party vendors or suppliers, and any material failure, weakness, interruption, cyber event, incident or breach of security could materially and adversely affect our business, financial condition and results of operations.

We are at risk for breaches of, and cyber events and other incidents impacting: operational systems, including business, financial, accounting, product development, data processing; facility security systems; our software; or confidential, proprietary, personally identifiable and other data, including the data of partners, customers and drivers, that we process or our third-party vendors or suppliers process on our behalf. Any such cyber incident could materially disrupt operational systems; result in the loss or disclosure of intellectual property, trade secrets or other proprietary or competitively sensitive information, technology or materials; compromise certain information of partners, customers, employees, suppliers, drivers or others, and lead to the loss or unavailability of, unauthorized access or damage to, or inappropriate access to, or use, disclosure or other processing of, confidential information and other data we maintain or otherwise process or that is maintained or otherwise processed on our behalf; jeopardize the security of our facilities; or affect the performance of our technology. Incidents such as these could result from software bugs and other technical errors, disasters, insiders (through inadvertence or with malicious intent) or malicious third parties (including nation-states or nation-state supported actors) using sophisticated, targeted methods to circumvent firewalls, encryption and other security defenses, including hacking, distributed denial of service attacks, fraud, social engineering, or other forms of deception. The techniques used by cyber attackers change frequently and may be difficult to detect for long periods of time. We may face difficulties and delays in identifying, responding to, and otherwise addressing security breaches and incidents. These challenges are compounded by recent trends toward hybrid and remote work, which may increase the risk of cyber-attacks, security breaches and incidents. Although we maintain and continue to develop information technology measures designed to protect us from cyber incidents, such measures will require updates and improvements, and we cannot guarantee that such measures will be adequate to detect, prevent or mitigate all potential cyber incidents. The implementation, maintenance, and improvement of these systems requires significant management time, support and cost. There are inherent risks associated with developing, improving, expanding and updating current systems, including the disruption of our data systems and challenges with implementing such changes. Further, we utilize reputable third-party service providers or vendors for storage and hosting of a substantial portion of our data and source code. Our business depends on OEMs and other third-party partners to integrate, deploy, and commercialize our technology, and such parties may also experience cyber incidents through no fault of our own, which could disrupt their commercialization of our technology. We cannot be sure that the systems upon which we rely, including those of our third-party vendors or suppliers, will be effectively implemented, maintained or expanded as planned, and our third-party partners, vendors or suppliers may also experience cyber incidents caused by software bugs and other technical errors, disasters, insiders, or malicious third parties. If we, or third parties on which we rely or partner with, do not successfully implement, maintain or expand systems as planned, our operations may be disrupted, we may be unable to effectively manage our data; we may be required to expend significant resources to make corrections or find alternative sources for performing these functions; we may be unable to adequately protect our intellectual property rights and proprietary or competitively sensitive information or technology; we may be unable to achieve and maintain compliance with applicable laws, regulations and contracts; our ability to accurately and timely report our financial results could be impaired and deficiencies may arise in our internal control over financial reporting.

A significant cyber incident could also harm our brand and reputation, result in indemnification obligations under our contracts with other parties or subject us to regulatory inquiries, investigations, and other proceedings, or claims, demands, or other litigation, and otherwise create material costs and liabilities, any of which could materially and adversely affect our business, financial condition and results of operations. Our insurance coverage for cyber-attacks may not be sufficient to cover all the losses we may experience as a result of a cyber incident, and any cyber incident may result in an increase in our costs for insurance or insurance not being available to us on economically feasible terms, or at all. Insurers may also deny us coverage as to any future claim. Any of these results could materially and adversely affect our business, financial condition and results of operations.

Unauthorized control, misuse or manipulation of systems in autonomous vehicles may compromise their operation, safety or data security, any of which could reduce confidence in us and our products and harm our business.

Autonomous vehicles on which our software is deployed contain complex IT systems and are designed with built-in data connectivity, including redundancy measures allowing for remote operation. Our software includes security measures intended to prevent unauthorized access to the information technology networks and systems installed in such vehicles. Hackers or third parties may attempt to bypass those protections to modify, alter, and use such networks and systems to gain control of, or to change, vehicles’ functionality, user interface and performance characteristics, or to access data stored in or generated by the vehicles. Hackers or other

59

Table of Contents

​

third parties may also attempt to gain physical access to individual vehicles to modify software, gain control of or change the vehicles’ functionality, or access data stored on the vehicles. Because the tactics used by such actors change frequently and may not be known until launched against us or our third-party service providers, there can be no assurance that we will be able to anticipate or protect against all potential attacks. Any such security incidents could result in unexpected control of or changes to the vehicles’ functionality and could compromise the safe operation of the vehicles. If hacking of autonomous vehicles occurs, is reported to have occurred or is perceived to have occurred, we may face legal claims or proceedings, regulatory inquiries, investigations, and other proceedings, and negative publicity and harm to our reputation. Similar issues, even if suffered by our competitors or other companies in the autonomous vehicle ecosystem, may also result in negative publicity and concerns about the security of autonomous vehicles in general, which could negatively affect our business, prospects, financial condition, and operating results.

Our technology may not function as intended due to flaws or errors in our software, hardware, systems or processes, product defects, or human error in administering these systems or processes, which may adversely affect our business, financial condition and results of operations.

Our software is highly technical and complex and may contain undetected flaws, errors or vulnerabilities that may cause our software not to perform as intended. Any such flaws, errors or vulnerabilities may adversely affect our business, particularly to the extent such flaws, errors or vulnerabilities are not detected and remedied quickly. Certain errors or defects in our solutions may only be discovered after they have been tested, commercialized, and deployed. Our software relies on neural networks and artificial intelligence, which are relatively newer concepts in computer science. Because software utilizing this approach is less well understood than traditional computational approaches, the prospect of undetected errors or defects may be increased. We have from time to time found defects and errors in our software, internal systems, manual processes, and technical integrations with third-party systems, including as a result of updates to our software and systems. Additionally, new errors or vulnerabilities may be introduced in the future. We may also face government inquiries or investigations, recalls and litigation, including with respect to personal injury or property damage, if our software does not operate as intended. As a result of such defects or errors, we may incur additional costs or expenses to remediate the issues. We rely on our OEM partners to deploy our software on vehicles. As a result, our control over these partners’ production and distribution is limited, which could reduce our ability to ensure proper implementation and configuration of our software or could result in changes to the hardware environment in which our software operates without our knowledge. If there are defects in the manufacture of such hardware or in the implementation and configuration of our software, we may face similar negative publicity, investigations, and litigation, and we may not be fully compensated by our OEM partners for any financial or other liability that we suffer as a result. As our business grows in size and complexity, these risks may increase.

We may also periodically release updates and functional enhancements for our software, which increase the possibility of errors. Our software is designed to rapidly process large volumes of sensor data to manipulate complex control components and navigate highly dynamic environments. As a result, the consequences of flaws or errors in our software may cause physical harm or other product safety issues. Similarly, security breaches or incidents, which may be caused by or result from cyber-attacks by hackers or others, computer viruses, worms, ransomware, other malicious software programs, security vulnerabilities, employee or service provider theft, misuse or negligence, phishing, identity theft or compromised credentials, denial-of-service attacks, or other causes, may disrupt the proper functioning of our solutions, cause errors, allow loss or unavailability of, unauthorized access to, or disclosure of, proprietary, confidential or otherwise sensitive data of ours or our customers, and other destructive outcomes. Any of the foregoing issues may lead to product recalls, result in costly and time-consuming efforts to patch or remediate our software, give rise to regulatory inquiries and investigations, and result in indemnification obligations, lawsuits and other liabilities and losses, and negative publicity and harm to our reputation, any of which may adversely affect our business, financial condition and results of operations.

We are subject to evolving and uncertain requirements regarding privacy, data protection, and cybersecurity in numerous jurisdictions and any actual or perceived failure to comply with such requirements may adversely impact our business or require changes to our policies and operations.

Our current and potential future operations and sales subject us to laws and regulations addressing privacy, data protection, cybersecurity, and the collection, use, storage, disclosure, transfer and protection of a variety of types of data. For example, the General Data Protection Regulation and California Consumer Privacy Act of 2018, as amended by the California Privacy Rights Act of 2020, provide for significant compliance obligations and potentially material penalties for non-compliance. Numerous other jurisdictions have proposed or enacted legislation addressing these matters, including state laws similar to the California Consumer Privacy Act that have taken effect, or will go into effect in the near term. These regimes may, among other things, impose privacy, data protection, and cybersecurity requirements, disclosure requirements, and restrictions on data collection, uses, and sharing that may impact our operations and the development of our business. These laws and regulations are evolving rapidly, with new laws and regulations proposed and enacted frequently in various jurisdictions. The nature of our software requires the collection and processing of data from a variety of

60

Table of Contents

​

sensors and although we endeavor to comply with laws and regulations governing the collection and processing of such data, we may not be successful in these efforts or may need to modify our software in response to changes in applicable laws and regulations. New features and functionality that we introduce, or new markets that we enter, may change our obligations under existing or future laws, regulations, contractual obligations, or other actual or asserted obligations to which we are or may become subject, including industry standards.

These laws, regulations and other obligations are rapidly evolving across jurisdictions and the full impact of these obligations on our business remains uncertain at this time. We are assessing evolving privacy, data protection, and cybersecurity regimes and measures we believe are appropriate in response. Since these regimes are evolving, uncertain, and complex, we may need to enhance or otherwise modify our compliance measures and practices as our products, markets, and customer demands further develop. We may incur significant costs, including implementation costs and costs to modify our compliance measures and practices with respect to data storage, data use, and other aspects of data processing, in response to evolving laws, regulations and obligations, and these costs may not be offset by our revenues from operating in applicable markets. In addition, we may not be able to monitor and react to all developments in a timely manner and the compliance measures we adopt may prove ineffective. Any failure, or perceived failure, by us to comply with current or future actual or asserted obligations relating to privacy, data protection, or cybersecurity under laws, regulations, or partner or customer requirements, or other obligations that apply, or are asserted to apply, to us relating to these matters, including any such actual or asserted obligations to prevent or mitigate security breaches or incidents, cyber-attacks, or improper access to, use of, or disclosure or other processing of data, or any cybersecurity issues or cyber-attacks affecting us, our data, or our business, could result in governmental enforcement actions, prosecutions, and other proceedings, private litigation, fines, penalties, and other liabilities, as well as adverse publicity, and may cause partners and customers to lose trust in us. Such events may result in significant costs (including the costs of mitigation and recovery) and liability, a material loss of revenue resulting from the adverse impact on our reputation and brand, disruption to our business and relationships and diminished ability to retain or attract partners and end-customers, any of which may have an adverse effect on our reputation and business, financial condition, and results of operations.

Issues associated with our use of artificial intelligence and machine learning, combined with an evolving and uncertain legal and regulatory environment, could materially and adversely affect our business, financial condition and results of operations.

Our software relies on artificial intelligence and machine learning technologies. There are significant risks involved in utilizing artificial intelligence. Issues relating to the use of new and evolving technologies such as artificial intelligence and machine learning may cause us to experience brand or reputational harm, competitive harm, legal liability, and new or enhanced governmental or regulatory scrutiny, and we may incur additional costs to resolve such issues. Known risks of artificial intelligence currently include inaccuracy, intellectual property infringement or misappropriation, privacy, data protection and cybersecurity issues, and data provenance disputes. Perceived or actual technical, legal, compliance, privacy, data protection, cybersecurity, ethical or other issues relating to the use of artificial intelligence may cause public confidence in artificial intelligence and machine learning technologies to be undermined, which could slow the adoption of our software. In addition, litigation or government regulation related to the use of artificial intelligence and machine learning may also adversely impact our and others’ abilities to develop and offer products that use artificial intelligence, as well as increase the cost and complexity of doing so. The use of artificial intelligence and machine learning technologies also presents emerging ethical and social issues and may draw public scrutiny or controversy and may also create or assist in producing unexpected results, flaws or errors in our software, any of which may not be easily detectable. Further, such technologies may not always operate as intended, which could lead to operational inefficiencies and risks. The rapid development of AI tools could also render obsolete certain technologies or tools we currently use, or otherwise provide competitors with a technological edge. Issues relating to our use of artificial intelligence and machine learning technologies and the evolving legal and regulatory landscape applicable to such technologies may adversely affect our reputation, business, prospects, financial condition, and results of operations.

Our customer contracts may not effectively limit our liability in the event of road or other safety incidents involving vehicles using our technology.

In the event that an autonomous vehicle on which our software was deployed experienced a crash or similar incident, our contracts with OEM partners generally apportion liability on the basis of relative fault. As such, the apportionment of liability in connection with any such safety or other incidents would need to be assessed on a case-by-case basis. Although our general approach to contract negotiations is to limit our liability to the extent such safety incidents are caused by or directly result from alleged flaws or errors in our technology, these provisions may not fully or effectively protect us from any or all claims under or as a result of federal, state, or local laws or ordinances, unfavorable judicial decisions in the United States or other countries, or otherwise. In addition, we may incur substantial costs to enforce such limitations of liability, and even claims that ultimately are unsuccessful could result in our expenditure of significant funds, diversion of management’s time and other resources, harm to our relationships with our partners, or damage to our brand and reputation.

61

Table of Contents

​

Our current or future insurance coverage may not be adequate to protect us from all business risks and sufficient insurance may not be available on commercially reasonable terms or at all.

We may be subject, in the ordinary course of business, to losses resulting from automobile liability, product liability, accidents, acts of God, and other claims against us, for which we may have no or limited insurance coverage. Further, because we operate in an emerging industry, insurance policies may not be available to us on terms and rates that are acceptable to us or at all. In addition, as a general matter, the policies that we do have may include significant deductibles or self-insured retentions, and we cannot be certain that our future insurance coverage will be available on the same terms or sufficient to cover all future losses or claims against us. A loss that is uninsured or which exceeds policy limits may require us to pay substantial amounts, which could materially and adversely affect our business, financial condition and results of operations. Further, actions or inactions of others in our industry, through no fault of our own, may materially increase the cost of insurance and/or materially decrease the coverages available to us on commercially reasonable terms. Insurance policies may not exist, or may be insufficient, for possible novel claims or causes of action which may be pled or come into existence in the future based upon our continued development of new technologies.

Our management team has limited experience in operating a public company.

Our executive officers have limited experience in the management of a publicly traded company. Our management team may not successfully or effectively manage our transition to being a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that they will likely need to devote a significant portion of their time to these activities, which will result in less time being devoted to the management and growth of our business. In addition, we may not have adequate personnel with the appropriate level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States. Increased use of professional services and advisors to develop and implement the standards and controls necessary for us to achieve the level of accounting standards required of a public company in the United States may increase our costs. It is also possible that we will be required to expand our employee base and hire additional employees to support our operations as a public company, which will increase our operating costs in future periods.

We identified material weaknesses in our internal control over financial reporting in connection with the preparation and audit of our consolidated financial statements for the years ended December 31, 2025 and 2024. We may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our consolidated financial statements. If we fail to remediate existing material weaknesses, identify additional material weaknesses or fail to establish and maintain effective internal control over financial reporting, our ability to accurately and timely report our financial results could be adversely affected.

In connection with the preparation of our consolidated financial statements, the Company identified material weaknesses in our internal control over financial reporting.

A material weakness is a deficiency or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our consolidated financial statements will not be prevented or detected on a timely basis. To date, we have had limited financial and accounting personnel to fully execute our accounting processes and address our internal control over financial reporting. In connection with the preparation of our consolidated financial statements for the years ended December 31, 2025 and 2024, the Company identified material weaknesses in our internal control over financial reporting due to a lack of a sufficient complement of personnel with an appropriate degree of internal controls and accounting knowledge, experience, and training to maintain an effective control environment commensurate with its financial reporting requirements. This material weakness in the control environment contributed to additional material weaknesses in the risk assessment, control activities, and monitoring components of the COSO framework.

Specifically, the Company determined that an insufficient risk assessment was performed to identify risks related to complex and/or non-routine transactions and financial reporting personnel failed to perform control activities and to provide necessary oversight and monitoring of the accounting and reporting of complex and/or non-routine transactions. This control deficiency creates a reasonable possibility that a material misstatement of the Company’s consolidated financial statements would not be prevented or detected on a timely basis and constitutes a material weakness in the Company’s internal control over financial reporting. These material weaknesses resulted in corrected misstatements in the reporting of warrant liabilities and redeemable convertible preferred stock for the fiscal year ended December 31, 2024 and convertible Simple Agreement for Future Equity notes for the fiscal year ended December 31, 2025.

62

Table of Contents

​

In December 2025, the Company restated its previously issued audited consolidated financial statements for the periods ended and as of December 31, 2024, June 30, 2025, and unaudited condensed consolidated financial statements for the period ended and as of September 30, 2025. The restatement changes the classification of outstanding liabilities related to certain Simple Agreements for Future Equity (“SAFEs”) that became optionally redeemable by the holders for cash beginning on January 1, 2025. The Company has restated the classification of the optionally redeemable SAFEs from noncurrent liabilities to current liabilities in the consolidated balance sheet as of December 31, 2024 to reflect such potential optional redemption right.

To remediate these material weaknesses, we believe that we must continue to add qualified accounting, finance and tax personnel, formalize and implement written policies, internal control activities and procedures for the review of account analyses for complex and non-routine transactions, and implement and improve systems to automate certain financial reporting processes and to improve efficiency and accuracy.

We have begun taking steps and plan to take additional steps to remediate the underlying causes of the material weaknesses. The actions that we are taking are subject to ongoing senior management review as well as board, and post-closing, audit committee oversight. We cannot estimate how long it will take to remediate the material weaknesses, and our initiatives may not prove to be successful in remediating this material weakness.

These material weaknesses will not be considered remediated until management completes the design and implementation of the measures described above, the controls operate for a sufficient period of time and management has concluded, through testing, that the controls are effective. The measures we have taken to date, and the controls we continue to design and implement, may not be sufficient to remediate the material weaknesses we have identified or avoid potential additional material weaknesses in our internal control over financial reporting in the future. If not remediated or management identifies other material weaknesses in internal control over financial reporting, the Company will be unable to assert that the internal control over financial reporting is effective, which could result in the loss of investor confidence and a decline in the market price of our SPAC Class A Common Stock. In addition, to date, the audit of the consolidated financial statements by our independent registered public accounting firm has included a consideration of internal control over financial reporting as a basis of designing their audit procedures, but not for the purpose of expressing an opinion on the effectiveness of our internal controls over financial reporting. When the company ceases to be an emerging growth company we will be required to have our independent registered public accounting firm perform such an evaluation, and additional material weaknesses or other control deficiencies may be identified.

We expect to incur significant additional costs to remediate these material weaknesses, though there can be no assurance that our efforts will be successful or avoid potential future material weaknesses. If not remediated, the company may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting, and our stock price may decline as a result. We also could become subject to investigations by Nasdaq, the SEC or other regulatory authorities, and become subject to litigation from investors and stockholders, which could harm our reputation and financial condition or divert financial and management resources from its regular business activities.

If we are unable to successfully remediate our current material weaknesses or avoid or remediate any future material weakness, our stock price may be adversely affected and we may be unable to maintain compliance with applicable stock exchange listing requirements. In addition, any such failures could result in litigation or regulatory actions by the SEC or other regulatory authorities, loss of investor confidence, delisting of our securities and harm to our reputation and financial condition, or diversion of financial and management resources from the operation of our business.

There is substantial doubt about our ability to continue as a “going concern,” and we may require additional future funding whether or not the Business Combination is consummated.

Although our audited consolidated financial statements for the years ended December 31, 2025 and 2024 were prepared under the assumption that we will continue our operations as a going concern, we have incurred and expect to continue to incur significant expenses and operating losses. These circumstances raise substantial doubt about our ability to continue as a going concern, and the report of our independent registered public accounting firm that accompanies our audited consolidated financial statements for the years ended December 31, 2025 and 2024 includes an explanatory paragraph that states certain conditions exist that raise substantial doubt about our ability to continue as a going concern in relation to the foregoing. If we are unable to continue as a going concern, we may be forced to liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our unaudited condensed consolidated financial statements.

63

Table of Contents

​

Our future capital requirements will depend on many factors, including our level of investment in research and development to develop and deploy our virtual driver software, the timing of commercial deployment of our virtual driver software and the rate of its adoption, and the net cash proceeds of the Business Combination. We expect our expenses and capital expenditures to increase in connection with our ongoing activities, including research and development to develop and deploy our virtual driver software and commercial deployment of our virtual driver software. In addition, upon the completion of the Business Combination, we expect to incur additional costs associated with operating as a public company. Certain costs are not reasonably estimable at this time, and we may require additional funding and our forecasts anticipate certain customer-sourced income that is not guaranteed.

If we are unable to raise sufficient capital when needed, including as a result of redemptions by Public Shareholders, our business, financial condition and results of operations may be adversely affected, and we may need to significantly modify our operational plans to continue as a going concern. We may enter into one or more additional financings prior to closing, beyond binding agreements for the Convertible Notes and PIPE Investment that have been executed as of the date of the Registration Statement, and we cannot guarantee that any such additional financing will be obtained. We may also enter into shorter term commercial agreements with our partners to supplement our cash needs, including one or more strategic commercial transactions. For example, in March 2026, TRATON and PlusAI entered into an Autonomy Acceleration Program Agreement to expand their global partnership to accelerate autonomous truck commercialization. Pursuant to the agreement, TRATON agreed to pay PlusAI up to an aggregate of $25 million upon certain agreed performance milestones, in exchange for providing certain autonomy data, tools & services to TRATON in support of the accelerated progression of their Level 2+ program. The agreement also contemplates that TRATON will receive warrants to purchase up to 7,500,000 shares of SPAC Class A Common Stock at an exercise price of $11.50 per share. As of the date of this Report, no binding agreement has been executed with respect to any additional strategic commercial transaction and we cannot guarantee that any such additional funding will be obtained.

The amount of cash on hand following the Business Combination is uncertain because we cannot predict the amount of redemptions by Public Shareholders in connection with the closing of the Business Combination or the final amount of any pre-Closing financing agreements. If the net cash proceeds from the Business Combination are less than expected, due to high levels of redemptions or otherwise, we may not have sufficient liquidity to meet our capital requirements and fund our operating plan. If we do not have sufficient cash to fund our operating plan, we may be required to seek additional funding from debt or equity offerings, reduce research and development initiatives, reduce our growth plans or liquidate our assets. In conjunction with such a liquidation, the values we receive for our assets in liquidation or dissolution may be significantly lower than the values reflected in our financial statements. Further, if we raise additional funds by issuing equity securities or securities convertible or exercisable into equity securities, our stockholders may experience dilution. Adequate additional funding may not be available to us on acceptable terms or at all. If we raise additional capital through debt financing, we may be subject to covenants that restrict our operations including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our securities, make certain investments, and engage in certain merger, consolidation, or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and members. If the required financing is not available, or if the terms of financing are less desirable than we expect, we may be required to delay, scale back or terminate some or all of our research and development programs. Our lack of cash resources and our potential inability to continue as a going concern may adversely affect our stock price and our ability to raise new capital or to enter into critical contractual relations with third parties due to concerns about our ability to meet our contractual obligations.

The financial statements contained elsewhere in the Registration Statement do not include any adjustments that might result from our inability to continue as a going concern.

A Tranche 1 SAFE investor has delivered a redemption notice with respect to its SAFE which could adversely impact our financial condition, operations and business.

In December 2025, we received a notice from a Tranche 1 SAFE holder to exercise its redemption right. The Company is obligated to pay the holder $10.0 million to settle the outstanding Tranche 1 SAFE, which represents a significant portion of our pre-closing available cash and cash equivalents. Unless the parties negotiate an alternative arrangement, the Company has communicated to the Tranche 1 holder its plans to make payment of $10.0 million to settle the outstanding SAFE upon the closing of the Transactions. Any such payment could materially impact our financial position and operations and require us to seek additional financing.

This redemption notice was sent following the filing for bankruptcy under Chapter 11 of the U.S. Bankruptcy Code by the SAFE holder, for the apparent purpose of funding the bankruptcy case and/or satisfying its obligations to creditors. Thereafter, the SAFE holder confirmed a chapter 11 plan and the SAFE was contributed to a creditor trust to be monetized for creditor recoveries. As a result, the SAFE holder will likely prefer that we satisfy our obligations in cash rather than with SPAC Class A Common Stock. In connection with this redemption request, we could be subject to litigation, which could potentially include the SAFE holder seeking relief from the

64

Table of Contents

​

Bankruptcy Court. The results of litigation cannot be predicted with certainty, and even if a dispute, if any, was resolved in our favor, such a dispute, and the time and resources necessary to litigate or resolve it, could harm our financial condition, operations and business.

We are subject to the tax laws of various jurisdictions, and we could be obligated to pay additional taxes.

We operate in multiple jurisdictions and will be subject to income taxes in federal, state, and local income taxes in the United States and numerous foreign jurisdictions, and our tax liabilities will be subject to the allocation of expenses in differing jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including changes in the valuation of our deferred tax assets and liabilities; expected timing and amount of the release of any tax valuation allowances; tax effects of stock-based compensation; changes in tax laws, regulations or interpretations thereof; or lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates. We may also be subject to audits of our income, sales, VAT and other transaction taxes by taxing authorities. Outcomes from these audits could materially and adversely affect our business, prospects, financial condition and results of operations. Our future effective tax rates could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities and changes in tax laws or their interpretation. In addition, we may be subject to income tax audits by various tax jurisdictions. Although we believe our income tax liabilities are reasonably estimated and accounted for in accordance with applicable laws and principles, an adverse resolution by one or more taxing authorities could have a material impact on the results of our operations.

Many countries are beginning to implement legislation and other guidance to align their international tax rules with the Organization for Economic Cooperation and Development’s (“OECD”) Base Erosion and Profit Shifting recommendations and action plan that aim to standardize and modernize global corporate tax policy, including changes to cross-border tax, transfer pricing documentation rules, and nexus-based tax incentive practices. The OECD is also continuing discussions surrounding fundamental changes in allocation of profits among tax jurisdictions in which companies do business, as well as the implementation of a global minimum tax (namely the “Pillar One” and “Pillar Two” proposals). Many countries have enacted or begun the process of enacting laws based on Pillar Two proposals, which may adversely impact our provision for income taxes, net income and cash flows.

Our ability to utilize our net operating loss carryforwards may be limited.

As of December 31, 2025 and 2024, we had estimated U.S. federal net operating loss carryforwards of $138.6 million and $88.9 million, respectively, which carry forward indefinitely. As of December 31, 2025 and 2024, we had estimated cumulative state net operating loss carryforwards of $70.1 million and $69.8 million, respectively, which will begin to expire in 2038. In general, we may potentially use these net operating losses to offset future taxable income for U.S. federal and state income tax purposes. Furthermore, U.S. federal net operating losses arising in tax years beginning after December 31, 2017 may only be used to offset 80% of our taxable income. This may require us to pay U.S. federal income taxes in future years despite generating a loss for U.S. federal income tax purposes in prior years. Limitations under state law may differ. We have established a 100% valuation allowance against the carrying value of these deferred tax assets.

In addition to the potential net operating loss carryforward limitations previously noted above, under Section 382 of the Internal Revenue Code, a corporation that undergoes an “ownership change” is subject to limitations on its ability to use its pre-change net operating loss carryforwards to offset future taxable income. The limitations apply if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50 percentage point change (by value) in its equity ownership by one or more stockholders or groups of stockholders who own at least 5% of a company’s stock over a three-year period. If we have experienced an ownership change at any time since our incorporation, we may already be subject to limitations on our ability to utilize our existing net operating loss carryforwards and other tax attributes to offset taxable income or tax liability. In addition, future changes in our stock ownership, which may be outside of our control, may trigger an ownership change. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. As a result, even if we earn net taxable income in the future, our ability to use these or our pre-change net operating loss carryforwards and other tax attributes to offset such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income tax liability to us. In addition, for state income tax purposes, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For example, California recently enacted legislation that limits the use of state net operating losses for taxable years beginning on or after January 1, 2024 and before January 1, 2027.

65

Table of Contents

​

Risks Related to Our Dependence on Third Parties

Our success is dependent on our ability to successfully maintain, manage, execute and expand on our existing partnerships and obtain new partnerships.

Our software is integrated into the vehicles of our OEM partners, who are primarily responsible for the design, manufacture and sale of the vehicles on which our software is deployed. Our current contractual arrangements with our OEM partners are collaboration and proof of concept arrangements only, and not definitive long-term contracts of the kind that we will need to have in place in order to commercialize our product. In order for this business model to be successful, we will need to enter into definitive long-term contracts and commercial arrangements with all of our partners, which expand upon or maintain the current agreements and historic working relationships we have in place. If such contracts do not materialize or our existing contracts terminate, we may not be able to implement our business strategy in the timeframe anticipated, or at all. If we are unable to enter into definitive agreements or are only able to do so on terms that are unfavorable to us, we may not be able to timely identify adequate strategic relationship opportunities, or form strategic relationships, and consequently, we may not be able to fully carry out our business plans. To the extent that we do enter into additional definitive agreements with our partners, these agreements may be subject to termination upon limited notice or may be subject to periodic renegotiation. There can be no assurance that we will be able to maintain or improve upon the terms of any such agreements or that we will be able to maintain our expected share of the value realized from autonomous vehicles. Investors should not place undue reliance on our statements about our development plans and partnerships or their feasibility in the timeframe anticipated, or at all. Furthermore, if our existing or potential OEM partners are acquired, reorganized or otherwise consolidate their business with other OEMs, or if OEMs change their business strategy, existing contracts may be terminated or future prospects lost. For example, in June 2025, IVECO, one of our OEM partners, announced an agreement to be acquired by Tata Motors, which may impact our ongoing OEM partnership with IVECO.

Partners and end-customers may be less likely to purchase our products if they are not convinced that our business will succeed or that our service, technology, and other operations will continue in the long-term. In particular, our OEM-focused approach to distribution may result in significant revenue concentration among our OEM partners and accordingly, in order to build and maintain our business, we must maintain confidence among partners, end-customers, suppliers, analysts, ratings agencies and other parties in our products, long-term financial viability and business prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside of our control, such as our limited operating history, end-customer unfamiliarity with our technology, any delays in scaling production, delivery and service operations to meet demand, competition and uncertainty regarding the future of self-driving vehicles or our other services compared with market expectations.

Our software must interoperate with a variety of sensors, systems and other technologies, and any failure to ensure broad interoperability could harm our business or prospects.

Our software is integrated into the vehicles of our OEM partners, who are primarily responsible for the design, manufacture and sale of the vehicles on which our software is deployed. These complex systems are developed, delivered and maintained by our OEM partners in conjunction with a myriad of vendors and suppliers. As a result, the components of our OEM’s designs may have different specifications, rapidly evolve, utilize differing standards, include multiple versions and generations of products or may be highly customized. Our software must be able to interoperate with these highly complex and customized systems, which requires careful planning and execution between us, our OEM partners, and their other vendors and suppliers. Further, when new or updated elements of our OEM partners’ designs or new industry standards, regulations, or specifications are introduced, we may have to update or enhance our software to allow us to continue to effectively interoperate with our OEM’s designs. We have in the past, and could in the future, experience delays in development and production when and if our OEM partners, or their vendors and suppliers, experience delays, disruptions or other constraints. In the event that we, our OEM partners, and their suppliers are unable to effectively collaborate, it could stop or delay our OEM partners’ vehicle design or production, which could delay our ability to recognize revenue, result in adverse publicity, or disrupt our business relationships. The expense and time required to adequately expand compatibility of our software with new designs and hardware may be significant, and the revenue we ultimately realize from such collaborations may not be sufficient to offset our investment. If we fail to ensure sufficient interoperability of our software with a variety of hardware, we may also be unable to expand our network of OEM partners or grow our business in a timely manner or at all. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.

66

Table of Contents

​

Our OEM partners may be dependent on limited suppliers for microchips and other component parts that are integral to our software’s deployment in their vehicles.

The rapid evolution in the market for artificial intelligence products, including our autonomous driving technology and its integration into vehicles, is dependent on GPU microchips and hosting services, which are essential for AI training and inference tasks, lidars, vehicle electronic control units, and automotive radar sensors. These components are susceptible to supply shortages, long lead times for components, and supply changes, any of which could disrupt our supply chain and could delay commercialization of our products to users. Supply of these components world-wide may be adversely affected by the business disruptions as well as industry consolidation and geopolitical conditions such as international trade wars like the U.S. trade war with China, tariff policy, Russia’s actions in Ukraine, conflicts and other hostilities in the Middle East, including in Iran, and increased political tensions in Russia, Europe or Asia. Such shortages, increased component lead times, reduced allocations of components and decommitments of orders have resulted in and may continue to result in increased component prices, fewer sourcing options, unpredictability of supply, prolonged manufacturing disruptions and increased product lead times.

In an effort to manage and reduce the costs of purchased goods and services, our OEM partners, like many automotive suppliers and automakers, may have consolidated their supply chains in recent years, resulting in such OEM partners being reliant on a limited number of third-party suppliers to design, develop, industrialize and manufacture components, including GPU microchips, that are integral to the deployment of our software. In order for these suppliers to undertake the investment needed to produce these components, they may require us to commit to terms, pricing or purchase volumes that are not acceptable to us or our OEM partners. If shortages of, or tariff policies on, GPU microchips or other critical components from other suppliers develop, continue longer than anticipated, or worsen, it could impact our or our OEM partners’ ability to meet production schedules and deployment of our software. Furthermore, unfavorable economic or industry conditions could result in financial distress within our or our OEM partners’ supply base, thereby increasing the risk of supply disruption.

Risks Related to Our Legal and Regulatory Environment

We are subject to evolving and uncertain regulations, including those governing motor carriers and autonomous vehicles, and unfavorable changes to these regulations or any failure by us to comply with these regulations may adversely affect our business, financial condition and results of operations. We may also need to expend significant time and resources, or make changes to our business plan and operations, to respond to regulatory developments and divergent requirements across the regions in which we operate, such as conformity with required safety standards, which may adversely affect our business, financial condition, and results of operations.

Currently, there are no domestic laws that explicitly allow the full implementation or deployment of a commercial autonomous truck with fully driverless operations. Our organizational, operational, and safety processes designed to ensure that the performance of our technology meets rigorous standards may not be sufficient to meet future regulatory requirements enacted by government bodies. Future regulatory requirements in the United States and abroad may also limit the operation and commercialization of autonomous vehicles. Certain jurisdictions may require us to present our own safety justification and evidence base, and in other areas, it is possible that we may be required to pass specific autonomous driving safety tests. We have not yet tested our technology to the full extent possible, in all conditions under which we anticipate operations to occur. The failure to pass required safety tests or receive appropriate regulatory approvals for commercialization would adversely impact our ability to generate revenue at the rate we anticipate, and we may be liable if we fail to comply with such laws and regulations. This might require us to stop or curtail operations or conduct or fund remedial or corrective measures, make additional investments into safety-related improvements or perform other actions.

It is also possible that future regulations of autonomous vehicles, including environmental and health and safety laws and regulations, are not standardized, subjecting our technology to differing regulations across jurisdictions (whether at the federal, state, local, or international level). For example, in Europe, certain vehicle safety regulations apply to automated braking and steering systems, and certain treaties also restrict the operations of certain higher levels of automation. As of September 30, 2026, 26 U.S. states have passed legislation allowing for the deployment of driverless trucks, and most other states allow testing with a safety driver in the vehicle. Many other states are considering legislation and regulations that may adversely affect autonomous and driverless technologies. Despite such advances in U.S. state legislation, there is currently no comprehensive U.S. federal framework for autonomous vehicle deployment. This regulatory patchwork, and the ongoing legislative and regulatory efforts at various jurisdictional levels, may hinder the commercial deployment of our technology and adversely affect our business prospects and financial condition.

67

Table of Contents

​

By their nature, high volume trade routes often traverse a variety of jurisdictions, meaning that our long-term access to promising opportunities may be dependent on addressing these potentially divergent regulations in a generalizable way. We are also subject to laws and regulations that commonly apply to software businesses, such as those related to privacy, data protection, cybersecurity, tax and consumer protection. These laws and regulations vary from one jurisdiction to another and future legislative and regulatory action, court decisions or other governmental action, which may be affected by, among other things, political pressures, attitudes and climates, as well as personal biases, may have a material impact on our operations and financial results. The enactment of more stringent laws, regulations or permit requirements or other such events may arise in the future and adversely impact the market for our products, which could materially and adversely affect our business, financial condition, and results of operations. Additionally, even if we are able to meet all the regulatory requirements in a single state jurisdiction or fulfill any applicable federal requirements in the United States, there can be no assurance that such measures will be sufficient to meet all regulatory requirements in other state or foreign jurisdictions or fulfill the requirements of any other applicable US or foreign regulatory authority. If any foreign regulatory authority does not accept our technology, it would result in the need for additional changes, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our technology not receiving the requisite approval or clearance for commercialization in the applicable jurisdiction.

Regulatory and legislative developments related to the use of artificial intelligence and machine learning could adversely affect our use of such technologies in our software.

We use artificial intelligence throughout our business, including as an integral foundation to our autonomous driving software. As the regulatory framework for artificial intelligence and machine learning (including generative AI) evolves, our business, financial condition and results of operations may be adversely affected. The regulatory framework for artificial intelligence and similar technologies is changing rapidly. It is possible that new laws and regulations will be adopted in the United States and in non-U.S. jurisdictions, or that existing laws and regulations may be interpreted in ways that would affect the operation of our software and the way in which we use artificial intelligence, machine learning and similar technologies. We may not be able to adequately anticipate or respond to these evolving laws and regulations, and we may need to expend additional resources to adjust our offerings in certain jurisdictions if applicable legal frameworks are inconsistent across jurisdictions. In addition, because these technologies are themselves highly complex and rapidly developing, it is not possible to predict all of the legal or regulatory risks that may arise relating to our use of such technologies. Further, the cost to comply with such laws or regulations could be significant and would increase our operating expenses, which could adversely affect our business, financial condition and results of operations.

For example, in Europe, the European Union’s Artificial Intelligence Act (AI Act) entered into force on August 1, 2024. The AI Act establishes a risk-based governance framework for regulating high-risk AI systems operating in or being used by the EU market. The AI Act could impact our products, business, and use of artificial intelligence, even with respect to our business outside of the EU. This framework categorizes artificial intelligence systems based on the risks associated with such AI systems’ intended purposes as creating “unacceptable”, “high” or “limited” risks. While the AI Act has not yet been enforced, there is a risk that our current or future AI-powered software or applications may be categorized as “high” risk or “limited” risk, obligating us to comply with the applicable requirements of the AI Act, which may impose additional costs on us, increase our risk of liability, or adversely affect our business. For example, “high” risk AI systems are required, amongst other things, to implement and maintain certain risk and quality management systems, conduct certain conformity and risk assessments, use appropriate data governance and management practices, including in development and training, and meet certain standards related to testing, technical robustness, transparency, human oversight, and cybersecurity. Even if our AI systems are not categorized as “high” risk we may be subject to additional transparency and other obligations for “low” risk AI system providers. The AI Act sets forth certain penalties, including fines of the greater of EUR 35 million or 7% of worldwide annual turnover (as defined in the AI Act) for the prior year for violations related to offering prohibited AI-systems or data governance, fines of the greater of EUR 15 million or 3% of worldwide annual turnover for the prior year for violations related to the requirements for “high” risk AI systems, and fines of the greater of EUR 7.5 million or 1.5% of worldwide annual turnover for the prior year for violations related to supplying incorrect, incomplete or misleading information to the EU and member state authorities. The AI Act’s regulatory framework is expected to have a material impact on the way AI is regulated in the EU and across the world. Other jurisdictions also have proposed, and in certain cases enacted, laws and regulations addressing the use and development of AI. For example, in the United States, numerous states have proposed or have enacted laws addressing these matters, and in the United Kingdom, the government has published a white paper calling for existing regulators to implement certain specific principles to guide and inform the responsible development and use of AI. The AI Act and other evolving laws and regulations addressing AI, together with developing guidance and/or decisions in this area, may affect our use of AI and our ability to provide and to improve our services, require additional compliance measures and changes to our operations and processes, result in increased compliance costs and potential increases in civil claims against us, and could adversely affect our business, financial condition and results of operations.

68

Table of Contents

​

We are subject to international labor laws and employee representative bodies and stakeholders.

While a majority of our operations are not subject to organized labor agreements, certain of our operations in Germany include a formal representation of employees by a works council and the application of a collective bargaining agreement. We regularly conduct, or are involved in, negotiations with the relevant employee representative bodies.

While we believe that we have good relations with the works council and employees generally today, there can be no assurance that such relations will not deteriorate and that we will not experience labor disputes in the future. Any deterioration of these relationships could adversely impact our business, financial condition and results of operations. We may face strikes or similar types of conflicts with works councils and our employees in the future. Any such strikes, conflicts, work stoppages or other industrial actions may disrupt our development timeline, damage our reputation and adversely affect our partnership relations, which could in turn have a material adverse effect on our business, financial condition and results of operations.

Works council and collective agreements may additionally increase our labor costs, divert management’s attention from operating our business, or impose obligations and restrictions on us that may adversely affect our flexibility to undertake adjustments to our workforce, restructurings, reorganizations and similar corporate actions. In addition, certain measures we undertake are generally subject to works councils’ co-determination rights, in particular in relation to occupational pension schemes, the implementation and use of IT systems, variable remuneration schemes and working time systems. Potentially extensive exercise of codetermination rights by the works councils may result in operational difficulties and in us being prevented from implementing planned policy or IT system changes, among other things.

Regulatory changes adverse to us or our customers or partners may be prompted by negative publicity of our industry, including due to any high-profile safety incidents associated with driverless technology or due to pressure from unions or labor groups on behalf of truck drivers.

Rulemaking and other regulatory activity in our industry often attracts significant public interest and public hearings. Instances of negative publicity following high profile safety incidents involving autonomous vehicles have attracted, and may in the future attract, significant public attention. Moreover, lawmakers in various jurisdictions have been the subjects of significant lobbying efforts and political action by unions or labor groups. For example, organized labor, in particular the International Brotherhood of Teamsters, has opposed autonomous driving technology and is increasingly using its political influence to attempt to slow or stop driverless deployment. In 2025, approximately 20 states introduced legislation promoted by supporters of organized labor that would require human drivers to be physically present in all commercial motor vehicles equipped with autonomous driving technology. These states included California, Colorado, Delaware, Nevada, New Mexico and Texas. As of September 30, 2026, no such introduced legislation has become law; however, organized labor and other opponents to driverless development may ultimately be successful and, even if unsuccessful, we may spend significant time and resources in opposition to such efforts, any of which may adversely affect our business, prospects, and results of operations. Such publicity and lobbying may result in additional restrictions, regulations, safety requirements or other constraints on the development or operation of autonomous vehicles, any of which may harm our business, results of operations and financial condition.

We are subject to governmental export and import control laws and regulations and trade and economic sanctions. Our failure to comply with these laws and regulations could materially and adversely affect our business, prospects, financial condition and results of operations.

Our products and solutions are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations and various economic and trade sanctions regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Controls as well as similar controls established in the countries in which we do business. Export control laws and regulations and economic sanctions prohibit the shipment of certain products and services to embargoed or sanctioned countries and their governments and restricted or sanctioned persons. In addition, complying with export control and sanctions regulations for a particular geography may be time-consuming and result in the delay or loss of revenue opportunities. Exports of our products and technology must be made in compliance with these laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges, fines, which may be imposed on us and responsible employees or managers and, in extreme cases, the incarceration of responsible employees or managers. Additionally, any allegations of non-compliance with sanctions laws could subject us to whistleblower complaints, adverse media coverage, investigations, prosecution, enforcement actions, fines, damages, severe administrative, civil and criminal sanctions, loss of export privileges, collateral consequences, remedial measures, suspension or

69

Table of Contents

​

debarment from government contracts and legal expenses, all of which could materially and adversely affect our business, prospects, financial condition and results of operations and also our reputation.

For example, the U.S. government has continued to increase controls restricting the ability to send, without an export license, certain products and technology related to semiconductors, semiconductor manufacturing, and supercomputing to China as well as other identified countries and companies headquartered in China and these other countries. These controls apply broadly to a continuously expanding list of items including certain integrated circuits, hardware containing these specified integrated circuits, semiconductor manufacturing equipment, and could be expanded to other products applicable to our business. Although we do not operate or plan to operate in China for the foreseeable future, it is possible that restrictions of this nature may be extended to other jurisdictions. Moreover, the Chinese government is expanding its control on exports, and these controls or other measures could impact our business or those of our OEM partners.

Federal and state governments may also seek to prohibit, restrict, or otherwise condition the procurement or use of products or components used in autonomous vehicles that are manufactured outside or by companies domiciled outside the United States. For example, on January 31, 2024, and again on October 21, 2024, the U.S. Department of Defense identified Hesai Technology Co., Ltd. (“Hesai”), a lidar manufacturer based in China, as a Chinese Military Company in accordance with Section 1260H of the National Defense Authorization Act for Fiscal Year 2021, which will prohibit the Defense Department from contracting with Hesai in the future. Additionally, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) recently issued a final rule imposing controls on transactions involving certain information and communications technology and services that are designed, developed, manufactured, or supplied by persons owned by, controlled by, or subject to the jurisdiction or direction of certain enumerated foreign adversaries (including China and Russia) and that are integral to passenger connected vehicles under 10,001 pounds. BIS noted in its announcement of the final rule that it intends to pursue a similar rulemaking to address trucks and buses in the near future but provided no additional information on this effort or its anticipated timeline. Legislation has also been introduced in some U.S. states that proposed to prohibit and/or condition the use of Chinese-origin lidar in autonomous vehicles. Enactment of any prohibitions, restrictions, or conditions on our or our OEM partners’ ability to procure or use such products or components could materially and adversely affect the development and deployment of our technology, our operating plans, and our anticipated commercialization timelines.

In addition, various countries regulate the import of certain encryption technology, including through import permit and license requirements, and have enacted laws that could limit our ability to distribute our products or could limit our OEM partners’ ability to deploy our software in those countries. Any change in export or import regulations, economic sanctions or related legislation, shift in the enforcement or scope of existing regulations or change in the countries, governments, persons or technologies targeted by such regulations could result in decreased use of our products by, or in our decreased ability to export or sell our products to, existing or potential partners with international operations or create delays in the introduction of our technology into certain international markets. Any decreased use of our technology or limitation on our ability to export or sell it could adversely affect our business, financial condition, results of operations and prospects.

We may become involved in legal and regulatory proceedings, investigations or actions, and commercial or contractual disputes, which could harm our business, financial condition and results of operations.

We may be, from time to time, involved in litigation, regulatory proceedings and commercial or contractual disputes that may be significant. These matters may include, without limitation, disputes with our suppliers and partners, intellectual property rights infringement or misappropriation claims, stockholder litigation, government investigations, class action lawsuits, personal injury claims, environmental issues, customs and value-added tax disputes and employment and tax issues. In addition, we have in the past and could face in the future a variety of labor and employment claims against us, which could include but is not limited to general discrimination, wage and hour, privacy and data protection, ERISA or disability claims. In such matters, government agencies or private parties may seek to recover from us very large, indeterminate amounts in penalties or monetary damages (including, in some cases, treble or punitive damages) or seek to limit our operations in some way. These types of disputes could require significant management time and attention or could involve substantial legal liability, adverse regulatory outcomes, and/or substantial expenses to defend. Often these proceedings raise complex factual and legal issues and create risks and uncertainties. No assurances can be given that any proceedings and claims will not have a material and adverse impact on our business, financial condition or results of operations or that our established reserves or our available insurance will mitigate this impact.

70

Table of Contents

​

We are subject to, and must remain in compliance with, numerous laws and governmental regulations concerning the manufacturing, use, distribution and sale of our products. Some of our commercial partners also require that we comply with their own unique requirements relating to these matters.

We develop and plan to sell software that must be integrated with electronic components, including sensors, vehicle controls and computing resources. Such components may be subject to or may contain materials that are subject to government regulation in both the locations where manufacture and assembly of our products takes place, as well as the locations where our software is deployed. This is a complex process which requires continual monitoring of regulations to ensure that we and our partners are in compliance with existing regulations in each market where we operate and where we intend to operate. If there is an unanticipated new regulation that significantly impacts the use and sourcing of various components or requires more expensive components, that regulation could materially and adversely affect our business, prospects, financial condition and results of operations. If we fail to adhere to new regulations or fail to continually monitor the updates, we may be subject to litigation, loss of partners or negative publicity and could materially and adversely affect our business, financial condition and results of operations.

We are subject to, and must remain in compliance with, environmental laws and regulations that may adversely affect our financial condition and results of operations.

Although we are primarily a software business, we are subject to federal, state, local and foreign laws, regulations and ordinances relating to the protection of the environment, including those relating to emissions to the air, discharges to surface and subsurface waters, safe drinking water, greenhouse gases and the management of hazardous substances, oils and waste materials. Federal, state and local laws and regulations relating to the protection of the environment may require the current or previous owner or operator of real estate to investigate and remediate hazardous or toxic substances or petroleum product releases at or from the property. Under federal law, generators of waste materials, and current and former owners or operators of facilities, can be subject to liability for investigation and remediation costs at locations that have been identified as requiring response actions. Compliance with environmental laws and regulations can require significant expenditures. In addition, we could incur costs to comply with such current or future laws and regulations, the violation of which could lead to substantial fines and penalties.

We may have to pay governmental entities or third parties for property damage and for investigation and remediation costs that they incurred in connection with any contamination at our current and former properties without regard to whether we knew of or caused the presence of the contaminants. Liability under these laws may be strict, joint and several, meaning that we could be liable for the costs of cleaning up environmental contamination regardless of fault or the amount of waste directly attributable to us. Even if more than one person may have been responsible for the contamination, each person covered by these environmental laws may be held responsible for all of the clean-up costs incurred. Environmental liabilities could arise and have a material adverse effect on our financial condition and performance. We do not believe, however, that pending environmental regulatory developments in this area will have a material effect on our capital expenditures or otherwise materially adversely affect its operations, operating costs, or competitive position.

We are subject to anti-corruption, anti-bribery, anti-money laundering, and similar laws, and non-compliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our business, prospects, financial condition and results of operations and also our reputation.

We are subject to anti-corruption and anti-bribery laws and anti-money laundering and similar laws and regulations in various jurisdictions in which we conduct or in the future may conduct activities, including the U.S. Foreign Corrupt Practices Act (the “FCPA”), the U.K. Bribery Act 2010, and other anti-corruption laws and regulations. The FCPA and the U.K. Bribery Act 2010 prohibit us and our officers, directors, employees and business partners acting on our behalf, including agents, from corruptly offering, promising, authorizing or providing anything of value to a “foreign official” for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The FCPA also requires publicly listed companies to make and keep books, records and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls. The U.K. Bribery Act 2010 and other anti-corruption laws also prohibit non-governmental “commercial” bribery and soliciting or accepting bribes. We sometimes leverage third parties to conduct our business abroad. We, our employees, agents, representatives, business partners and third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we may be held liable for the corrupt or other illegal activities of these employees, agents, representatives, business partners or third-party intermediaries even if we do not explicitly authorize such activities. Our policies and procedures that are designed to ensure compliance with these laws and regulations may not be sufficient and our directors, officers, employees, representatives, consultants, agents, and business partners could engage in improper conduct for which we may be held responsible. As we increase our international conduct of business, our risks under these laws may increase.

71

Table of Contents

​

Any allegations or non-compliance with anti-corruption and anti-bribery laws or anti-money laundering laws could subject us to whistleblower complaints, adverse media coverage, investigations, prosecution, enforcement actions, fines, damages, severe administrative, civil and criminal sanctions, loss of export privileges, collateral consequences, remedial measures, and legal expenses, all of which could materially and adversely affect our business, prospects, financial condition and results of operations and also our reputation. Responding to any investigation or action will likely result in a materially significant diversion of management’s attention and resources and significant defense costs and other professional fees.

We may be subject to product liability that could result in significant direct or indirect costs, which could materially and adversely affect our business, financial condition and results of operations.

Our autonomous vehicle technology presents the risk of significant injury, including fatalities. We may be subject to claims if our technology is involved in an accident and persons are injured or purport to be injured. The occurrence of any errors or defects in our software could make us liable for damages and legal claims. In addition, we could incur significant costs to correct such issues, potentially including product recalls. Any negative publicity related to the perceived quality of our technology could affect our brand image, partner and end-customer demand, and could materially and adversely affect our business, financial condition and results of operations. Liability claims may also result in litigation, including class actions, the occurrence of which could be costly, lengthy and distracting and could materially and adversely affect our business, financial condition and results of operations.

Any product recall of ours or our partners in the future may result in adverse publicity, damage our brand and could materially and adversely affect our business, financial condition and results of operations. In the future, we may voluntarily or involuntarily initiate a recall if any vehicles on which our software is deployed prove to be defective or non-compliant with applicable Federal Motor Vehicle Safety Standards. A recall would prevent the sale of vehicles equipped with our software until the issues are remedied and would involve significant expense and diversion of management’s attention and other resources, which could materially and adversely affect our brand reputation, as well as our business, prospects, financial condition and results of operations.

Risks Related to Our Intellectual Property Rights

We may not be able to adequately obtain, maintain, protect, defend or adequately enforce our intellectual property rights or prevent unauthorized parties from copying or reverse engineering our solutions. We may not be able to protect our intellectual property rights globally, and changes in patent law may diminish the value of patents in general, thereby impairing our ability to protect our products.

The success of our products and our business depends in part on our ability to obtain patents and other intellectual property rights and maintain adequate legal protection for our products in the United States and other international jurisdictions. Even if we are able to protect our intellectual property rights, our competitors may be able to offer similar products and services without infringing or misappropriating our rights. We rely on a combination of copyright, patent, service mark, trademark and trade secret laws, as well as confidentiality procedures and contractual restrictions, to establish and protect our intellectual property and proprietary rights. Intellectual property laws and our procedures and restrictions provide only limited protection and any of our intellectual property rights may be challenged, invalidated, circumvented, infringed or misappropriated. If we fail to protect our intellectual property rights adequately, we may lose an important advantage in the markets in which we compete. While we take measures to protect our intellectual property, such efforts may be insufficient or ineffective, and any of our intellectual property rights may be challenged, which may result in them being narrowed in scope or declared invalid or unenforceable. Other parties may also independently develop technologies that are substantially similar or superior to ours. We may also be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. The measures we take to protect our intellectual property from unauthorized use by others may not be effective and there can be no assurance that our intellectual property rights will be sufficient to protect against others offering products, services or technologies that are substantially similar or superior to ours and that compete with our business.

We cannot assure you that any patents will be issued with respect to our currently pending patent applications or that any trademarks will be registered with respect to our currently pending applications in a manner that gives us adequate defensive protection or competitive advantages, if at all, or that any patents issued to us or any trademarks registered by us will not be challenged, invalidated or circumvented. We have filed for patents and trademarks in the United States and in certain international jurisdictions, but such protections may not be available in all countries in which we operate or in which we seek to enforce our intellectual property rights or may be difficult to enforce in practice. Our currently-issued and applied-for patent and trademark registrations and applications, and any future patents and trademarks that may be issued, registered or applied for, as applicable, may not provide sufficiently broad protection

72

Table of Contents

​

or may not prove to be enforceable in actions against alleged infringers. We also cannot be certain that the steps we have taken will prevent unauthorized use of our technology or the reverse engineering of our technology.

We rely on trademark protection in various jurisdictions to protect our rights to the mark “PlusAI,” as well as our distinctive logos and other marks associated with our business. We cannot assure you that these measures will be adequate, that we have secured, or will be able to secure, appropriate protection for all of our branding rights in selected jurisdictions or that third parties will not infringe upon or misappropriate our trademarks and brand names. When we update a brand name or logo or when we enter a new territory, we may decide to submit new trademark applications, but there is no guarantee that a new name or logo, or the PlusAI marks in a new territory can be successfully registered where we do not have existing registration for those or similar trademarks. In addition, effective trademark protection may be unavailable or limited for some of our trademarks in some foreign countries in which we operate. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our services, which could result in loss of brand recognition, and could require us to devote resources advertising and marketing new brands.

We cannot assure you that third parties will not infringe our intellectual property rights or that we will have sufficient resources to enforce our rights. The protection against unauthorized use of our intellectual property rights, products and other proprietary rights is expensive and difficult, particularly internationally. Unauthorized parties may attempt to copy or reverse engineer our technology or certain aspects of our solutions that we consider proprietary. Litigation may be necessary in the future to enforce or defend our intellectual property rights, to prevent unauthorized parties from copying or reverse engineering our solutions, to determine the validity and scope of the proprietary rights of others or to block the importation of infringing products into the United States.

Any such litigation, whether initiated by us or a third party, could result in substantial costs and diversion of resources and management’s attention, either of which could materially and adversely affect our business, financial condition and results of operations. Any litigation to enforce our intellectual property rights may be met with defenses, counterclaims and countersuits, including attacks on the validity and enforceability of our intellectual property, which could lead to the invalidation of, or render unenforceable, our intellectual property rights, or may otherwise have negative consequences for us. Even if we obtain favorable outcomes in litigation, we may not be able to obtain adequate remedies, especially in the context of unauthorized parties copying or reverse engineering our solutions. In addition, many of our current and potential competitors have the ability to dedicate substantially greater resources to defending intellectual property rights infringement claims and to enforcing their intellectual property rights than we have.

We may not be able to protect our intellectual property rights if we are unable to enforce them or if we do not detect infringement or misappropriation. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, may delay the introduction and implementation of new technologies, resulting in our substituting inferior or more costly technologies or injure our reputation. Moreover, policing unauthorized use of our technologies, trade secrets and intellectual property may be difficult, expensive and time-consuming, particularly in foreign countries where the laws may not be as protective of intellectual property rights as those in the United States and where mechanisms for enforcement of intellectual property rights may be weak. If we fail to meaningfully establish, maintain, protect and enforce our intellectual property and proprietary rights, our business, financial condition and results of operations may be adversely affected.

Our proprietary works, technologies and information are developed by our employees and contractors. Although it is our policy to require our employees and consultants who may be involved in the conception or development of intellectual property to execute agreements assigning the intellectual property and related rights to us, we may be unsuccessful in executing such an agreement with each party who conceives or develops intellectual property and related rights that we regard as our own or such party may breach the assignment agreement. We may be subject to lawsuits filed by employees or contractors claiming ownership of such intellectual property and related rights. Litigation may be necessary to obtain ownership or to defend against claims challenging inventorship. If we fail in any such litigation, in addition to paying monetary damages, we may lose valuable intellectual property rights. Such an outcome could substantially harm our business, results of operations, and financial condition. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to our management and other employees, and such claims could substantially harm our business, results of operations and financial condition.

Although not strictly an intellectual property right, we consider our registered domain names to be part of our intellectual property portfolio. We are the registrants for domain names for websites that we use in our business. We may not be able to, or it may not be cost effective to, acquire or maintain all domain names that utilize the name “PlusAI” or other business brands in all of the countries in which we currently conduct or intend to conduct business. Further, we may be unable to prevent competitors or other third parties from acquiring or using domain names that are similar to or diminishes the value of our domain names. If such third party domain name incorporates any of the trademarks that we have registered in the relevant jurisdiction, then we may be able to bring a claim of trademark

73

Table of Contents

​

infringement (see risks related to enforcement of trademark above). If we lose the ability to use a domain name or have to contend with the existence of confusingly similar domain names held by third parties, we could incur additional expenses to market our brand within that country. This could substantially harm our business, results of operations, and financial condition.

We may not be able to protect our intellectual property rights globally, and changes in U.S. intellectual property law may diminish the value of our intellectual property in general, thereby impairing our ability to protect our products.

There are a number of recent changes to the patent laws that may have a significant impact on our ability to protect our technology and enforce our intellectual property rights. Other intellectual property rights, for example rights around the scope of protection that can be claimed for AI/ ML models, datasets, weights, and biases are not fully understood, and may continue to change. Any change to the treatment of intellectual property rights, or to the scope of intellectual property rights may adversely affect our business, financial condition, and results of operations.

Further, the standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably within an organization, or between organizations As such, we do not know the degree of future protection that we will have on our technologies, products, and services. While we will endeavor to try to protect our technologies, products, and services with intellectual property rights such as patents, as appropriate, the process of obtaining patents is time-consuming, expensive, and sometimes unpredictable.

In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents may change in unpredictable ways that may weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. Actions in foreign jurisdictions may create similar problems or may create divergent issues based on uncertain or different results.

Third-party claims that we are infringing intellectual property rights, whether successful or not, could subject us to costly and time-consuming litigation or expensive licenses, and our business could be adversely affected.

Although we hold key patents related to our technology, a number of companies, organizations, or individuals, both within and outside of the autonomous vehicle industry, hold other patents covering aspects of autonomous vehicle technology. In addition to these patents, participants in this industry typically also protect their technology, especially embedded software, through copyrights and trade secrets. In recent years, there has been significant litigation globally involving patents and other intellectual property rights. We may in the future receive inquiries from other intellectual property rights holders and may become subject to claims that we infringe their intellectual property rights, particularly as we expand our presence in the market, expand to new use cases and face increasing competition. We are also party to certain agreements that may limit our trademark rights in certain jurisdictions; while we believe these agreements are unlikely to have a significant impact on our business as currently conducted, our ability to use our existing trademarks in new business lines in the future may be limited. In addition, parties may claim that the names and branding of our products infringe their trademark rights in certain countries or territories. Although we intend to vigorously defend our intellectual property rights, if such a claim were to prevail, we may have to change the names and branding of our products in the affected territories and we could incur other costs.

We may not be able to obtain a license on commercially reasonable terms, or on terms that resolve, in whole or in part, the potential risks of intellectual property rights infringement. As we face increasing competition and as a public company, the possibility of intellectual property rights claims against us grows. Such claims and litigation may involve one or more of our competitors focused on using their patents and other intellectual property rights to obtain a competitive advantage, or patent holding companies or other adverse intellectual property rights holders who have no relevant product and service revenue. Our own pending patents and other intellectual property rights may provide little or no deterrence to these rights holders in bringing intellectual property rights claims against us. Patent holding companies may also be advantaged in a lawsuit by limited costs, at least partially because of the lack of products and services. There may be intellectual property rights held by others, including issued or pending patents and trademarks, that cover significant aspects of our technologies or business methods. We cannot assure you that we are not infringing or violating or have not infringed or violated, any third-party intellectual property rights or that we will not be held to have done so or be accused of doing so in the future. In addition, because patent applications can take many years until the patents issue, and may file continuing applications that extend when new claims can be filed at patent and trademark offices, there may be applications now pending of which we are unaware, which may later result in issued patents that our products and services may infringe. We expect that in the future we may receive notices that claim we or our collaborators have misappropriated or misused other parties’ intellectual property rights, particularly as the number of competitors in our market grows.

74

Table of Contents

​

We currently have a number of agreements in effect pursuant to which we have agreed to defend, indemnify and hold harmless our partners, suppliers, and channel partners and other partners from damages and costs which may arise from the infringement or misappropriation by our products of third-party patents or other intellectual property rights. The scope of these indemnity obligations varies, but may, in some instances, include indemnification for damages and expenses, including attorneys’ fees. We do not carry insurance to cover intellectual property rights infringement or misappropriation claims. A claim that our products infringe or misappropriate a third party’s intellectual property rights, even if untrue, could adversely affect our relationships with our partners, may deter future partners from purchasing our products and could expose us to costly litigation and settlement expenses. Even if we are not a party to any litigation between a partner and a third party relating to infringement or misappropriation by our products, an adverse outcome in any such litigation could make it more difficult for us to defend our products against intellectual property rights infringement or misappropriation claims in any subsequent litigation in which we are a named party. Any of these results could materially and adversely affect our business, financial condition and results of operations.

Our defense of intellectual property rights claims brought against us or our partners, regardless of merit, could be time-consuming and expensive to litigate or settle, could divert resources and management’s attention. If our technology is determined to infringe a valid and enforceable patent, or if we wish to avoid intellectual property litigation on any alleged infringement, misappropriation or other violation of third party intellectual property rights, we may be required to do one or more of the following: (1) cease development, sales, provision or use of our solutions that incorporate, use, implement, or rely on the asserted intellectual property right; (2) obtain a license from the owner of the asserted intellectual property right, which may be unavailable on commercially reasonable terms, or at all, or which may be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us; (3) pay substantial royalties or other damages; or (4) redesign our technology or one or more aspects or systems of our autonomous driving vehicles to avoid any infringement or allegations thereof. The aforementioned options sometimes may not be commercially feasible. Any of these events could materially and adversely affect our business, financial condition and results of operations. Further, a party may secure a judgment against our intellectual property rights and licenses that requires us to pay substantial damages or obtain an injunction.

Our intellectual property rights applications may not issue or be registered, which may adversely affect our ability to prevent others from commercially exploiting products and technologies similar to ours.

We cannot be certain that we are the first inventor of the subject matter to which we have filed a particular patent application, or if we are the first party to file such a patent application. If another party has filed a patent application to the same subject matter as we have or has already published the claimed inventions, we may not be entitled to the protection sought by the patent application. We also cannot be certain whether the claims included in a patent application will ultimately be allowed in the applicable issued patent. Further, the scope of protection of issued patent claims is often difficult to determine. As a result, we cannot be certain that the patent applications that we file will issue, or that our issued patents will afford protection against competitors with similar technology. In addition, our competitors may design around our issued patents, which may adversely affect our business, financial condition and results of operations. Changes to patent law may limit the scope of our patents, limit the enforceability or validity of our patents, or be limited by subject matter eligibility, in part or fully.

As our patents may expire, our patent applications may not be granted and our patent rights may be contested, circumvented, invalidated, or limited in scope. In particular, we may not be able to prevent others from developing or exploiting competing technologies, which may adversely affect our business, prospects, financial condition and results of operations.

We cannot be assured that we will be granted patents pursuant to our pending applications. Even if our patent applications succeed and we are issued patents in accordance with them, these patents may still be contested, circumvented or invalidated in the future. Future innovations by others may provide opportunities to design around our granted patents and pending applications. In addition, the rights granted under any issued patents may not provide us with meaningful protection or competitive advantages. The claims under any patents that issue from our patent applications may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. The intellectual property rights of others may also bar us and third-party customers and licensees from exploiting any patents that issue from our pending applications or may otherwise limit the breadth of any issued patent claims. Numerous patents and pending patent applications owned by others exist in the fields in which we have developed and are developing our technology. These patents and patent applications may subject our patent applications to invalidation. Finally, any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable.

75

Table of Contents

​

We rely on licenses from third parties for intellectual property rights that are critical to our business, and we would lose the rights to such intellectual property rights if those agreements were terminated or not renewed.

We expect that the long-term contracts and commercial arrangements that we have and intend to enter into with partners may include licenses. We rely on these licenses from our partners for certain intellectual property rights that are or may become critical to our business. Termination of our current or future agreements could cause us to have to negotiate new or amended agreements with less favorable terms or cause us to lose our rights under the original agreements.

In the event that we lose intellectual property rights relating to technology used in or in conjunction with our software, we may not be able to continue to ensure the interoperability of our software with certain hardware or may experience disruption to our development and commercialization efforts as we test and re-qualify any potential replacement technology. Even if we retain licenses, the licenses may not be exclusive with respect to such component design or technologies, which could aid our competitors and have a negative impact on our business. If such licenses were to terminate prematurely (including due to a breach) or we otherwise fail to maintain such licenses, we may lose the ability to continue our operations that rely on such licenses, which could have a negative impact on our business, financial condition and results of operations.

In addition to patented technology, we rely on our unpatented proprietary technology, trade secrets, processes and know-how.

We rely on technical measures and contractual measures to protect proprietary or competitively sensitive information, technology or materials (such as trade secrets, know-how and confidential information) that may not be patentable or subject to copyright, trademark, trade dress or service mark protection, or that we believe is best protected by means that do not require public disclosure. We typically seek to protect this proprietary information by limiting its disclosure and by entering into confidentiality agreements, consulting services or employment agreements that contain non-disclosure and non-use provisions. We may fail to enter into the necessary agreements, or such agreements may be breached or may otherwise fail to prevent disclosure, third-party infringement or misappropriation of our proprietary information, may be limited as to their term or may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information. Trade secrets or confidential information may also be willfully or unintentionally disclosed, including by employees, who may leave our company to join our competitors. We have limited control over the protection of trade secrets used by our current or future OEM partners and suppliers and could lose future trade secret protection if any unauthorized disclosure of such information occurs. In addition, our proprietary information may otherwise become known or be independently developed by our competitors or other third parties. To the extent that our employees, consultants, contractors, advisors and other third parties use intellectual property rights or other technology or materials owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. Unauthorized or accidental disclosure of proprietary information or trade secrets may be disclosed to large language models or other artificial intelligence which may in turn disclose that information to third parties. In addition, our proprietary information may otherwise become known or be independently developed by our competitors or other third parties. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain protection for our proprietary information could adversely affect our competitive business position, and any recovery from a litigation may be insufficient to address any harm we have suffered. Furthermore, laws regarding trade secret rights in certain markets where we operate may afford little or no protection to our trade secrets.

We also rely on physical and electronic security measures to protect our proprietary information, but there can be no assurance that they will provide adequate protection or that they will not be breached. Third parties may obtain and improperly utilize our proprietary information to our competitive disadvantage, and we may not be able to detect or prevent the unauthorized use of such information or take appropriate and timely steps to enforce our intellectual property rights. We have limited control over the protection of our trade secrets used by our third-party partners, suppliers, and customers and may lose future trade secret protection if any unauthorized disclosure of such information occurs. Any confidentiality or non-disclosure agreements may be breached or may otherwise fail to prevent disclosure. If any of our trade secrets were to be lawfully obtained by a competitor or other third party from our partners, suppliers, and customers, we may have no right to prevent them from using that trade secret to compete with us. If any of our trade secrets were to be disclosed (whether lawfully or otherwise) to a competitor or other third party, our business, financial condition and results of operations may be adversely affected.

We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees’ former employers.

We may be subject to claims that we or our employees have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of an employee’s former employers. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. A loss

76

Table of Contents

​

of key personnel or their work product could hamper or prevent our ability to commercialize our products, which could severely harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and demands on resources and management’s attention.

Our software contains third-party “open source” software components, and failure to comply with the terms of the underlying open source software licenses could restrict our ability to sell our products or our use of those components give rise to disclosure obligations of proprietary software, which could negatively affect our ability to sell our platform and subject us to possible litigation.

Some aspects of our technology incorporate open source software licensed under so-called “open source,” “free” or other similar licenses, and we intend to continue to use open source software in the future. Open source software is generally freely accessible, usable, and modifiable. However, certain open source licenses may, in certain circumstances, require us to offer our software that incorporates the open source software for no cost, make available source code for modifications or derivative works we create based upon the open source software, incorporate or use the open source software, and/or license such modifications or derivative works under the terms of the particular open source license or otherwise unfavorable terms. The terms of certain open source licenses to which we are subject have not been interpreted by U.S. or foreign courts, and there is a risk that open source software licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to monetize our software or enforce our intellectual property rights. While we try to insulate our proprietary code from the effects of such open source license provisions, we cannot guarantee that we will be successful, that all open source software is reviewed prior to use in our software, that our developers have not incorporated open source software into our software in potentially problematic ways, or that they will not do so in the future. Additionally, we may from time to time face claims from third parties claiming ownership of, or demanding release of, the open source software or derivative works that we developed using such software, which could include our proprietary source code, or otherwise seeking to enforce the terms of the applicable open source software license. These claims could result in costly litigation and could require us to make our software source code freely available, purchase a costly license, or cease offering the implicated software unless and until we can re-engineer them to avoid infringement or violation. This re-engineering process could require significant additional research and development resources, and we may not be able to complete it successfully. We could also be subject to suits by parties claiming ownership of what we believe to be open source software. In addition to risks related to license requirements, use of certain open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or controls on the origin of software and, thus, may contain security vulnerabilities or broken code. Moreover, some open-source projects have known security and other vulnerabilities and architectural instabilities, or are otherwise subject to security attacks due to their wide availability, and are provided on an “as-is” basis. There is typically no support available for open source software, and we cannot ensure that the authors of such open source software will implement or push updates to address security risks or will not abandon further development and maintenance. Any of these risks could be difficult to eliminate or manage, and if not addressed, could have a negative effect on our business, operating results, and financial condition.

General Risk Factors

Our business is subject to the risks of earthquakes, fire, floods and other natural catastrophic events, global pandemics, and interruptions by man-made problems, such as terrorism. Material disruptions of our business or information systems resulting from these events could materially and adversely affect our business, financial condition and results of operations.

A significant natural disaster, such as an earthquake, fire, flood, hurricane or significant power outage or other similar events, such as infectious disease outbreaks or pandemic events (such as the outbreak of the COVID - 19 pandemic), could materially and adversely affect our business, financial condition and results of operations. We have several offices located in the San Francisco Bay Area, a region known for seismic activity. In addition, natural disasters, acts of terrorism or war, including the ongoing geopolitical tensions related to Russia’s actions in Ukraine and conflicts in the Middle East, including in Iran, could cause disruptions in our remaining operations, our or our partners’ businesses, our suppliers’ or the economy as a whole. We also rely on information technology systems to communicate among our workforce and with third parties. Any disruption to our communications, whether caused by a natural disaster or by man-made problems, such as power disruptions, could adversely affect our business. To the extent that any such disruptions result in development or commercialization delays or impede our partners’ and suppliers’ ability to timely deliver product components, or the deployment of our products, this could materially and adversely affect our business, financial condition and results of operations.

77

Table of Contents

​

As part of growing our business, we may in the future make acquisitions. If we do not successfully select, execute or integrate our acquisitions, it could materially and adversely affect our business, financial condition and results of operations, and our stock price could decline.

From time to time, we may undertake acquisitions to add new products and technologies, acquire talent, form new strategic partnerships, or enter into new markets or geographies. These transactions may be subject to approval by our stockholders or by relevant government authorities, which could result in increased delay and costs, and may disrupt our business strategy if such approvals are ultimately denied. Acquisitions and the subsequent integration of new assets, businesses, key personnel, partners, customers, vendors and suppliers would likely require significant attention from our management and could result in a diversion of resources from our existing business, which in turn could have an adverse effect on our operations. Acquired assets or businesses may also fail to generate the business or financial results we expect. Key personnel or large numbers of employees who join us through acquisitions may decide to leave to work for other businesses, including our competitors, thereby diminishing the value of our acquisitions. Acquisitions may also entail significant cash expenditures, dilutive issuances of equity securities, the incurrence of significant indebtedness, potential impairments of goodwill, amortization expenses for other intangible assets and exposure to unknown liabilities of acquired businesses. The professional services and other transactional costs associated with selecting, executing and integrating acquisitions may also be significant. Any failure to successfully identify, complete, manage and integrate acquisitions could materially and adversely affect our business, prospects, financial condition and results of operations, and could cause our stock price to decline.

Adverse economic conditions or reduced global trade, including as a result of recent and further changes in the tariff and trade policies, may adversely impact our business.

Our operations, performance and growth depend in part on worldwide economic conditions and the impact these conditions have on levels of activity in global trade and ground transportation. The United States and the global economy have in the past few years experienced high levels of inflation. While inflation rates have recently moderated, the existence of inflation in the U.S. and global economy and the pricing pressure created by rising inflation in prior periods has resulted, and may continue to result, in high interest rates and capital costs, shipping costs, supply shortages, increased costs of labor, weakening exchange rates and other similar effects. Elevated inflation rates can affect our expenses, especially employee compensation. In addition, rising interest rates could adversely affect the value of our investments and cash on hand and increase our borrowing costs. Governments have implemented and are implementing fiscal policy interventions in response to high levels of inflation, including raising interest rates or keeping them at elevated levels. These interventions may also reduce economic growth rates, create recessions and increase unemployment rates.

In addition, we may be affected by changes in trade policies, treaties, government regulations, and tariffs, as well as geopolitical volatility. For example, uncertainty as to the level and impact of the imposition of existing, new or threatened tariffs on certain countries by the current U.S. presidential administration, as well as any existing or potential further retaliatory measures by impacted trade partners, could adversely impact trade relations, reduce global trade and create general market instability. Trade protection measures, retaliatory actions, tariffs and increased barriers, policies favoring domestic industries, or increased import or export licensing requirements or restrictions could have a negative effect on the overall macro economy and the ground transportation industry in particular.

The impact of economic conditions, including the ongoing effects of inflation, high interest rates, trade policy, and regional or global recessions could materially and adversely affect our business, results of operations and financial condition in a number of ways, including by reducing the demand for ground transportation or delaying or reducing customers’ level of investment in the adoption of autonomous trucks.

Risks Related to Our Organizational Structure Following the Business Combination

We have incurred and will continue to incur significant expenses and administrative burdens as a public company, which may adversely affect our business, prospects, financial condition, and results of operations.

We will face increased legal, accounting, administrative and other costs and expenses as a public company that we did not incur as a private company. The Exchange Act, Sarbanes-Oxley Act, including the requirements of Section 404, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, as well as the Public Company Accounting Oversight Board and the stock exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements will increase costs and make certain activities more time-consuming. A number of those requirements require us to carry out activities we have not done previously. For example, we will create new board committees and adopt new internal controls and disclosure controls

78

Table of Contents

​

and procedures. In addition, expenses associated with SEC reporting requirements will be incurred. Furthermore, if any issues in complying with those requirements are identified, we may incur additional costs rectifying those issues, and the existence of those issues may adversely affect our reputation or investor perceptions of it. For example, in connection with the audit of our consolidated financial statements, our management and independent registered accounting firms identified material weaknesses related to our internal control over financial reporting. In addition, we will obtain director and officer liability insurance. Risks associated with our status as a public company may make it more difficult to attract and retain qualified persons to serve on our Board or as executive officers. The additional reporting and other obligations imposed by these rules and regulations increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. To the extent necessary to supplement our internal personnel with professional advisors, such costs may be significantly increased. These increased costs will require us to divert a significant amount of money that may otherwise be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, resulting in further increased costs.

If we are unable to develop and maintain an effective systems of internal control over financial reporting and disclosure controls, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business, financial condition and results of operations.

As a public company, we will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, and the listing standards. Among other things, the Sarbanes-Oxley Act and related Exchange Act rules require that we maintain effective disclosure controls and procedures and internal control over financial reporting. Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls. In addition, we will be required to have our independent public accounting firm attest to and report on our internal control over financial reporting when we cease qualifying as an “emerging growth company” pursuant to the JOBS Act.

In connection with the preparation and audits of our consolidated financial statements, we and our independent registered public accounting firms identified material weaknesses in internal control over financial reporting. We have begun taking steps and plan to take additional steps to remediate the underlying causes of the material weaknesses. The measures we have taken to date, and the controls we continue to design and implement, may not be sufficient to remediate the material weaknesses we have identified or avoid potential additional material weaknesses in our internal control over financial reporting in the future. If in future periods we determine that these material weaknesses have not been remediated or we identify other material weaknesses in internal control over financial reporting, we will be unable to assert that our internal control over financial reporting is effective, which could result in the loss of investor confidence and a decline in the market price of our SPAC Class A Common Stock.

We are also continuing to develop and refine our disclosure controls and other procedures that are designed to assure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. We have expended, and anticipate that we will continue to expend, significant resources to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting.

Our current controls and any new controls that we develop may become inadequate because of changes in the conditions in our business. Further, weaknesses in our disclosure controls or our internal control over financial reporting may not be remediated in a timely manner or additional weaknesses may be discovered in the future. Any failure to remediate such weaknesses or to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, may harm our results of operations or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal control over financial reporting may also adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we will eventually be required to include in our periodic reports that will be filed with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting may also cause investors to lose confidence in our reported financial and other information, which would likely adversely affect the market price of our securities. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on a stock exchange.

Any failure to maintain effective disclosure controls and internal control over financial reporting may adversely affect our business, financial condition, and results of operations and may cause a decline in the market price of our securities.

79

Table of Contents

​

The Proposed Bylaws will designate a state or federal court located within the State of Delaware as the exclusive forum for certain types of actions and proceedings, and the federal district courts as the exclusive forum for Securities Act claims, which could limit stockholders’ ability to choose the judicial forum for disputes with the Domesticated SPAC or its directors, officers, stockholders or employees.

The Proposed Bylaws will provide that, unless the Domesticated SPAC consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the U.S. District Court for the District of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for:

●any derivative action, suit or proceeding brought on behalf of the Domesticated SPAC;
●any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any director, stockholder, officer or other employee of the Domesticated SPAC to the Domesticated SPAC or its stockholders;
●any action, suit or proceeding arising pursuant to any provision of the DGCL, the Proposed Certificate of Incorporation or the Proposed Bylaws (as either may be amended from time to time); or
●any action, suit or proceeding asserting a claim governed by the internal affairs doctrine.

Nothing in the Proposed Bylaws will preclude stockholders that assert claims under the Exchange Act from bringing such claims in federal court, subject to applicable law. The Proposed Bylaws will also provide that, to the fullest extent permitted by law, the federal district courts of the United States will be the sole and exclusive forum for the resolutions of any complaint asserting a cause or causes of action arising under the Securities Act.

Any person or entity purchasing, holding or otherwise acquiring any interest in any of the securities of the Domesticated SPAC will be deemed to have notice of and consented to the provisions of the Proposed Bylaws described in the preceding paragraphs. These exclusive-forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with the Domesticated SPAC or its directors, officers, stockholder or other employees, which may discourage lawsuits against the Domesticated SPAC and its directors, officers, stockholders and other employees. The enforceability of similar exclusive-forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with one or more actions or proceedings described above, a court could rule that this provision in the Proposed Bylaws is inapplicable or unenforceable. We also note that stockholders cannot waive compliance (or consent to noncompliance) with the federal securities laws and the rules and regulations thereunder. If a court were to find these exclusive-forum provisions to be inapplicable or unenforceable in an action, the Domesticated SPAC may incur additional costs associated with resolving the dispute in other jurisdictions, which could harm its results of operations.

Our business and operations could be negatively affected if we become subject to any securities litigation or stockholder activism, which could cause us to incur significant expense, hinder execution of business and growth strategy and impact our stock price.

In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Stockholder activism, which could take many forms or arise in a variety of situations, has been increasing recently. Volatility in the stock price of the SPAC Class A Common Stock or other reasons may in the future cause it to become the target of securities litigation or stockholder activism. Securities litigation and stockholder activism, including potential proxy contests, could result in substantial costs and divert management’s and the Board’s attention and resources from our business, which may adversely affect our business, financial condition and results of operations. Additionally, such securities litigation and stockholder activism could give rise to perceived uncertainties as to our future, adversely affect our relationships with service providers and make it more difficult to attract and retain qualified personnel. We may also be required to incur significant legal fees and other expenses related to any securities litigation and activist stockholder matters.

Further, our stock price could be subject to significant fluctuation or otherwise be adversely affected by the events, risks and uncertainties of any securities litigation and stockholder activism.

80

Table of Contents

​

Securities of companies formed through mergers such as the Business Combination may experience a material decline in price relative to the share price of the Public Shares prior to the Business Combination.

As with most initial public offerings of SPACs in recent years, the Company issued Public Shares as part of the Public Units for $10.00 per unit upon the closing of the Initial Public Offering. As with other SPACs, the $10.00 per unit price of the Public Units reflected each share having a right to redeem such share for a pro rata portion of the proceeds held in the Trust Account prior to the Closing and certain other events. Following the Initial Public Offering, the proceeds held in the Trust Account were initially equal to $10.05 per Public Share. As of October 31, 2026, amounts held in the Trust Account related to redeemable shares was equal to approximately $10.68364 per share. Following the Closing, the shares outstanding will no longer have any such redemption right and will be solely dependent upon the fundamental value of the combined company, which, like the securities of other companies formed through SPAC mergers in recent years, may be significantly less than both the redemption price and the amount per share initially held in the Trust Account upon consummation of the Initial Public Offering.

Following the Closing, the multi-class structure of common stock of the Domesticated SPAC will have the effect of concentrating voting control with the holders of Class B common stock of the Domesticated SPAC. This ownership will limit or preclude your ability to influence corporate matters.

Following the Closing, Class B common stock of the Domesticated SPAC will have 20 votes per share, SPAC Class A Common Stock will have one vote per share, and Class C common stock of the Domesticated SPAC will have one fourth of one vote per share. Entities affiliated with David Liu and Hao Zheng, our Chief Executive Officer and Chief Technology Officer, respectively, will be the sole holders of the Class B common stock of the Domesticated SPAC. Following the Closing, Messrs. Liu and Zheng, together with their affiliates, will hold in the aggregate 82.1% of the voting power of our capital stock [(assuming no additional redemptions of Public Shares)] and 83.0% of the voting power of our capital stock [(assuming maximum redemptions of Public Shares)] and will be able to control all matters submitted to our stockholders for approval. This concentrated control will limit or preclude the ability of holders of SPAC Class A Common Stock to influence corporate matters for the foreseeable future, including the election of directors, amendments of our organizational documents, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate transaction requiring stockholder approval. In addition, this may prevent or discourage unsolicited acquisition proposals or offers for our capital stock that holders of SPAC Class A Common Stock may feel are in their best interest as one group of our stockholders.

Future transfers by holders of shares of Class B common stock of the Domesticated SPAC will generally result in those shares converting to SPAC Class A Common Stock, except for certain transfers permitted by the Proposed Certificate of Incorporation, including transfers for tax and estate planning purposes so long as the transferring holder of Class B common stock of the Domesticated SPAC continues to hold exclusive voting and dispositive power with respect to the shares transferred or shares voting and dispositive power with respect to such shares only with certain family members or professional service providers. Further, all shares of Class B common stock of the Domesticated SPAC will be converted into shares of SPAC Class A Common Stock following the earliest to occur of certain events as described in the Proposed Certificate of Incorporation.

We cannot predict the effect our multi-class structure may have on the trading price of SPAC Class A Common Stock.

We cannot predict whether our multi-class structure will result in a lower or more volatile trading price of SPAC Class A Common Stock, adverse publicity, or other adverse consequences. For example, certain index providers have announced restrictions affecting companies with multiple-class share structures in certain of their indices. In July 2017, FTSE Russell announced that it would require new constituents of its indices to have greater than 5% of a company’s voting rights in the hands of Public Shareholders. Under this policy, the multi-class structure of our common stock could make us ineligible for inclusion in certain indices and, as a result, mutual funds, exchange-traded funds, and other investment vehicles that attempt to passively track those indices would not invest in SPAC Class A Common Stock. Because of the multi-class structure of our common stock, we may be excluded from certain indices, and other stock indices may take similar actions. Given the sustained flow of investment funds into passive strategies that seek to track certain indices, exclusion from certain stock indices could preclude investment by many of these funds and could make the SPAC Class A Common Stock less attractive to other investors. As a result, the trading price of the SPAC Class A Common Stock could be adversely affected.

81

Table of Contents

​

Provisions contained in the Proposed Certificate of Incorporation, the Proposed Bylaws and Delaware law could prevent a takeover that stockholders consider favorable and could also reduce the market price of our stock.

The Proposed Certificate of Incorporation, the Proposed Bylaws and Delaware law contain provisions that could delay or prevent a change in control of the Domesticated SPAC. These provisions could also make it more difficult for stockholders to elect directors and take other corporate actions. These include:

●providing that our Board will be classified into three classes of directors with staggered three-year terms;
●allowing stockholders to remove directors only for cause;
●providing that authorized number of directors may be fixed only by resolution of our Board acting pursuant to a resolution adopted by a majority of the total number of authorized directorships (regardless of vacancies or unfilled seats, the “Whole Board”);
●providing that vacancies on our Board of Directors may be filled only by a majority of directors then in office, even though less than a quorum;
●authorizing the Board of Directors to adopt or amend bylaws;
●prohibiting cumulative voting in the election of directors;
●eliminating stockholders’ ability to act via written consent;
●providing that a special meeting of stockholders may only be called by the Chairperson, Chief Executive Officer, President or the Board of Directors acting pursuant to a resolution of the Whole Board;
●requiring advance notification of stockholder nominations and proposals;
●limiting the liability of, and providing for the indemnification of, our directors;
●requiring the consent of the Board of Directors acting pursuant to a resolution of the Whole Board and the affirmative vote of 66 2/3% of the voting power of the then outstanding voting securities to amend or repeal certain of the foregoing provisions; and
●authorizing our Board of Directors to issue preferred stock with voting or other rights or preferences that could discourage a takeover attempt or delay changes in control.

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board of Directors, which is responsible for appointing the members of our management. In addition, the provisions of Section 203 of the DGCL govern the Domesticated SPAC. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with the Domesticated SPAC for a certain period of time without the consent of its Board of Directors unless certain provisions are met.

These and other provisions in the Proposed Certificate of Incorporation and Proposed Bylaws and under Delaware law could discourage potential takeover attempts, reduce the price investors might be willing to pay in the future for shares of the common stock of the Domesticated SPAC and result in the market price of our common stock being lower than it would be without these provisions.

Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.

The Proposed Certificate of Incorporation and Proposed Bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law.

82

Table of Contents

​

In addition, as permitted by Section 145 of the DGCL, the Proposed Bylaws and our indemnification agreements that we entered into with our directors and officers provide that:

●we will indemnify our directors and officers for serving in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful;
●we may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law;
●we will be required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification;
●we will not be obligated pursuant to the Proposed Bylaws to indemnify a person with respect to proceedings initiated by that person against the Domesticated SPAC or our other indemnitees, except with respect to proceedings authorized by our Board of Directors or brought to enforce a right to indemnification;
●the rights conferred in the Proposed Bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons; and
●we may not retroactively amend the Proposed Bylaws provisions to reduce our indemnification obligations to directors, officers, employees and agents.

We do not intend to pay dividends for the foreseeable future.

We have never declared or paid any cash dividends on our capital stock and do not intend to pay any cash dividends in the foreseeable future. We expect to retain future earnings, if any, to fund the development and growth of our business. Any future determination to pay dividends on our capital stock will be at the discretion of our Board of Directors. Accordingly, investors must rely on sales of the common stock of the Domesticated SPAC after price appreciation, which may never occur, as the only way to realize any future gains on their investments.

The market price and trading volume of the common stock of the Domesticated SPAC may be volatile and materially and adversely affected by several factors.

Even if an active, liquid and orderly trading market develops and is sustained for the common stock of the Domesticated SPAC, the market price of our common stock may be volatile and may decline significantly. In addition, the trading volume in our common stock may fluctuate and cause significant price variations to occur. If the market price of our common stock declines significantly, you may be unable to resell your shares at an attractive price, or at all. The market price and trading volume of our common stock could fluctuate significantly in response to various factors and events, including the realization of any of the risk factors presented in the Registration Statement.

Such market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance. Securities markets, including Nasdaq, on which we plan to list our common stock, have from time to time experienced significant price and volume fluctuations that are unrelated to the performance of particular companies.

We may be subject to securities litigation, which is expensive and could divert management’s attention.

The market price of the common stock of the Domesticated SPAC may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm our business.

83

Table of Contents

​

Future resales of common stock may cause the market price of our securities to drop significantly, even if our business is doing well.

Sales of a substantial number of shares of SPAC Class A Common Stock in the public market could occur. Following the Closing, we will have 47,570,410 shares of SPAC Class A Common Stock, 14,132,900 shares of Class B common stock of the Domesticated SPAC and 14,421,789 shares of Class C common stock of the Domesticated SPAC outstanding that were issued in the Business Combination to the PlusAI stockholders. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of SPAC Class A Common Stock in the public market, the market price of our stock could decline significantly.

Following the Closing, the Sponsor, the Insiders and former securityholders of PlusAI will be subject to certain transfer restrictions with respect to their shares of the Domesticated SPAC as follows: (1) as to 50% of such holder’s shares upon the earlier of 180 days after the Closing and the date on which the volume-weighted average price of the SPAC Class A Common Stock equals or exceeds $12.50 per share during any 20 trading days within any 180 consecutive trading day period following the Closing, and (2) other than Earnout Shares and shares held by PlusAI’s founders, with respect to all of a holder’s shares upon the date on which the volume-weighted average price of the SPAC Class A Common Stock equals or exceeds $15.00 per share during any 20 trading days within any 180 consecutive trading day period following the Closing. Furthermore, the Sponsor is not subject to certain other transfer restrictions as described in the amended and restated registration rights agreement to be entered into at the Closing, and, with respect to all shares of SPAC Class A Common Stock into which the Class B Ordinary Shares convert upon the Domestication, the transfer restrictions will terminate 120 days after the Closing. In addition, pursuant to side letters entered into with certain investors in the Convertible Notes and the PIPE Investment, such investors have been granted modified lock-up terms that may result in the early release of their shares relative to the lock-up period described above.

Once such securities are released from lock-up restrictions, the applicable stockholders will not be restricted from selling shares of the common stock of the Domesticated SPAC held by them, other than by applicable securities laws. Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock.

As restrictions on resale end, the sale or possibility of sale of these shares could have the effect of increasing the volatility in our share price or the market price of our common stock could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them.

Moreover, following the Closing, the amended and restated registration rights agreement to be entered into at the Closing will obligate us to file one or more registration statements with the SEC for the registration for resale of certain securities held by the Sponsor and certain of our significant stockholders. If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of the SPAC Class A Common Stock could decline.

Future issuances of debt securities and equity or equity-linked securities may adversely affect the market price of the SPAC Class A Common Stock and may be dilutive to existing stockholders.

In the future, we may incur debt or issue equity ranking senior to the SPAC Class A Common Stock. Those securities will generally have priority upon liquidation. Such securities also may be governed by an indenture or other instrument containing covenants restricting its operating flexibility. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of the SPAC Class A Common Stock. Because our decision to issue debt or equity in the future will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts. As a result, future capital raising efforts may reduce the market price of the SPAC Class A Common Stock and be dilutive to existing stockholders.

Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities.

If we fail to satisfy the continued listing requirements of Nasdaq, such as Nasdaq’s requirements with respect to corporate governance or the minimum closing bid price, Nasdaq may take steps to delist our securities. Such a delisting would likely have a negative effect on the price of the securities and would impair your ability to sell or purchase the securities when you wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our securities from dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq’s listing requirements. Additionally, if our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price

84

Table of Contents

​

of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

Macroeconomic Risks Relating to Our Business

Uncertain global macroeconomic and political conditions could materially adversely affect our business prospects, financial condition, results of operations and cash flows.

Our results of operations could be materially affected by economic and political conditions in the United States and internationally, including inflation, deflation, interest rates, availability of capital, energy and commodity prices, trade laws and the effects of governmental initiatives to manage economic conditions. Potential customers may delay or decrease spending as their business and budgets are impacted by economic conditions. The inability of potential customers to pay us for our services may adversely affect our earnings and cash flows.

Further, the ongoing military conflict in Ukraine and the resulting sanctions and related countermeasures by North Atlantic Treaty Organization (“NATO”) states, the United States and other countries, as well as ongoing conflicts in the Middle East, including in Iran, have led to, and are likely to lead to additional, market disruptions, including significant volatility in commodity prices, energy prices, credit and capital markets, as well as supply chain interruptions for equipment, which could have an adverse impact on our operations and financial performance. Global supply chain disruptions have increasingly affected both the availability and cost of materials, component manufacturing and deliveries. Disruptions such as military conflicts, sanctions, and other countermeasures between nations, as well as any escalation in tension between nations, may result in delays in equipment deliveries and cost escalations that could adversely affect our business prospects, financial condition, results of operations and cash flows.

Our deployment cost estimates are highly sensitive to a range of economic factors, and our ability to control or manage our costs may be limited.

Capital and operating costs for the deployment of autonomous vehicles, are difficult to project, inherently variable and are subject to significant change based on a variety of factors including regulatory oversight, operating agreements, supply chain availability, inflation and other factors. Opportunities for cost reductions in deployment and fleet operation are similarly uncertain. While we believe our cost estimates are reasonable, they may increase significantly through design maturity, when accounting for supply chain availability, fabrication costs of autonomous trucking fleets, as we progress through the regulatory process with our OEM partners, or as a result of other factors. To the extent cost reductions in the operation of autonomous trucking fleets utilizing our software are not achieved within the expected timeframe or magnitude, our products, may not be cost competitive with alternative technologies, which may have a material adverse effect on our business prospects, financial condition, results of operations and cash flows and could harm our reputation.

The occurrence of adverse events, cancellations of significant projects, delays in project timelines, adjustments in cost structures, and other negative developments announced by competitors could have an impact on our operations, financial performance, and future prospects.

The occurrence of newsworthy events in the autonomous vehicle industry as a whole, including, but not limited to, the delay of key business milestones, inflated cost adjustments, fluctuations in product pricing strategies, cancellations of public offerings, customer withdrawals, or disruptions in supply chain may adversely affect our business in several ways, including:

●Negative news or events associated with industry peers may lead to decreased investor confidence in the sector, which could impact the broader stock market performance of companies operating within the industry, including PlusAI. This could result in fluctuations or declines in our stock price irrespective of our internal performance.
●Adverse events involving our competitors may alter the competitive landscape, affecting market share dynamics, pricing strategies, and overall positioning within in the industry. This could impact our ability to retain or expand our market presence.
●Changes in market dynamics influenced by competitors’ actions, such as inflated cost adjustments or potential cancellations, could have ripple effects on our financial stability and profitability, influencing our financial metrics and potentially impacting investor perceptions.

85

Table of Contents

​

While we implement risk mitigation strategies and highlight our unique business approach and how it differentiates us from our competitors, there is no guarantee that we will be insulated from the adverse effects of such events and the occurrence of any of these events could negatively impact our business operations and financial condition.

Risks Relating to Compliance with Law, Government Regulation and Litigation

Our operations and business plans could be significantly impacted by changes in federal, state, and local government policies and priorities.

The current environment of bipartisan political support of autonomous vehicles at the U.S. federal level could change. Changes in support, in policies, or in priorities by the legislative or executive branch could have impacts on the leadership at the U.S. Department of Transportation or any other federal agency which affects policy related to autonomous driving. Each of these agencies themselves may experience changes in policies and priorities which impact our operations and business plans. Federal, state, and local policies and priorities could affect regulatory oversight, supply chain availability, tax and other financial incentives or costs, availability of financing, labor force initiatives or restrictions, and many other possible areas.

Additionally, changes in federal, state, or local government policies and priorities can impact our operations. These could include changes in interpretations of regulatory requirements, increased inspection or enforcement activities, changes in budgetary priorities, changes in tax laws and regulations and other government actions or inaction. Any of these local, state, and federal agencies may have the authority to impose civil penalties and additional requirements, which could adversely affect our results of operations.

We may become involved in litigation that may materially adversely affect us.

From time to time, we may become involved in various legal proceedings relating to matters incidental to the ordinary course of our business, including intellectual property, commercial, product liability, employment, class action, whistleblower and other litigation and claims, and governmental and other regulatory investigations and proceedings. Such matters can be time-consuming, divert management’s attention and resources from the operation of our business and cause us to incur significant expenses or liability or require us to change our business practices. Because of the potential risks, expenses, and uncertainties of litigation, from time to time, we may settle disputes, even where we believe that we have meritorious claims or defenses. Because litigation is inherently unpredictable, we cannot assure you that the results of any of these actions will not have a material adverse effect on our business.

Our failure to timely and effectively implement controls and procedures required by Section 404(a) of the Sarbanes- Oxley Act that will be applicable to us after the Business Combination is consummated could negatively impact our business.

We are not currently subject to Section 404 of the Sarbanes-Oxley Act. However, following the consummation of the Business Combination, we will be required to provide management’s attestation on internal controls. The standards required for a public company under Section 404(a) of the Sarbanes-Oxley Act are significantly more stringent than those required of us as a privately held company. Management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory compliance and reporting requirements that will be applicable after the Business Combination. If our management is unable to conclude that we have effective internal control over financial reporting, or to certify the effectiveness of such controls, and our independent registered public accounting firm cannot render an unqualified opinion on management’s assessment and the effectiveness of our internal control over financial reporting at such time as it is required to do so, and material weaknesses in our internal control over financial reporting are identified, we could be subject to regulatory scrutiny, a loss of public and investor confidence, and to litigation from investors and stockholders, which could have a material adverse effect on our business and our stock price. In addition, if we do not maintain adequate financial and management personnel, processes, and controls, we may not be able to manage our business effectively or accurately report our financial performance on a timely basis, which could cause a decline in the common stock of the Domesticated SPAC price and adversely affect our business, financial condition, and results of operations. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, the exchange upon which our securities are listed or other regulatory authorities, which would require additional financial and management resources.

Changes in tax laws could adversely affect our business prospects and financial results.

We are subject to income and other taxes in the United States and other jurisdictions, each of which has its own rules. Our current and future effective tax rates may be subject to volatility or adversely affected by a number of factors, including changes in the valuation of our deferred tax assets and liabilities; expected timing and amount of the release of any tax valuation allowances; tax effects of stock-based compensation; changes in tax laws, regulations or interpretations thereof; or lower than anticipated future earnings in jurisdictions

86

Table of Contents

​

where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates.

In addition, we may be subject to audits of our income, sales and other transaction taxes by taxing authorities. Outcomes from these audits may adversely affect our business, financial condition, and results of operations.

Our current and future effective tax rates may be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities and changes in tax laws or their interpretation. In addition, we may be subject to tax audits by various tax jurisdictions. Although we believe our tax liabilities are reasonably estimated and accounted for in accordance with applicable laws and principles, an adverse resolution by one or more taxing authorities may have a material impact on the results of our operations.

Risks Relating to Being a Public Reporting Company

Our financial results may vary significantly from quarter to quarter.

Following the Business Combination, we will be required to comply with the periodic reporting obligations of the Exchange Act, Sarbanes-Oxley and other applicable securities rules and regulations, including the preparation of annual reports, quarterly reports, and current reports. We expect our revenue and operating results to vary materially from quarter to quarter. We may incur significant operating expenses during the start-up and early stages of large contracts and may not be able to recognize corresponding revenue in that same quarter. We may also incur additional expenses when contracts are terminated or expire and are not renewed. We may also incur additional expenses when customers are newly acquired. Additionally, payments due to us from our customers may be delayed for a variety of reasons, and these delays could cause significant fluctuations from quarter to quarter.

Additional factors that may cause our financial results to fluctuate from quarter to quarter include those addressed elsewhere in this “Risk Factors” section and the following factors, among others:

●the terms of customer contracts that affect the timing of revenue recognition;
●variability in demand for our services and solutions;
●commencement, completion, or termination of contracts during any particular quarter;
●timing of shipments and product deliveries;
●timing of award or performance incentive fee notices;
●timing of significant bid and proposal costs;
●the costs of remediating unknown defects, errors, or performance problems of our product offerings;
●variable purchasing patterns under blanket purchase agreements and other indefinite delivery/ indefinite quantity contracts;
●costs related to government inquiries;
●strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs and joint ventures;
●strategic investments or changes in business strategy;
●changes in the extent to which we use subcontractors;
●seasonal fluctuations in our staff utilization rates;

87

Table of Contents

​

●changes in our effective tax rate, including changes in our judgment as to the necessity of the valuation allowance recorded against our deferred tax assets; and
●the length of sales cycles.

Significant fluctuations in our operating results for a particular quarter could cause us to fall out of compliance with the financial covenants related to our debt, which if not waived, could restrict our access to capital and cause us to take extreme measures to pay down the debt, if any.

Following the Business Combination, we expect to be an emerging growth company within the meaning of the Securities Act and a smaller reporting company within the meaning of the Exchange Act, and if we take advantage of certain exemptions from disclosure requirements available to “emerging growth companies” or “smaller reporting companies,” this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

Following the Business Combination, we expect to be an emerging growth company within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from say-on-pay, say- on-frequency and say-on-golden parachute voting requirements. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year: (a) following April 23, 2030 the fifth anniversary of the Initial Public Offering; (b) in which we have total annual gross revenue of at least $1,235,000,000; or (c) in which we are deemed to be a large accelerated filer, which means the market value of the shares of SPAC Class A Common Stock that are held by non-affiliates exceeds $700,000,000 as of the last business day of our prior second fiscal quarter, and (2) the date on which we have issued more than $1,000,000,000 in non- convertible debt securities during the prior three-year period.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We intend to take advantage of the benefits of this extended transition period. This may make comparison of our financial statements with those of public companies that comply with public company effective dates difficult or impossible because of the potential differences in accounting standards used.

Even after the Domesticated SPAC no longer qualifies as an emerging growth company, it may still qualify as a “smaller reporting company,” which would allow it to continue to take advantage of many of the same exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements. Moreover, smaller reporting companies may choose to present only the two most recent fiscal years of audited financial statements in their Annual Reports on Form 10 - K. For so long as we are a smaller reporting company and not classified as an “accelerated filer” or “large accelerated filer” pursuant to SEC rules, we will be exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act.

We cannot predict whether investors will find our securities less attractive because we rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

88

Table of Contents

​

Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of the common stock of the Domesticated SPAC.

Securities research analysts may establish and publish their own periodic projections for us or our industry. These projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline. Moreover, if no analysts commence coverage of us, or if analysts provide more favorable relative recommendations or reports about our competitors, the market price and volume for our common shares could be adversely affected.

Market values of growth-oriented companies like ours, particularly companies that entered into business combination agreements with SPACs, have been affected by adverse economic and market forces which may induce downward pressure on the price and trading volume of the common stock of the Domesticated SPAC.

In recent years, there have been fluctuations in the valuation of growth-oriented companies, particularly those that entered into business combination agreements with SPACs. Inflationary pressures, increases in interest rates and other adverse economic and market forces have contributed to these drops in market value. As a result, our securities are subject to potential downward pressures, which may result in high redemptions of the cash available from the Trust Account. If there are substantial redemptions, there will be a lower float of our common stock outstanding, which may cause further volatility in the price of our securities and adversely impact our ability to secure financing following the Closing.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

Other than the issuance of the Working Capital Note described below, there were no sales of unregistered securities during the quarterly period covered by the Report.

As disclosed in Items 1.01, 2.03 and 3.02 of our Current Report on Form 8-K filed with the SEC on October 8, 2026, on September 30, 2026, we issued the Working Capital Note in the aggregate principal amount of $250,000 to the New Sponsor. Pursuant to the terms of the Working Capital Note, the principal balance shall not accrue interest; shall be payable by us on the earlier of the date on which we consummate our initial Business Combination or the date that our winding up is effective; and is convertible at the New Sponsor’s election upon the consummation of our initial Business Combination. Should the New Sponsor elect to convert all or a portion of the principal balance, the elected principal balance amount will convert, at a price of $10.00 per unit, into New Units, rounded down to the nearest whole number, with each New Unit consisting of the same securities as those contained in the units issued in connection with our Initial Public Offering. The Working Capital Note was convertible into a maximum of 25,000 New Units. We relied upon Section 4(a)(2) of the Securities Act in connection with the issuance of the Working Capital Note.

Subsequent to the quarterly period covered by the Report, as disclosed in Items 1.01, 2.03 and 3.02 of our Current Report on Form 8-K filed with the SEC on November 10, 2026, on November 8, 2026, the New Sponsor agreed to loan us up to an additional $500,000 for working capital purposes and, in order to document such additional loan, we issued the A&R Working Capital Note to the New Sponsor in the aggregate principal amount of up to $750,000, which amends, restates, supersedes and replaces the Working Capital Note in its entirety. The A&R Working Capital Note has the same interest, maturity and conversion terms as the Working Capital Note and is convertible into a maximum of 75,000 New Units. We relied upon Section 4(a)(2) of the Securities Act in connection with the issuance of the A&R Working Capital Note. In addition, simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 7,568,750 Private Placement Warrants to the Prior Sponsor, Cohen & Company and Clear Street in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $7,568,750. Of those 7,568,750 Private Placement Warrants, the Prior Sponsor purchased 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants) and Cohen & Company and Clear Street purchased an aggregate of 2,868,750 Private Placement Warrants. The Private Placement Warrants (and underlying securities) are identical to the Public Warrants, except that, so long as they are held by our Sponsor or its permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial Business Combination, (ii) will be entitled to registration rights and (iii) with respect to Private Placement Warrants held by Cohen & Company and/or its designees, will not be exercisable more than five years from the commencement of sales in the IPO in accordance with FINRA Rule 5110(g)(8)(A).

89

Table of Contents

​

If we do not complete our initial Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Use of Proceeds

There have been no offerings of registered securities and therefore no planned use of proceeds from such offerings during the quarterly period covered by the Report. For a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the SEC on June 6, 2025. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

​

90

Table of Contents

​

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Report on Form 10-Q.

Exhibit No.

  ​ ​

Description

2.1

​

Agreement and Plan of Merger and Reorganization, dated as of September 2, 2026, by and among the Company, TVAC Merger Sub I, Inc., TVAC Merger Sub II, LLC and Plus Automation, Inc. (incorporated by reference to Exhibit 2.1 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

3.1*

​

Amended and Restated Memorandum and Articles of Association, as amended.

4.1

​

Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-284793), filed with the SEC on March 18, 2025).

4.2

​

Specimen Class A Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 of Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-284793), filed with the SEC on March 18, 2025).

4.3

​

Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1 (File No. 333-284793)).

4.4

​

Warrant Agreement, dated as of April 22, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K, as filed with the SEC on April 28, 2025).

4.5

​

Amendment No. 1 to the Warrant Agreement, dated December 31, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.5 of the Company’s Annual Report on Form 10-K, as filed with the SEC on April 15, 2026).

10.1

​

Prior Insider Letter Agreement, dated April 22, 2025, by and among the Company, its officers and directors, and TV Partners III, LLC (incorporated by reference to Exhibit 10.5 to Current Report on Form 8-K filed with the SEC on April 28, 2025).

10.2

​

Investment Management Trust Agreement, dated as of April 22, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on April 28, 2025).

10.3

​

Registration Rights Agreement, dated April 22, 2025, by and among the Company and certain security holders (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed with the SEC on April 28, 2025).

10.4

​

Administrative Services Agreement, dated April 22, 2025, by and between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K, as filed with the SEC on April 28, 2025).

10.5

​

Form of Indemnity Agreement (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on January 7, 2026).

10.6

​

Securities Subscription Agreement, dated August 1, 2024, by and between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.9 to Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-284793), filed with the SEC on April 4, 2025).

10.7

​

Private Placement Warrants Purchase Agreement, dated April 22, 2025, between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed with the SEC on April 28, 2025).

10.8

​

Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and among the Company, Cohen & Company Capital Markets and Clear Street LLC (incorporated by reference to Exhibit 10.4 to Current Report on Form 8-K filed with the SEC on April 28, 2025).

10.9

​

Purchase Agreement, dated September 18, 2025, by and among the Company, TV Partners III, LLC, and Yorkville Acquisition Sponsor II, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on September 24, 2025).

10.10

​

New Insider Letter Agreement, dated September 18, 2025, by and among Yorkville Acquisition Sponsor II, LLC, the Insiders and the Company (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K, as filed with the SEC on September 18, 2025).

10.11

​

The September 18, 2025 Joinder to and Amendment of the Registration Rights Agreement dated April 22, 2025, by Yorkville Acquisition Sponsor II, LLC, and acknowledged and accepted by the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K, as filed with the SEC on September 18, 2025).

10.12

​

Working Capital Note, dated September 30, 2026, issued by the Company to Yorkville Acquisition Sponsor II, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on October 8, 2026)

10.13

​

Form of Company Voting and Support Agreement, dated as of September 2, 2026, by and among the Company, Plus Automation, Inc. and the stockholders named therein (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.14

​

Sponsor Support Agreement, dated as of September 2, 2026, by and among the Company, Yorkville Acquisition Sponsor II, LLC, Plus Automation, Inc., Troy Rillo, Mark Angelo, Scott Glabe, Alan Garten and Lawrence Glick (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.15

​

Form of Convertible Note and Warrant Subscription Agreement, dated September 2, 2026, by and among the Company, PlusAI, and the purchasers named therein (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.16

​

Form of PIPE Subscription Agreement, dated as of September 2, 2026, by and among the Company, PlusAI and the purchasers named therein (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.17

​

Amended and Restated Registration Rights Agreement, dated as of September 2, 2026, by and among PlusAI Holdings, Inc. (F/K/A Texas Ventures Acquisition III Corp) and the counterparties named therein (incorporated by reference to Exhibit 10.5 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.18

​

Confirmation of an OTC Equity Prepaid Forward Transaction, dated as of August 27, 2026, by and between the Company and YA II PN, Ltd. (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K, as filed with the SEC on September 3, 2026).

10.19

​

Amendment No. 1 to Investment Management Trust Agreement, dated as of October 19, 2026, by and between the Company and Continental Stock Transfer and Trust Company, as Trustee (incorporated by reference to Exhibit 10.1 of the Company’s 8-K, as filed with the SEC on October 20, 2026).

10.20

​

Non-Convertible Promissory Note, dated October 20, 2026, issues by the Company to Yorkville Acquisition Sponsor II, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on October 21, 2026).

10.21

​

A&R Working Capital Note, dated November 8, 2026, issued by the Company to Yorkville Acquisition Sponsor II, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on November 10, 2026).

31*

 

Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32**

 

Certification of the Principal Executive Officer and the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

Inline XBRL Instance Document.

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

91

Table of Contents

​

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104

 

Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).

* Filed herewith.

** This certification is deemed not filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

​

92

Table of Contents

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

TEXAS VENTURES ACQUISITION III CORP

 

 

 

Date: November 18, 2026

By:

/s/ Troy Rillo

 

Name:

Troy Rillo

 

Title:

Chief Executive Officer & Chief Financial Officer

 

 

(Principal Executive Officer and Principal Financial and Accounting Officer)

​

93

Keep reading